Original Article
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
N Engl J Med 2000; 343:78-85July 13, 2000
- Abstract
Background
The contribution of hereditary factors to the causation of sporadic cancer is unclear. Studies of twins make it possible to estimate the overall contribution of inherited genes to the development of malignant diseases.
Methods
We combined data on 44,788 pairs of twins listed in the Swedish, Danish, and Finnish twin registries in order to assess the risks of cancer at 28 anatomical sites for the twins of persons with cancer. Statistical modeling was used to estimate the relative importance of heritable and environmental factors in causing cancer at 11 of those sites.
Results
At least one cancer occurred in 10,803 persons among 9512 pairs of twins. An increased risk was found among the twins of affected persons for stomach, colorectal, lung, breast, and prostate cancer. Statistically significant effects of heritable factors were observed for prostate cancer (42 percent of the risk may be explained by heritable factors; 95 percent confidence interval, 29 to 50 percent), colorectal cancer (35 percent; 95 percent confidence interval, 10 to 48 percent), and breast cancer (27 percent; 95 percent confidence interval, 4 to 41 percent).
Conclusions
Inherited genetic factors make a minor contribution to susceptibility to most types of neoplasms. This finding indicates that the environment has the principal role in causing sporadic cancer. The relatively large effect of heritability in cancer at a few sites (such as prostate and colorectal cancer) suggests major gaps in our knowledge of the genetics of cancer.
Media in This Article
Table 1
Effects Estimated in the Quantitative Genetic Analyses.Table 2
Types of Cancers Included in the Study and Concordance According to Sex and Zygosity in 44,788 Pairs of Twins from Sweden, Denmark, and Finland.Article Activity
- Article
Except for certain types of familial cancer, such as adenomatous polyposis coli, the contribution of hereditary factors to the development of cancer is thought to be relatively minor.1-3 This premise, however, applies mainly to dominant genes, which have been assessed in family studies that cover two or more generations. By contrast, the contributions of recessive traits and combinations of genes to the causation of sporadic cancer are difficult to determine from family studies.4 Consequently, the risks associated with single-gene mutations with low penetrance, recessive genes, and oncogenic mechanisms that involve multiple genes are poorly understood.
Family studies of breast, prostate, ovarian, and uterine cancer can estimate risks for siblings and parent–offspring pairs5-12 but cannot distinguish between genetic and nongenetic (environmental or infectious) causes of familial aggregations of cancer. By contrast, comparisons of the concordance of cancer between monozygotic and dizygotic pairs of twins provide information on whether the familial pattern is due to hereditary or environmental influences.13
If studies of groups of twins show that concordance for cancer is higher among monozygotic twins (who share all genes) than among dizygotic twins (who, on average, share 50 percent of their segregating genes), genetic effects are likely to be important. If, however, the concordance is similar for both types of twins, then shared environmental effects are probably important. Furthermore, the use of statistical models to analyze data from large samples of twins makes it possible to estimate the magnitude of the genetic and environmental effects on susceptibility to sporadic cancer.
For these reasons, studies of twins can not only point to hereditary effects, but also estimate heritability, a term denoting the magnitude of the genetic effect. However, the rarity of twins limits this approach, even for the common forms of cancer.14-19
In the present study, we used data from the Swedish, Danish, and Finnish twin registries to estimate the effects of genetic and environmental factors on the most common cancers. We also assessed how age at the time of diagnosis modified these estimates.
Methods
Swedish Twins
The Swedish Twin Registry consists of two birth cohorts.20 The first is made up of 10,503 pairs of twins of the same sex who were alive in 1961 and who were born during the period from 1886 through 1925. Information from questionnaires completed by both twins was available for 81 percent of the eligible pairs. A second cohort consists of 12,883 pairs of twins of the same sex born from 1926 through 1958. In this cohort, both twins were living in Sweden in 1972 and had responded to a questionnaire in that year. The rate of response to this questionnaire was 83 percent.
We determined vital status and any diagnoses of cancer from the records of the Swedish Mortality Registry and the Swedish Cancer Registry, using the unique national registration number assigned to each Swedish citizen. According to these records, cancer was diagnosed in 4490 persons in the first cohort from 1961 through 1995 and in 1157 persons in the second cohort from 1973 through 1995.
Danish Twins
The Danish Twin Registry holds data on 8461 pairs of twins of the same sex with known zygosity who were born between 1870 and 1930. This registry, established in 1954, includes all twins born in Denmark from 1870 through 1910,21 and it was later expanded to include twins of the same sex born from 1911 through 1930.21-23 Included in the registry are all pairs of twins who both survived to the age of six years. A questionnaire was mailed to the twins, or to their closest relatives if one or both twins had emigrated or were dead at the time of identification.
We checked vital status annually through 1979 by obtaining copies of death certificates from the Central Register of Deaths. After 1979 vital status was regularly updated by linkage to the Civil Registration System, which includes all persons living in Denmark since April 1, 1968.
The Danish Cancer Registry contains information on all malignant diseases diagnosed in Denmark since 1943.24-26 All pairs of twins of the same sex who were born from 1870 through 1930 and were both alive on January 1, 1943, have been linked to the Cancer Registry for the period from 1943 through 1993. A total of 3572 persons in this cohort received a diagnosis of cancer (excluding nonmelanoma skin cancer).
Finnish Twins
The Finnish twin cohort includes 12,941 pairs of twins who were born from 1880 through 1958 and who were both living in Finland on December 31, 1975.27 The cohort was compiled from the Central Population Register in 1974. The following year, a questionnaire was mailed to all twins who were 18 years of age or older and for whom an adequate address was available. The overall response rate was 89 percent.
Malignant neoplasms that were diagnosed among the Finnish twins from 1976 through 1996 were identified by linkage of records to national cancer registry data with the use of the personal identification number assigned to every resident of Finland. The Finnish Cancer Registry has information on all cancers diagnosed in Finland since 1953.28 In addition, the study cohort was linked to the Central Population Register to obtain data on death and emigration. Cancer was diagnosed in 1584 persons in the cohort.
Determination of Zygosity
For all three studies, zygosity was determined by a questionnaire that has been shown in validation studies to classify more than 95 percent of pairs of twins correctly.22,29,30
Statistical Analysis
The relative risk of cancer for persons whose twins had a particular type of cancer, as compared with those whose twins did not, was calculated according to sex and zygosity for cancer at each anatomical site. The risk was estimated as an odds ratio. Ninety-five percent confidence intervals were estimated according to the Mantel–Haenszel method.31
The absolute risk of cancer for the twin of a person with cancer within the period of the study was calculated as the proportion of all persons with cancer whose twins had cancer at the same site (i.e., the concordance).32 For clinical guidance, we also calculated the risk for twins up to the age of 75 years for the sites for which significant effects of heritable factors were found.
Quantitative genetic analyses were used to estimate the relative importance of hereditary and environmental factors in determining variations in susceptibility to cancer,13,33,34 on the usual assumptions of a classic twin study (that there was random mating, no interaction between genes and environment, and equivalent environments for monozygotic and dizygotic twins).35 Phenotypic variance was divided into a component due to inherited genetic factors (heritability), a component due to environmental factors common to both members of the pair of twins (the shared environmental component), and a component due to environmental factors unique to each twin (the nonshared environmental component) (Table 1Table 1
Effects Estimated in the Quantitative Genetic Analyses.). Structural-equation modeling,36 which incorporates data on all types of twins (male and female monozygotic and dizygotic twins from the three countries) simultaneously, provided estimates of the unobserved variables — that is, additive genetic, shared environmental, and nonshared environmental factors.The correlations between the genetic and environmental factors for the twins were set to their theoretical values (1.0 and 0.5 for additive genetic effects for monozygotic and dizygotic twins, respectively, and 1.0 for shared environmental effects for both types of twins). These values, 1.0 and 0.5, reflect the facts that monozygotic twins share their entire genomes (theoretical value, 1.0) and dizygotic twins share 50 percent of their segregating genes (theoretical value, 0.5). This method, which uses two-by-two contingency tables of disease status in pairs of twins, also tests for the sex specificity of the genetic and environmental effects. Because of considerations related to statistical power, analyses were performed only for cancers for which there were at least four pairs of twins in which both twins had the cancer. We assumed an underlying normal distribution of susceptibility to the disease.
We defined susceptibility as the sum of the effects of many genetic and environmental factors. When a person receives a diagnosis of cancer, a value (the threshold) in the distribution of susceptibility is assumed to have been exceeded. The threshold value was estimated in the model from the prevalence of the disease.13,37 The relative importance of hereditary and environmental effects for individual differences in this underlying susceptibility was then estimated. When sex-specific models did not fit significantly better than a model in which estimates were defined as being the same in men and women, the latter model is presented. Because the birth dates and follow-up periods of the twin cohorts differed among countries, the threshold values were also allowed to differ among countries. However, the estimates for genetic and environmental components were set to be equal in all countries, because no evidence of heterogeneity according to country was found for cancer at any site.
For colorectal, breast, and prostate cancers, there were enough affected persons (i.e., more than 50 pairs of twins who were concordant for the cancer) to enable structural model-fitting analysis to be performed in two age groups. Because of power considerations, the groups were defined so that the younger group included about 35 percent of the affected twins. For colorectal cancer, the younger group was followed up to 63 years of age; for breast cancer, it was followed up to 56 years of age; and for prostate cancer, it was followed up to 70 years of age. Persons in the younger group were followed until they reached the maximal age for that group, until they died, or until the study ended. For the older group, follow-up started when they reached the maximal age for the younger group and ended at death or at the end of the study period. At the end of follow-up in the younger and older groups, each pair of twins was recorded as concordant for cancer (if both twins had had cancer at the same anatomical site) or discordant for cancer (if only one twin had had cancer at a particular site). For colorectal, breast, and prostate cancer, we examined the differences in the ages at which cancer was diagnosed in pairs of twins who were concordant for cancer.
Results
Among the 44,788 pairs of twins included in this analysis, we identified 10,803 persons (among 9512 pairs) in whom at least one cancer had been diagnosed.
Overall, the twin of a person with cancer had an increased risk of having the same cancer. This was especially evident for cancer of the stomach, colorectum, lung, breast, and prostate (Table 2Table 2
Types of Cancers Included in the Study and Concordance According to Sex and Zygosity in 44,788 Pairs of Twins from Sweden, Denmark, and Finland.). The twin of a male monozygotic twin who had stomach cancer had a risk of stomach cancer that was 9.9 times that of the monozygotic twin of a person without stomach cancer. The concordance for stomach cancer in male monozygotic twins was 0.08, which means that there is an 8 percent probability that the identical twin of a man with stomach cancer will have the same cancer. The concordance was usually less than 0.10, and no concordant pairs were observed for cancers at nine sites (non-Hodgkin's lymphoma, Hodgkin's disease, and cancer of the lip, oral cavity, pharynx, kidney, thyroid, bone, and soft tissue). For cancers at most of the remaining sites, the concordance between monozygotic twins, whether male or female, was greater than the concordance between dizygotic twins.Table 3Table 3
Effects of Heritable and Environmental Factors in Cancers at Various Sites, According to Data from the Swedish, Danish, and Finnish Twin Registries. presents the results of model fitting, which we used to obtain estimates of the contributions of heritability and environmental effects. For stomach cancer, for example, heritability was estimated to account for 28 percent of the variation in susceptibility to that neoplasm, shared environmental effects for 10 percent, and nonshared environmental effects for the remaining 62 percent. Stated another way, these estimates indicate that of the various factors that together constitute the total risk of developing stomach cancer, inherited genes contribute 28 percent to the risk, shared environmental effects contribute 10 percent, and nonshared environmental factors make up the remaining 62 percent of the risk. For stomach cancer, therefore, our model predicts the involvement of major environmental factors plus minor genetic components, which may or may not interact with these environmental factors.The statistical model we used provided an excellent fit to the observed data (ξ2=8.9, with 38 df; P=1.0). Estimated effects of heritability — the proportion of susceptibility to cancer that was accounted for by genetic defects — that were statistically significant (i.e., for which the 95 percent confidence interval did not include zero) were obtained for cancers of the colorectum (35 percent), breast (27 percent), and prostate (42 percent). The estimates for the shared environmental effects ranged from 0 to 20 percent, but none were statistically significant. There were no significant differences between the sexes in the heritability of cancer at any of the sites that we studied.
Table 4Table 4
Absolute Risks of Colorectal, Breast, and Prostate Cancer (Concordance Rates) in Twins of an Affected Person up to the Age of 75 Years. presents the risks of having the same cancer before the age of 75 years among twins of persons with cancer at sites involving statistically significant genetic factors. For colorectal, breast, and prostate cancer, the estimated hereditary components were slightly greater in the younger than in the older groups (data not shown).The time interval between the diagnoses of prostate cancer was significantly shorter for concordant pairs of monozygotic twins than that for concordant pairs of dizygotic twins (5.7 vs. 8.8 years) (Table 5Table 5
Difference in Age at the Diagnosis of Cancer in Concordant Pairs of Monozygotic and Dizygotic Twins.). There were no significant differences between dizygotic and monozygotic twins in the time between diagnoses of colorectal and breast cancer.Discussion
Assessments of the contributions of inherited and environmental factors to the causation of cancer in studies of twins have had a relatively small effect on research and clinical practice, because twins are rare, and only a few twin registries go back far enough in time to provide enough cases of cancer for reliable conclusions to be drawn. The fact that we combined data from three Nordic countries with population-based twin registries and well-established cancer registries adds strength to the present study. Moreover, with statistical methods, it was possible to go beyond a simple comparison of concordance rates. With the knowledge that monozygotic twins are genetically identical and dizygotic twins share, on average, 50 percent of their segregating genes, we could estimate the magnitude of the contributions of genetic factors and environmental factors (both shared and nonshared) to the development of cancer.
There is general agreement that environmental factors and somatic events are the predominant contributors to the causation of sporadic cancer,38 and our results support this notion. Even though we found familial (hereditary or nonhereditary) effects for cancer at many sites, the rates of concordance in twins were generally below 0.10. This result indicates that, for nearly all sites, the twin of a person with cancer has only a moderate absolute risk of having cancer at the same site. Using a statistical model, we also estimated the contribution of nonshared environmental factors, which include any unique environmental cause of cancer that is not inherited and not shared between twins. For different cancers, this contribution ranged from 58 to 82 percent.
In our model, shared environment, the sum of the common family experiences and habits of the twins, accounted for 0 to 20 percent of causation, but none of these values were statistically significant, partly because studies of twins have limited power to detect shared environmental effects in dichotomous phenotypes (e.g., the presence or absence of cancer).39 Risk factors in the environment shared by a family could include human papillomavirus infection for cervical cancer, smoking (passive or active) for lung cancer, and diet and Helicobacter pylori infection for stomach cancer.
The total contribution of hereditary factors to the causation of sporadic cancer is unclear; previous assessments have estimated only the proportion of cancers caused by genetic syndromes. It has been argued that “unmistakable hereditary cancer syndromes” account for about 1 percent of cancers and “upward of 10 to 15 percent of all cancers have a major inherited component, albeit one that may be enigmatic”3; that “highly penetrant single-gene mutation” accounts for 5 percent1; and that “primary genetic factors” account for 5 to 10 percent of all cancers.40 The results of our study summarize the total effects of heritable factors, but it should be noted that our estimates are population-specific. Thus, if environmental effects are very different in Scandinavia and in other regions, the proportion of susceptibility to cancer that is due to hereditary effects will also differ. And for populations consisting entirely of smokers or of nonsmokers, the contribution of smoking to the variation in risk would be much lower than in a mixed population. Previous studies of cancer in twins have found higher rates of concordance among monozygotic twins than among dizygotic twins for cancer at some sites,14-19,41-44 but generally with very wide confidence intervals.
We found statistically significant effects of heritable factors, ranging from 27 percent to 42 percent, for colorectal, breast, and prostate cancer. These results are in agreement with those of most previous studies.14-16,43 Our model also revealed suggestive evidence of limited heritability of leukemia and of cancer of the stomach, lung, pancreas, ovary, and bladder, but the estimates did not reach statistical significance. Population-based studies in Utah and Sweden have found a familial effect for cancers at all of these sites.45-47
If we consider that the contribution of inherited genetic factors to the causation of these types of cancer is indeed 27 to 42 percent, and that single-gene mutations in familial cancer syndromes account for 1 to 15 percent of all cancers,1,3,40 then there must be major gaps in our understanding of the genetic basis of colorectal, breast, and prostate cancer. The frequency of mutations in the known high-risk susceptibility genes — BRCA1 and BRCA2 in breast cancer, DNA mismatch-repair genes in hereditary nonpolyposis colorectal cancer, and the candidate gene HPC1 in prostate cancer — is too low to explain more than a fraction of the genetic effects we found. For example, in a recent study of 12 pairs of Swedish monozygotic twins who were concordant for breast cancer (and who were also included in the present study), 2 pairs had a BRCA2 mutation and none had a BRCA1 mutation (unpublished data). Our findings suggest that other genes are yet to be identified, but because they are likely to be relatively common and carry only a moderate risk, proving that they are involved in causing cancer will be difficult.2
Although model fitting can be used to estimate the magnitude of the heritable component of susceptibility to cancer, it cannot reveal how this component acts or how it interacts with other factors. For example, a cancer gene could be expressed without any environmental influence or only when activated by environmental factors. For this reason, we cannot exclude a modifying effect of environment on the genetic component found in our analyses of twins. However, without specific environmental measurements, interactions cannot be assessed. For colorectal, breast, and prostate cancer, the estimated hereditary components were slightly higher in the younger than in the older groups; this finding is in accordance with observations that hereditary effects are strongest in early-onset cancers.5,7,45,46,48
The absolute risk of the same cancer before the age of 75 years for the monozygotic twin of a person with colorectal, breast, or prostate cancer was between 11 percent and 18 percent. For dizygotic twins, who have the same degree of genetic similarity as full siblings, the risk of these cancers was 3 to 9 percent. These figures could be valuable in providing clinical guidance not only to the twins of persons with cancer but also to other first-degree relatives.
One limitation of our study is that, despite its size, it did not have enough power to distinguish heritable genetic effects from environmental factors as causes of the familial aggregation of the less common types of cancer. The main reason for this limitation is that birth-cohort and calendar-period restrictions of twin registries set limits for analyses. Because errors in determining zygosity or diagnoses of cancer lead to an overestimation of nonshared environmental effects, the familial effects are, if anything, underestimated. The incidence of cancer among twins in the Finnish study did not differ from that in the general population,15 and in the Danish study, twins who responded to the questionnaire had the same distribution of zygosity and incidence of cancer as those who did not respond.49 Thus, bias due to selective response rates is improbable.
We conclude that the overwhelming contributor to the causation of cancer in the populations of twins that we studied was the environment. For some forms of cancer, in which a shared environment is important, it may be possible to find clues in studies of childhood environment or long-lasting family habits. The relatively large heritability proportions for cancers at some sites, despite the wide confidence intervals, suggest major gaps in our understanding of heritable cancer. Even for cancers for which there is statistically significant evidence of a heritable component, most pairs of twins were discordant for the cancer — indicating that, on the population level, the increase in the risk of cancer even among close relatives of affected persons is generally moderate.
Supported by the Nordic Cancer Union. The Swedish Twin Registry is supported by grants from the John D. and Catherine T. MacArthur Foundation and the Swedish Council for Planning and Coordination of Research. The Danish twin study was supported by research grants from the Danish Cancer Society (36/79), the National Cancer Institute (R35 CA 42581), and the National Institute on Aging (PO1-AG08761). The Finnish part of the study was supported by grants from the Finnish Cancer Organizations and the Academy of Finland.
We are indebted to all the participants and staff of the Nordic twin studies, without whom this study would not have been possible.
Source Information
From the Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden (P.L., A.I.); the Institute of Public Health (Epidemiology) and the Danish Twin Registry, University of Southern Denmark, Odense (N.V.H., A.S.); the Department of Public Health, University of Helsinki, Helsinki, Finland (P.K.V., J.K., M.K.); the Department of Public Health and General Practice, University of Oulu, Oulu, Finland (J.K.); the Department of Public Health, University of Turku, Turku, Finland (M.K.); the Finnish Cancer Registry, Helsinki, Finland (E.P.); and the Department of Biosciences at Novum, Karolinska Institute, Stockholm, Sweden (K.H.).
Address reprint requests to Dr. Lichtenstein at the Department of Medical Epidemiology, Karolinska Institute, Box 281, SE-171 77 Stockholm, Sweden, or at paul.lichtenstein@mep.ki.se.
- References
References
1
Li FP . Phenotypes, genotypes, and interventions for hereditary cancers. Cancer Epidemiol Biomarkers Prev 1995;4:579-582
Web of Science | Medline2
Easton DF . The inherited component of cancer. Br Med Bull 1994;50:527-535
Web of Science | Medline3
Fearon ER . Human cancer syndromes: clues to the origin and nature of cancer. Science 1997;278:1043-1050
CrossRef | Web of Science | Medline4
Lander ES ,Schork NJ . Genetic dissection of complex traits. Science 1994;265:2037-2048[Erratum, Science 1994;266:353.]
CrossRef | Web of Science | Medline5
Thompson WD . Genetic epidemiology of breast cancer. Cancer 1994;74:Suppl:279-287
CrossRef | Web of Science | Medline6
Peto J ,Easton DF ,Matthews FE ,Ford D ,Swerdlow AJ . Cancer mortality in relatives of women with breast cancer: the OPCS Study. Int J Cancer 1996;65:275-283
CrossRef | Web of Science | Medline7
Lesko SM ,Rosenberg L ,Shapiro S . Family history and prostate cancer risk. Am J Epidemiol 1996;144:1041-1047
Web of Science | Medline8
Gruber SB, Thompson WD, Cancer and Steroid Hormone Study Group
Web of Science | Medline9
Easton DF ,Matthews FE ,Ford D ,Swerdlow AJ ,Peto J . Cancer mortality in relatives of women with ovarian cancer: the OPCS Study. Int J Cancer 1996;65:284-294
CrossRef | Web of Science | Medline10
Auranen A ,Grenman S ,Makinen J ,Pukkala E ,Sankila R ,Salmi T . Borderline ovarian tumors in Finland: epidemiology and familial occurrence. Am J Epidemiol 1996;144:548-553
Web of Science | Medline11
Aarino M ,Sankila R ,Pukkala E , et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-218
CrossRef | Web of Science | Medline12
Auranen A ,Pukkala E ,Makinen J ,Sankila R ,Grenman S ,Salmi T . Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 1996;74:280-284
CrossRef | Web of Science | Medline13
Neale MC, Cardon LR. Methodology for genetic studies of twins and families. Dordrecht, the Netherlands: Kluwer Academic, 1992.
14
Ahlbom A ,Lichtenstein P ,Malmstrom H ,Feychting M ,Hemminki K ,Pedersen NL . Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997;89:287-293
CrossRef | Web of Science | Medline15
Verkasalo PK ,Kaprio J ,Koskenvuo M ,Pukkala E . Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976-1995. Int J Cancer 1999;83:743-749
CrossRef | Web of Science | Medline16
Page WF ,Braun MM ,Partin AW ,Caporaso N ,Walsh P . Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997;33:240-245
CrossRef | Web of Science | Medline17
Braun MM ,Caporaso NE ,Page WF ,Hoover RN . Genetic component of lung cancer: cohort study of twins. Lancet 1994;344:440-443
CrossRef | Web of Science | Medline18
Holm NV ,Hauge M ,Harvald B . Etiologic factors of breast cancer elucidated by a study of unselected twins. J Natl Cancer Inst 1980;65:285-298
Web of Science | Medline19
Holm NV ,Hauge M ,Jensen OM . Studies of cancer aetiology in a complete twin population: breast cancer, colorectal cancer and leukaemia. Cancer Surv 1982;1:17-3220
Cederlöf R, Lorich U. The Swedish Twin Registry. In: Nance WE, Allen G, Parisi P, eds. Twin research. Part B. Biology and epidemiology. Vol. 24B of Progress in clinical and biological research. New York: Alan R. Liss, 1978:189-95.
21
Hauge M ,Harvald B ,Fischer M , et al. The Danish Twin Register. Acta Genet Med Gemellol (Roma) 1968;17:315-332
Web of Science | Medline22
Hauge M. The Danish Twin Register. In: Mednick SA, Baert AE, eds. Prospective longitudinal research: an empirical basis for the primary prevention of psychosocial disorders. Oxford, England: Oxford University Press, 1981:217-21.
23
Kyvik KO ,Christensen K ,Skytthe A ,Harvald B ,Holm NV . The Danish Twin Register. Dan Med Bull 1996;43:467-470
Web of Science | Medline24
Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. Vol. 1. Review and results. Copenhagen, Denmark: Munksgaard, 1965.
25
Storm HH ,Michelsen EV ,Clemmensen IH ,Pihl J . The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997;44:535-539
Web of Science | Medline26
Storm HH, Pihl J, Michelsen E, Nielsen AL. Cancer incidence in Denmark 1993. Copenhagen, Denmark: Danish Cancer Society, 1996.
27
Kaprio J ,Sarna S ,Koskenvuo M ,Rantasalo I . The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res 1978;24:179-184
Medline28
Teppo L ,Pukkala E ,Lehtonen M . Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol 1994;33:365-369
CrossRef | Web of Science | Medline29
Cederlof R ,Friberg L ,Jonsson E ,Kaij L . Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet 1961;11:338-362
Medline30
Sarna S ,Kaprio J ,Sistonen P ,Koskenvuo M . Diagnosis of twin zygosity by mailed questionnaire. Hum Hered 1978;28:241-254
CrossRef | Web of Science | Medline31
Kuritz SJ ,Landis JR ,Koch GG . A general overview of Mantel-Haenszel methods: applications and recent developments. Annu Rev Public Health 1988;9:123-160
CrossRef | Web of Science | Medline32
McGue M . When assessing twin concordance, use the probandwise not the pairwise rate. Schizophr Bull 1992;18:171-176
Web of Science | Medline33
Heath AC ,Neale MC ,Hewitt JK ,Eaves LJ ,Fulker DW . Testing structural equation models for twin data using LISREL. Behav Genet 1989;19:9-35
CrossRef | Web of Science | Medline34
Sham P. Statistics in human genetics. London: Arnold, 1997.
35
Martin N ,Boomsma D ,Machin G . A twin-pronged attack on complex traits. Nat Genet 1997;17:387-392
CrossRef | Web of Science | Medline36
Neale MC. Mx: statistical modeling. 5th ed. Richmond: Virginia Commonwealth University, 1999.
37
Falconer DS . The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet 1965;29:51-76
CrossRef | Web of Science38
Cancer: causes, occurrence and control. Lyon, France: International Agency for Research on Cancer, 1990. (IARC scientific publications no. 100.)
39
Neale MC ,Eaves LJ ,Kendler KS . The power of the classical twin study to resolve variation in threshold traits. Behav Genet 1994;24:239-258
CrossRef | Web of Science | Medline40
Lynch HT ,Smyrk T . Hereditary nonpolyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 1996;78:1149-1167
CrossRef | Web of Science | Medline41
Swerdlow AJ ,De Stavola BL ,Swanwick MA ,Maconochie NES . Risks of breast and testicular cancers in young adult twins in England and Wales: evidence on prenatal and genetic aetiology. Lancet 1997;350:1723-1728
CrossRef | Web of Science | Medline42
Mack TM ,Cozen W ,Shibata DK , et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995;332:413-418
Full Text | Web of Science | Medline43
Gronberg H ,Damber L ,Damber J-E . Studies of genetic factors in prostate cancer in a twin population. J Urol 1994;152:1484-1489
Web of Science | Medline44
Braun MM ,Caporaso NE ,Page WF ,Hoover RN . A cohort study of twins and cancer. Cancer Epidemiol Biomarkers Prev 1995;4:469-473
Web of Science | Medline45
Goldgar DE ,Easton DF ,Cannon-Albright LA ,Skolnick MH . Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-1608
CrossRef | Web of Science | Medline46
Hemminki K ,Vaittinen P ,Kyyronen P . Age-specific familial risks in common cancers of the offspring. Int J Cancer 1998;78:172-175
CrossRef | Web of Science | Medline47
Hemminki K ,Vaittinen P . Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer 1999;35:1109-1117
CrossRef | Web of Science | Medline48
Gronberg H ,Smith J ,Emanuelsson M , et al. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet 1999;65:134-140
CrossRef | Web of Science | Medline49
Holm NV. Application of twin studies in the elucidation of causal relation in diseases of complex etiology with cancer as an example. (Ph.D. thesis. Odense, Denmark: Odense University, 1983.) (In Danish.)
- Citing Articles (797)
Citing Articles
1
Viswanathan Ramakrishnan, Leroy R. Thacker. (2012) Population Attributable Fraction as a Measure of Heritability in Dichotomous Twin Data. Communications in Statistics - Simulation and Computation 41:3, 405-418
CrossRef2
S. Castellvi-Bel, C. Ruiz-Ponte, C. Fernandez-Rozadilla, A. Abuli, J. Munoz, X. Bessa, A. Brea-Fernandez, M. Ferro, M. D. Giraldez, R. M. Xicola, X. Llor, R. Jover, J. M. Pique, M. Andreu, A. Castells, A. Carracedo, . (2012) Seeking genetic susceptibility variants for colorectal cancer: the EPICOLON consortium experience. Mutagenesis 27:2, 153-159
CrossRef3
R. S. Houlston, . (2012) COGENT (COlorectal cancer GENeTics) revisited. Mutagenesis 27:2, 143-151
CrossRef4
B. Pardini, A. Naccarati, P. Vodicka, R. Kumar. (2012) Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk. Mutagenesis 27:2, 161-167
CrossRef5
T. van Wezel, A. Middeldorp, J. T. Wijnen, H. Morreau. (2012) A review of the genetic background and tumour profiling in familial colorectal cancer. Mutagenesis 27:2, 239-245
CrossRef6
I. Hlavata, B. Mohelnikova-Duchonova, R. Vaclavikova, V. Liska, P. Pitule, P. Novak, J. Bruha, O. Vycital, L. Holubec, V. Treska, P. Vodicka, P. Soucek. (2012) The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27:2, 187-196
CrossRef7
R. Watson, B. Benelam. (2012) Physical activity: the latest on its contribution to energy balance and health. Nutrition Bulletin 37:1, 78-85
CrossRef8
Patricia Rodrigues, Jessica Furriol, Eduardo Tormo, Sandra Ballester, Ana Lluch, Pilar Eroles. (2012) The single-nucleotide polymorphisms +936 C/T VEGF and −710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population. Breast Cancer Research and Treatment
CrossRef9
Hongxia Ma, Huizhang Li, Guangfu Jin, Juncheng Dai, Jing Dong, Zhenzhen Qin, Jiaping Chen, Shui Wang, Xinru Wang, Zhibin Hu, Hongbing Shen. (2012) Genetic Variants at 14q24.1 and Breast Cancer Susceptibility: a Fine-Mapping Study in Chinese Women. DNA and Cell Biology120207090235006
CrossRef10
Raju K. Mandal, Ginu P. George, Rama D. Mittal. (2012) Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Molecular Biology Reports
CrossRef11
Lian-sheng ZHANG, Xing-xing XU, Xin-gang CUI, Guo-ping WANG, Jian-guo HOU, Guang-wen CAO, Hong-wei ZHANG, Fei-lun CUI. (2012) Relationship of kallikrein 3 and vitamin D receptor polymorphisms and environmental factors with prostate cancer predisposition. Academic Journal of Second Military Medical University 31:12, 1310-1315
CrossRef12
Zhaoming Wang, Hemang Parikh, Jinping Jia, Timothy Myers, Meredith Yeager, Kevin B. Jacobs, Amy Hutchinson, Laurie Burdett, Arpita Ghosh, Michael J. Thun, Susan M. Gapstur, W. Ryan Diver, Jarmo Virtamo, Demetrius Albanes, Geraldine Cancel-Tassin, Antoine Valeri, Olivier Cussenot, Kenneth Offit, Ed Giovannucci, Jing Ma, Meir J. Stampfer, J. Michael Gaziano, David J. Hunter, Ana Dutra-Clarke, Tomas Kirchhoff, Michael Alavanja, Laura B. Freeman, Stella Koutros, Robert Hoover, Sonja I. Berndt, Richard B. Hayes, Ilir Agalliu, Robert D. Burk, Sholom Wacholder, Gilles Thomas, Laufey Amundadottir. (2012) Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Human Genetics
CrossRef13
Maya Ghoussaini, Olivia Fletcher, Kyriaki Michailidou, Clare Turnbull, Marjanka K Schmidt, Ed Dicks, Joe Dennis, Qin Wang, Manjeet K Humphreys, Craig Luccarini, Caroline Baynes, Don Conroy, Melanie Maranian, Shahana Ahmed, Kristy Driver, Nichola Johnson, Nicholas Orr, Isabel dos Santos Silva, Quinten Waisfisz, Hanne Meijers-Heijboer, Andre G Uitterlinden, Fernando Rivadeneira, Per Hall, Kamila Czene, Astrid Irwanto, Jianjun Liu, Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, Alfons Meindl, Rita K Schmutzler, Bertram Müller-Myhsok, Peter Lichtner, Jenny Chang-Claude, Rebecca Hein, Stefan Nickels, Dieter Flesch-Janys, Helen Tsimiklis, Enes Makalic, Daniel Schmidt, Minh Bui, John L Hopper, Carmel Apicella, Daniel J Park, Melissa Southey, David J Hunter, Stephen J Chanock, Annegien Broeks, Senno Verhoef, Frans B L Hogervorst, Peter A Fasching, Michael P Lux, Matthias W Beckmann, Arif B Ekici, Elinor Sawyer, Ian Tomlinson, Michael Kerin, Frederik Marme, Andreas Schneeweiss, Christof Sohn, Barbara Burwinkel, Pascal Guénel, Thérèse Truong, Emilie Cordina-Duverger, Florence Menegaux, Stig E Bojesen, Børge G Nordestgaard, Sune F Nielsen, Henrik Flyger, Roger L Milne, M Rosario Alonso, Anna González-Neira, Javier Benítez, Hoda Anton-Culver, Argyrios Ziogas, Leslie Bernstein, Christina Clarke Dur, Hermann Brenner, Heiko Müller, Volker Arndt, Christa Stegmaier, Christina Justenhoven, Hiltrud Brauch, Thomas Brüning, Shan Wang-Gohrke, Ursula Eilber, Thilo Dörk, Peter Schürmann, Michael Bremer, Peter Hillemanns, Natalia V Bogdanova, Natalia N Antonenkova, Yuri I Rogov, Johann H Karstens, Marina Bermisheva, Darya Prokofieva, Elza Khusnutdinova, Annika Lindblom, Sara Margolin, Arto Mannermaa, Vesa Kataja, Veli-Matti Kosma, Jaana M Hartikainen, Diether Lambrechts, Betul T Yesilyurt, Giuseppe Floris, Karin Leunen, Siranoush Manoukian, Bernardo Bonanni, Stefano Fortuzzi, Paolo Peterlongo, Fergus J Couch, Xianshu Wang, Kristen Stevens, Adam Lee, Graham G Giles, Laura Baglietto, Gianluca Severi, Catriona McLean, Grethe Grenaker Alnæs, Vessela Kristensen, Anne-Lise Børrensen-Dale, Esther M John, Alexander Miron, Robert Winqvist, Katri Pylkäs, Arja Jukkola-Vuorinen, Saila Kauppila, Irene L Andrulis, Gord Glendon, Anna Marie Mulligan, Peter Devilee, Christie J van Asperen, Rob A E M Tollenaar, Caroline Seynaeve, Jonine D Figueroa, Montserrat Garcia-Closas, Louise Brinton, Jolanta Lissowska, Maartje J Hooning, Antoinette Hollestelle, Rogier A Oldenburg, Ans M W van den Ouweland, Angela Cox, Malcolm W R Reed, Mitul Shah, Ania Jakubowska, Jan Lubinski, Katarzyna Jaworska, Katarzyna Durda, Michael Jones, Minouk Schoemaker, Alan Ashworth, Anthony Swerdlow, Jonathan Beesley, Xiaoqing Chen, Kenneth R Muir, Artitaya Lophatananon, Suthee Rattanamongkongul, Arkom Chaiwerawattana, Daehee Kang, Keun-Young Yoo, Dong-Young Noh, Chen-Yang Shen, Jyh-Cherng Yu, Pei-Ei Wu, Chia-Ni Hsiung, Annie Perkins, Ruth Swann, Louiza Velentzis, Diana M Eccles, Will J Tapper, Susan M Gerty, Nikki J Graham, Bruce A J Ponder, Georgia Chenevix-Trench, Paul D P Pharoah, Mark Lathrop, Alison M Dunning, Nazneen Rahman, Julian Peto, Douglas F Easton. (2012) Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics
CrossRef14
M. D. Giraldez, A. Lopez-Doriga, L. Bujanda, A. Abuli, X. Bessa, C. Fernandez-Rozadilla, J. Munoz, M. Cuatrecasas, R. Jover, R. M. Xicola, X. Llor, J. M. Pique, A. Carracedo, C. Ruiz-Ponte, A. Cosme, J. M. Enriquez-Navascues, V. Moreno, M. Andreu, A. Castells, F. Balaguer, S. Castellvi-Bel, . (2012) Susceptibility Genetic Variants Associated With Early-Onset Colorectal Cancer. Carcinogenesis
CrossRef15
Rui Ding, Shilei Lin, Daojun Chen. (2012) Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. International Journal of Colorectal Disease
CrossRef16
Brandie Heald, Emily Edelman, Charis Eng. (2012) Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. European Journal of Human Genetics
CrossRef17
Wenshan He, Sijia Luo, Tao Huang, Jinghua Ren, Xiaoling Wu, Jun Shao, Qingyao Zhu. (2012) The Ku70 −1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population. Molecular Biology Reports 39:1, 577-583
CrossRef18
Christopher E Barbieri, Francesca Demichelis, Mark A Rubin. (2012) Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Histopathology 60:1, 187-198
CrossRef19
Rama Devi Mittal, Tulika Mittal, Abhinav K. Singh, Raju K. Mandal. (2012) Association of Caspases with an Increased Prostate Cancer Risk in North Indian Population. DNA and Cell Biology 31:1, 67-73
CrossRef20
Mohammad Reza Safarinejad, Saba Safarinejad, Nayyer Shafiei, Shiva Safarinejad. (2012) Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: Evidence for association with risk and histopathological tumor characteristics in Iranian men. Molecular Carcinogenesisn/a-n/a
CrossRef21
Joseph S. Alpert, Qin M. Chen. (2012) Has the Genomic Revolution Failed?. Clinical Cardiologyn/a-n/a
CrossRef22
Peter M. Visscher, Matthew A. Brown, Mark I. McCarthy, Jian Yang. (2012) Five Years of GWAS Discovery. The American Journal of Human Genetics 90:1, 7-24
CrossRef23
F.Z. Laarabi, I. Cherkaoui Jaouad, S. Baert-Desurmont, K. Ouldim, A. Ibrahimi, N. Kanouni, T. Frebourg, A. Sefiani. (2012) The first mutations in the MYH gene reported in Moroccan colon cancer patients. Gene
CrossRef24
Arvind B. Bambhroliya, Keith D. Burau, Ken Sexton. (2012) Spatial Analysis of County-Level Breast Cancer Mortality in Texas. Journal of Environmental and Public Health 2012, 1-8
CrossRef25
Polly A. Newcomb, Anamaria Savu, Amanda I. Phipps, Anna E. Coghill, Yutaka Yasui. (2012) Impact of Colon Cancer Screening on Family History Phenotype. Epidemiology1
CrossRef26
Jiaping Chen, Yue Jiang, Xiaoan Liu, Zhenzhen Qin, Juncheng Dai, Guangfu Jin, Hongxia Ma, Shui Wang, Xinru Wang, Zhibin Hu, Hongbing Shen. (2011) Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population. Breast Cancer Research and Treatment
CrossRef27
Yong Xie, Guo-Qing Liu, Xiong-Ying Miao, Yi Liu, Wei Zhou, De-Wu Zhong. (2011) CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis. Tumor Biology
CrossRef28
Melanie Bevier, Kristina Sundquist, Kari Hemminki. (2011) Risk of breast cancer in families of multiple affected women and men. Breast Cancer Research and Treatment
CrossRef29
Jin Li, Chuang Sun, Yuerong Yuan, Li Liu, Guanglian Xiong, Jing Wu. (2011) Bone morphogenetic protein-4 polymorphism and colorectal cancer risk: a meta analysis. Molecular Biology Reports
CrossRef30
S J Lubbe, A M Pittman, B Olver, A Lloyd, J Vijayakrishnan, S Naranjo, S Dobbins, P Broderick, J L Gómez-Skarmeta, R S Houlston. (2011) The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting regulation of BMP4. Oncogene
CrossRef31
S. J. Lubbe, M. C. Di Bernardo, P. Broderick, I. Chandler, R. S. Houlston. (2011) Comprehensive Evaluation of the Impact of 14 Genetic Variants on Colorectal Cancer Phenotype and Risk. American Journal of Epidemiology
CrossRef32
Issa J. Dahabreh, Samuel Murray. (2011) Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiology 35:6, 503-509
CrossRef33
Li-Xin Qiu, Jing He, Meng-Yun Wang, Ruo-Xin Zhang, Ting-Yan Shi, Mei-Ling Zhu, Chen Mao, Si Sun, Fang-Fang Lv, Chun-Lei Zheng, Xiao-Dong Zhu. (2011) The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine 56:3, 695-698
CrossRef34
Li-Xin Qiu, You Wang, Zu-Guang Xia, Bo Xi, Chen Mao, Jia-Lei Wang, Bi-Yun Wang, Fang-Fang Lv, Xiang-Hua Wu, Ling-Qing Hu. (2011) miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine 56:3, 589-592
CrossRef35
Laura Fachal, Antonio Gómez-Caamaño, Catuxa Celeiro-Muñoz, Paula Peleteiro, Ana Blanco, Ana Carballo, Jerónimo Forteza, Ángel Carracedo, Ana Vega. (2011) BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data. The Prostate 71:16, 1768-1779
CrossRef36
Barry B. McGuire, Brian T. Helfand, Shilajit Kundu, Qiaoyan Hu, Jessica A. Banks, Phillip Cooper, William J. Catalona. (2011) Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance. BJU Internationalno-no
CrossRef37
Päivi Peltomäki. (2011) Mutations and epimutations in the origin of cancer. Experimental Cell Research
CrossRef38
Hidewaki Nakagawa, Shusuke Akamatsu, Ryo Takata, Atsushi Takahashi, Michiaki Kubo, Yusuke Nakamura. (2011) Prostate Cancer Genomics, Biology, and Risk Assessment through Genome-wide Association Studies. Cancer Scienceno-no
CrossRef39
Hyo Jin Kang, Young Bin Hong, Hee Jeong Kim, Antai Wang, Insoo Bae. (2011) Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast epithelial cells. Toxicology Letters
CrossRef40
Cheryl D. Cropp, Claire L Simpson, Tiina Wahlfors, Nati Ha, Asha George, MaryPat S. Jones, Ursula Harper, Damaris Ponciano-Jackson, Tiffany A. Green, Teuvo L. J. Tammela, Joan Bailey-Wilson, Johanna Schleutker. (2011) Genome-wide linkage scan for prostate cancer susceptibility in Finland: Evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22. International Journal of Cancer 129:10, 2400-2407
CrossRef41
Hao Liu, Jan Sundquist, Kari Hemminki. (2011) Familial Renal Cell Carcinoma from the Swedish Family-Cancer Database. European Urology 60:5, 987-993
CrossRef42
Yi Su, Li-Juan Chen, Jian-Rong He, Xue-Jiao Yuan, Yu-Ling Cen, Feng-Xi Su, Lu-Ying Tang, Ai-Hua Zhang, Wei-Qing Chen, Ying Lin, Shen-Ming Wang, Ze-Fang Ren. (2011) Urinary rubidium in breast cancers. Clinica Chimica Acta 412:23-24, 2305-2309
CrossRef43
Simon J. Willcox, Bernard W. Stewart, Freddy Sitas. (2011) What factors do cancer patients believe contribute to the development of their cancer? (New South Wales, Australia). Cancer Causes & Control 22:11, 1503-1511
CrossRef44
He-ping Xiang, Xiao-ping Geng, Wei-wei Ge, He Li. (2011) Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility. European Journal of Cancer 47:17, 2546-2551
CrossRef45
Xing-Xing Chen, Ru-Ping Zhao, Li-Xin Qiu, Hui Yuan, Chen Mao, Xi-Chun Hu, Xiao-Mao Guo. (2011) Glutathione S-transferase T1 polymorphism is associated with breast cancer susceptibility. Cytokine 56:2, 477-480
CrossRef46
Charlotta Ryk, N. Peter Wiklund, Tommy Nyberg, Petra J. De Verdier. (2011) Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis. Scandinavian Journal of Urology and Nephrology 45:5, 319-325
CrossRef47
N. Becker. (2011) Epidemiologie des Prostatakarzinoms. Der Radiologe 51:11, 922-929
CrossRef48
Laura A. McGuinn, Armen A. Ghazarian, Gary L. Ellison, Chinonye E. Harvey, Christine M. Kaefer, Britt C. Reid. (2011) Cancer and environment: Definitions and misconceptions. Environmental Research
CrossRef49
S. J. Lubbe, N. Whiffin, I. Chandler, P. Broderick, R. S. Houlston. (2011) Relationship between 16 susceptibility loci and colorectal cancer phenotype in 3146 patients. Carcinogenesis
CrossRef50
Yadong Wang, Haiyan Yang, Li Li, Haiyu Wang, Congke Zhang, Xiangqun Xia. (2011) E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer. International Journal of Colorectal Disease
CrossRef51
Stella Koutros, Gabriella Andreotti, Sonja I. Berndt, Kathryn Hughes Barry, Jay H. Lubin, Jane A. Hoppin, Freya Kamel, Dale P. Sandler, Laurie A. Burdette, Jeffrey Yuenger, Meredith Yeager, Michael C.R. Alavanja, Laura E. Beane Freeman. (2011) Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer. Pharmacogenetics and Genomics 21:10, 615-623
CrossRef52
Phillip R. Cooper, Barry B. McGuire, Brian T. Helfand, Stacy Loeb, Qiaoyan Hu, William J. Catalona. (2011) Prostate Cancer Risk Alleles and Their Associations With Other Malignancies. Urology 78:4, 970.e15-970.e20
CrossRef53
Min-Bin Chen, Chen Li, Wen-Xiang Shen, Yu-Jiang Guo, Wei Shen, Pei-Hua Lu. (2011) Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls. Molecular Biology Reports 38:7, 4687-4695
CrossRef54
Claudia S. Plottel, Martin J. Blaser. (2011) Microbiome and Malignancy. Cell Host & Microbe 10:4, 324-335
CrossRef55
Ali Basiri, Daniel L. Edelstein, Jenna Graham, Afshin Nabili, Francis M. Giardiello, Jessica C. Ramella-Roman. (2011) Detection of familial adenomatous polyposis with orthogonal polarized spectroscopy of the oral mucosa vasculature. Journal of Biophotonics 4:10, 707-714
CrossRef56
Li-Xin Qiu, Ke Wang, Sheng Yang, Chen Mao, Lei Zhao, Lei Yao, Jian Zhang, Qun-Ling Zhang, Si Sun, Kai Xue. (2011) Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Molecular Biology Reports 38:7, 4491-4494
CrossRef57
Charlotta Ryk, N. Peter Wiklund, Tommy Nyberg, Petra J. de Verdier. (2011) Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide 25:3, 338-343
CrossRef58
Lou-Qian Zhang, Jun Wang, Jun-Qing Shang, Jian-ling Bai, Fu-Yin Liu, Xin Guan, Jian-Nong Zhou. (2011) Cyclin D1 G870A polymorphism and colorectal cancer susceptibility: a meta-analysis of 20 populations. International Journal of Colorectal Disease 26:10, 1249-1255
CrossRef59
Andrea Gsur, Kathrin Bernhart, Andreas Baierl, Elisabeth Feik, Gerhard Führlinger, Philipp Hofer, Gernot Leeb, Karl Mach, Michael Micksche. (2011) No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiology 35:5, e38-e41
CrossRef60
F. R. Schumacher, S. I. Berndt, A. Siddiq, K. B. Jacobs, Z. Wang, S. Lindstrom, V. L. Stevens, C. Chen, A. M. Mondul, R. C. Travis, D. O. Stram, R. A. Eeles, D. F. Easton, G. Giles, J. L. Hopper, D. E. Neal, F. C. Hamdy, J. L. Donovan, K. Muir, A. A. Al Olama, Z. Kote-Jarai, M. Guy, G. Severi, H. Gronberg, W. B. Isaacs, R. Karlsson, F. Wiklund, J. Xu, N. E. Allen, G. L. Andriole, A. Barricarte, H. Boeing, H. Bas Bueno-de-Mesquita, E. D. Crawford, W. R. Diver, C. A. Gonzalez, J. M. Gaziano, E. L. Giovannucci, M. Johansson, L. Le Marchand, J. Ma, S. Sieri, P. Stattin, M. J. Stampfer, A. Tjonneland, P. Vineis, J. Virtamo, U. Vogel, S. J. Weinstein, M. Yeager, M. J. Thun, L. N. Kolonel, B. E. Henderson, D. Albanes, R. B. Hayes, H. Spencer Feigelson, E. Riboli, D. J. Hunter, S. J. Chanock, C. A. Haiman, P. Kraft. (2011) Genome-wide association study identifies new prostate cancer susceptibility loci. Human Molecular Genetics 20:19, 3867-3875
CrossRef61
ROBERT P. YOUNG, RAEWYN J. HOPKINS. (2011) How the genetics of lung cancer may overlap with COPD. Respirology 16:7, 1047-1055
CrossRef62
Sophia Harlid, Malin I.L. Ivarsson, Salma Butt, Shehnaz Hussain, Ewa Grzybowska, Jorunn Erla Eyfjörd, Per Lenner, Asta Försti, Kari Hemminki, Jonas Manjer, Joakim Dillner, Joyce Carlson. (2011) A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP. International Journal of Cancer 129:7, 1689-1698
CrossRef63
Alexander Dietz, Dorthe Almind Pedersen, Rune Jacobsen, George L. Wehby, Jeffrey C. Murray, Kaare Christensen. (2011) Risk of Breast Cancer in Families with Cleft Lip and Palate. Annals of Epidemiology
CrossRef64
Raju K. Mandal, Rama D. Mittal. (2011) Polymorphisms in COX-2 Gene Influence Prostate Cancer Susceptibility in a Northern Indian Cohort. Archives of Medical Research
CrossRef65
Phoebe Lee, Yi-Ping Fu, Jonine D. Figueroa, Ludmila Prokunina-Olsson, Jesus Gonzalez-Bosquet, Peter Kraft, Zhaoming Wang, Kevin B. Jacobs, Meredith Yeager, Marie-Josèphe Horner, Susan E. Hankinson, Amy Hutchinson, Nilanjan Chatterjee, Montserrat Garcia-Closas, Regina G. Ziegler, Christine D. Berg, Saundra S. Buys, Catherine A. McCarty, Heather Spencer Feigelson, Michael J. Thun, Ryan Diver, Ross Prentice, Rebecca Jackson, Charles Kooperberg, Rowan Chlebowski, Jolanta Lissowska, Beata Peplonska, Louise A. Brinton, Margaret Tucker, Joseph F. Fraumeni, Robert N. Hoover, Gilles Thomas, David J. Hunter, Stephen J. Chanock. (2011) Fine mapping of 14q24.1 breast cancer susceptibility locus. Human Genetics
CrossRef66
Gwendolyn P. Quinn, Tuya Pal, Devin Murphy, Susan T. Vadaparampil, Ambuj Kumar. (2011) High-risk consumers’ perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis. Genetics in Medicine
CrossRef67
Qi You, Xi-shan Wang, Song-bin Fu, Xiao-ming Jin. (2011) Downregulated Expression of Inhibitor of Growth 4 (ING4) in Advanced Colorectal Cancers: A Non-Randomized Experimental Study. Pathology & Oncology Research 17:3, 473-477
CrossRef68
Hye Lim Kim, Young Rok Seo. (2011) Synergistic genotoxic effect between gene and environmental pollutant: Oxidative DNA damage induced by thioredoxin reductase 1 silencing under nickel treatment. Molecular & Cellular Toxicology 7:3, 251-257
CrossRef69
Jian Zhang, Li-Xin Qiu, Shiang-Jiin Leaw, Xi-Chun Hu, Jian-Hua Chang. (2011) The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects. Medical Oncology 28:3, 655-660
CrossRef70
Eric W Klee, Nicole L Hoppman-Chaney, Matthew J Ferber. (2011) Expanding DNA diagnostic panel testing: is more better?. Expert Review of Molecular Diagnostics 11:7, 703-709
CrossRef71
B Wei, Y Zhou, Z Xu, J Ruan, M Zhu, K Jin, D Zhou, Q Hu, Q Wang, Z Wang, Z Yan. (2011) XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer and Prostatic Diseases 14:3, 225-231
CrossRef72
Zhengyu Fang, Yi Xiong, Jiana Li, Li Liu, Manhui Li, Wei Zhang, Lei Shi, Jun Wan. (2011) Detection of APC Gene Deletions in Colorectal Malignancies Using Quantitative PCR in a Chinese Population. Pathology & Oncology Research 17:3, 657-661
CrossRef73
S. I. Berndt, J. Sampson, M. Yeager, K. B. Jacobs, Z. Wang, A. Hutchinson, C. Chung, N. Orr, S. Wacholder, N. Chatterjee, K. Yu, P. Kraft, H. S. Feigelson, M. J. Thun, W. R. Diver, D. Albanes, J. Virtamo, S. Weinstein, F. R. Schumacher, G. Cancel-Tassin, O. Cussenot, A. Valeri, G. L. Andriole, E. D. Crawford, C. Haiman, B. Henderson, L. Kolonel, L. Le Marchand, A. Siddiq, E. Riboli, R. C. Travis, R. Kaaks, W. Isaacs, S. Isaacs, K. E. Wiley, H. Gronberg, F. Wiklund, P. Stattin, J. Xu, S. L. Zheng, J. Sun, L. J. Vatten, K. Hveem, I. Njolstad, D. S. Gerhard, M. Tucker, R. B. Hayes, R. N. Hoover, J. F. Fraumeni, D. J. Hunter, G. Thomas, S. J. Chanock. (2011) Large-scale fine mapping of the HNF1B locus and prostate cancer risk. Human Molecular Genetics 20:16, 3322-3329
CrossRef74
T. A. Wallace, D. N. Martin, S. Ambs. (2011) Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis 32:8, 1107-1121
CrossRef75
Mirna Sučić, Vesna Bišof, Mirjana Čačić, Sanda Bašić Kinda, Danijela Kolenc, Nives Ljubić, Tena Sučić, Kristina Potočki. (2011) A patient with prostate cancer and multiple myeloma—diagnostics and possible association of both diseases. Annals of Diagnostic Pathology
CrossRef76
Riikka Nurminen, Tiina Wahlfors, Teuvo L. J. Tammela, Johanna Schleutker. (2011) Identification of an aggressive prostate cancer predisposing variant at 11q13. International Journal of Cancer 129:3, 599-606
CrossRef77
Sadia Javed, Muhammad Ali, Sobia Sadia, Muhammad Assad Aslam, Ahmed Ijaz Masood, Rehan Sadiq Shaikh, Ali H. Sayyed. (2011) Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population. Maturitas 69:4, 377-382
CrossRef78
Ilir Agalliu, Victoria A. Kirsh, Nancy Kreiger, Colin L. Soskolne, Thomas E. Rohan. (2011) Oxidative balance score and risk of prostate cancer: Results from a case-cohort study. Cancer Epidemiology 35:4, 353-361
CrossRef79
Raffaela Barbano, Massimiliano Copetti, Giuseppe Perrone, Valerio Pazienza, Lucia Anna Muscarella, Teresa Balsamo, Clelia Tiziana Storlazzi, Maria Ripoli, Monica Rinaldi, Vanna Maria Valori, Tiziana Pia Latiano, Evaristo Maiello, Pietro Stanziale, Massimo Carella, Alessandra Mangia, Fabio Pellegrini, Michele Bisceglia, Andrea Onetti Muda, Vittorio Altomare, Roberto Murgo, Vito Michele Fazio, Paola Parrella. (2011) High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome. International Journal of Cancer 129:3, 536-545
CrossRef80
Xiangming Cao, Tingrong Zhang, Zhen Zhao, Tao Zhao. (2011) MDM2 SNP309 Polymorphism and Colorectal Cancer Risk: A Meta-analysis. DNA and Cell Biology110719092133008
CrossRef81
C. C. Chung, J. Ciampa, M. Yeager, K. B. Jacobs, S. I. Berndt, R. B. Hayes, J. Gonzalez-Bosquet, P. Kraft, S. Wacholder, N. Orr, K. Yu, A. Hutchinson, J. Boland, Q. Chen, H. S. Feigelson, M. J. Thun, W. R. Diver, D. Albanes, J. Virtamo, S. Weinstein, F. R. Schumacher, G. Cancel-Tassin, O. Cussenot, A. Valeri, G. L. Andriole, E. D. Crawford, C. A. Haiman, B. E. Henderson, L. Kolonel, L. Le Marchand, A. Siddiq, E. Riboli, T. J. Key, R. Kaaks, W. B. Isaacs, S. D. Isaacs, H. Gronberg, F. Wiklund, J. Xu, L. J. Vatten, K. Hveem, I. Njolstad, D. S. Gerhard, M. Tucker, R. N. Hoover, J. F. Fraumeni, D. J. Hunter, G. Thomas, N. Chatterjee, S. J. Chanock. (2011) Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Human Molecular Genetics 20:14, 2869-2878
CrossRef82
Amy J. Tucker, Branden Deschambault, Marica Bakovic. 2011. Nutritional Genomics: Fundamental Role of Diet in Chronic Disease Prevention and Control. , 45-74.
CrossRef83
Johanna Schleutker. (2011) Polymorphisms in androgen signaling pathway predisposing to prostate cancer. Molecular and Cellular Endocrinology
CrossRef84
Kshitij Srivastava, Anvesha Srivastava, Kiran Lata Sharma, Balraj Mittal. (2011) Candidate gene studies in gallbladder cancer: A systematic review and meta-analysis. Mutation Research/Reviews in Mutation Research 728:1-2, 67-79
CrossRef85
Quannetta T. Edwards, Ann Maradiegue, Diane Seibert, Kory Jasperson. (2011) Pre- and postassessment of nurse practitioners' knowledge of hereditary colorectal cancer. Journal of the American Academy of Nurse Practitioners 23:7, 361-369
CrossRef86
D. Chen, S. Song, J. Lu, Y. Luo, Z. Yang, Q. Huang, X. Fu, X. Fan, Y. Wei, J. Wang, L. Wang. (2011) Functional variants of -1318T > G and -673C > T in c-Jun promoter region associated with increased colorectal cancer risk by elevating promoter activity. Carcinogenesis 32:7, 1043-1049
CrossRef87
Li-Xin Qiu, Ke Wang, Fang-Fang Lv, Zhi-Yu Chen, Xin Liu, Chun-Lei Zheng, Wen-Hua Li, Xiao-Dong Zhu, Wei-Jian Guo, Jin Li. (2011) GSTM1 null allele is a risk factor for gastric cancer development in Asians. Cytokine 55:1, 122-125
CrossRef88
Charles C. Chung, Stephen J. Chanock. (2011) Current status of genome-wide association studies in cancer. Human Genetics 130:1, 59-78
CrossRef89
T H Ågesen, M Berg, T Clancy, E Thiis-Evensen, L Cekaite, G E Lind, J M Nesland, A Bakka, T Mala, H J Hauss, T Fetveit, M H Vatn, E Hovig, A Nesbakken, R A Lothe, R I Skotheim. (2011) CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer. Genes and Immunity
CrossRef90
Yuan Zheng, Jing-Jun Wang, Liang Sun, Hong-Lei Li. (2011) Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Molecular Biology Reports
CrossRef91
S. Eser, M. Messer, P. Eser, A. von Werder, B. Seidler, M. Bajbouj, R. Vogelmann, A. Meining, J. von Burstin, H. Algul, P. Pagel, A. E. Schnieke, I. Esposito, R. M. Schmid, G. Schneider, D. Saur. (2011) In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging. Proceedings of the National Academy of Sciences 108:24, 9945-9950
CrossRef92
Nega Berhane, Rabinder Chandera Sobti, Salih Abdul Mahdi. (2011) DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Molecular Biology Reports
CrossRef93
Weisheng Shen, Xiangming Cao, Lei Xi, Lichun Deng. (2011) CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis. Molecular Biology Reports
CrossRef94
C. L. Pearce, J. A. Doherty, D. J. Van Den Berg, K. Moysich, C. Hsu, K. L. Cushing-Haugen, D. V. Conti, S. J. Ramus, A. Gentry-Maharaj, U. Menon, S. A. Gayther, P. D. P. Pharoah, H. Song, S. K. Kjaer, E. Hogdall, C. Hogdall, A. S. Whittemore, V. McGuire, W. Sieh, J. Gronwald, K. Medrek, A. Jakubowska, J. Lubinski, G. Chenevix-Trench, , J. Beesley, P. M. Webb, A. Berchuck, J. M. Schildkraut, E. S. Iversen, P. G. Moorman, C. K. Edlund, D. O. Stram, M. C. Pike, R. B. Ness, M. A. Rossing, A. H. Wu. (2011) Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics 20:11, 2263-2272
CrossRef95
H. Zhang, G. Jin, H. Li, C. Ren, Y. Ding, Q. Zhang, B. Deng, J. Wang, Z. Hu, Y. Xu, H. Shen. (2011) Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. Carcinogenesis 32:6, 848-852
CrossRef96
R. Plomin. (2011) Commentary: Why are children in the same family so different? Non-shared environment three decades later. International Journal of Epidemiology 40:3, 582-592
CrossRef97
Zongli Xu, Jeannette T. Bensen, Gary J. Smith, James L. Mohler, Jack A. Taylor. (2011) GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). The Prostate 71:8, 881-891
CrossRef98
Jincai Zhang, Xi Sun, Limin Xiao, Chengjie Xie, Dongying Xuan, Gang Luo. (2011) Gene polymorphisms and periodontitis. Periodontology 2000 56:1, 102-124
CrossRef99
E. Comen, L. Balistreri, M. Gönen, A. Dutra-Clarke, M. Fazio, J. Vijai, Z. Stadler, N. Kauff, T. Kirchhoff, C. Hudis, K. Offit, M. Robson. (2011) Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Research and Treatment 127:2, 479-487
CrossRef100
Yongsheng Huang, Youjin Hao, Binghui Li, Jingtian Xie, Ji Qian, Chen Chao, Long Yu. (2011) Lack of significant association between TGF-β1 -590C/T polymorphism and breast cancer risk: a meta-analysis. Medical Oncology 28:2, 424-428
CrossRef101
Y. Gao, R. B. Hayes, W.-Y. Huang, N. E. Caporaso, L. Burdette, M. Yeager, S. J. Chanock, S. I. Berndt. (2011) DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas. Carcinogenesis 32:6, 882-887
CrossRef102
Qiong Wang, Dongying Gu, Meilin Wang, Zhengdong Zhang, Jinhai Tang, Jinfei Chen. (2011) The E-cadherin ( CDH1) −160C>A Polymorphism Associated with Gastric Cancer Among Asians But Not Europeans. DNA and Cell Biology 30:6, 395-400
CrossRef103
James R. Cerhan. (2011) Host genetics in follicular lymphoma. Best Practice & Research Clinical Haematology 24:2, 121-134
CrossRef104
M R Safarinejad, N Shafiei, S H Safarinejad. (2011) Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Prostate Cancer and Prostatic Diseases 14:2, 105-113
CrossRef105
G. D. Smith. (2011) Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice. International Journal of Epidemiology 40:3, 537-562
CrossRef106
N Shao, B Xu, Y-y Mi, L-x Hua. (2011) IL-10 polymorphisms and prostate cancer risk: a meta-analysis. Prostate Cancer and Prostatic Diseases 14:2, 129-135
CrossRef107
Markus Aly, Fredrik Wiklund, Henrik Grönberg. (2011) Early detection of prostate cancer with emphasis on genetic markers. Acta Oncologica 50:S1, 18-23
CrossRef108
Kasper Broedbaek, Rasmus Ribel-Madsen, Trine Henriksen, Allan Weimann, Morten Petersen, Jon T. Andersen, Shoaib Afzal, Brian Hjelvang, L. Jackson Roberts, Allan Vaag, Pernille Poulsen, Henrik E. Poulsen. (2011) Genetic and environmental influences on oxidative damage assessed in elderly Danish twins. Free Radical Biology and Medicine 50:11, 1488-1491
CrossRef109
A. Daraei, R. Salehi, M. Salehi, M. H. Emami, M. Jonghorbani, F. Mohamadhashem, H. Tavakoli. (2011) Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Medical Oncology
CrossRef110
Ben Zhang, Alicia Beeghly-Fadiel, Jirong Long, Wei Zheng. (2011) Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. The Lancet Oncology 12:5, 477-488
CrossRef111
Jian Gu, Xifeng Wu. (2011) Genetic susceptibility to bladder cancer risk and outcome. Personalized Medicine 8:3, 365-374
CrossRef112
Raju K. Mandal, Vibha Singh, Rakesh Kapoor, R. D. Mittal. (2011) Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population?. Biomarkers 16:3, 236-242
CrossRef113
Sanna Pakkanen, Paula M. Kujala, Nati Ha, Mika P. Matikainen, Johanna Schleutker, Teuvo L.J. Tammela. (2011) Clinical and histopathological characteristics of familial prostate cancer in Finland. BJU Internationalno-no
CrossRef114
Bernd Epe, Markus Fußer. 2011. Endogenous DNA Damage and Its Relevance for the Initiation of Carcinogenesis. , 25-40.
CrossRef115
Romualdo Benigni, Cecilia Bossa. (2011) Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for Predictive Toxicology. Chemical Reviews 111:4, 2507-2536
CrossRef116
Stephen M. Rappaport, He Li, Hasmik Grigoryan, William E. Funk, Evan R. Williams. (2011) Adductomics: Characterizing exposures to reactive electrophiles. Toxicology Letters
CrossRef117
Li-Xin Qiu, Jian Zhang, Wen-Hua Li, Qun-Ling Zhang, Hui Yu, Bi-Yun Wang, Lei-Ping Wang, Jia-Lei Wang, Hui-Jie Wang, Xiao-Jian Liu, Zhi-Guo Luo, Xiang-Hua Wu. (2011) Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility. Molecular Biology Reports 38:4, 2295-2299
CrossRef118
Singh Pooja, Amirtharaj Francis, Hemant Kumar Bid, Sandeep Kumar, Singh Rajender, K. Ramalingam, Kumarasamy Thangaraj, Rituraj Konwar. (2011) Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India. Breast Cancer Research and Treatment 126:3, 739-747
CrossRef119
Anneke C. Blackburn, D. Joseph Jerry. (2011) Map Making in the 21st Century: Charting Breast Cancer Susceptibility Pathways in Rodent Models. Journal of Mammary Gland Biology and Neoplasia 16:1, 57-64
CrossRef120
Jonathan L. Wright, Marian L. Neuhouser, Daniel W. Lin, Erika M. Kwon, Ziding Feng, Elaine A. Ostrander, Janet L. Stanford. (2011) AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk. The Prostate 71:5, 498-506
CrossRef121
Maynard Olson. (2011) Personal genomics to the people. Nature Genetics 43:4, 285-286
CrossRef122
Anders Bjartell. (2011) Genetic Markers and the Risk of Developing Prostate Cancer. European Urology
CrossRef123
Stephan Madersbacher, Antonio Alcaraz, Mark Emberton, Peter Hammerer, Anton Ponholzer, Fritz H. Schröder, Andrea Tubaro. (2011) The influence of family history on prostate cancer risk: implications for clinical management. BJU International 107:5, 716-721
CrossRef124
Jielin Sun, A. Karim Kader, Fang-Chi Hsu, Seong-Tae Kim, Yi Zhu, Aubrey R. Turner, Tao Jin, Zheng Zhang, Jan Adolfsson, Fredrik Wiklund, S. Lilly Zheng, William B. Isaacs, Henrik Grönberg, Jianfeng Xu. (2011) Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. The Prostate 71:4, 421-430
CrossRef125
F. J. Hosking, S. E. Dobbins, R. S. Houlston. (2011) Genome-wide association studies for detecting cancer susceptibility. British Medical Bulletin 97:1, 27-46
CrossRef126
Francesca Marcon, Francesco Silvestrini, Ester Siniscalchi, Domenico Palli, Calogero Saieva, Riccardo Crebelli. (2011) Gene expression in response to ionizing radiation and family history of gastric cancer. Familial Cancer 10:1, 107-118
CrossRef127
Cinnamon S. Bloss, Dilip V. Jeste, Nicholas J. Schork. (2011) Genomics for Disease Treatment and Prevention. Psychiatric Clinics of North America 34:1, 147-166
CrossRef128
Min-Bin Chen, Xiao-Yang Wu, Wei Shen, Mu-Xin Wei, Chen Li, Bin Cai, Guo-Qing Tao, Pei-Hua Lu. (2011) Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects. Breast Cancer Research and Treatment 126:1, 177-183
CrossRef129
George Davey Smith. (2011) Use of genetic markers and gene-diet interactions for interrogating population-level causal influences of diet on health. Genes & Nutrition 6:1, 27-43
CrossRef130
Pei-Hua Lu, Mu-Xin Wei, Shu-Ping Si, Xiao Liu, Wei Shen, Guo-Qing Tao, Min-Bin Chen. (2011) Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies. Breast Cancer Research and Treatment 126:1, 141-148
CrossRef131
B. Frank, B. Hoeft, M. Hoffmeister, J. Linseisen, L. P. Breitling, J. Chang-Claude, H. Brenner, A. Nieters. (2011) Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk. Carcinogenesis 32:2, 190-196
CrossRef132
M Madsen, P K Andersen, M Gerster, A-M Nybo Andersen, K Christensen, M Osler. (2011) Does the association of education with breast cancer replicate within twin pairs? A register-based study on Danish female twins. British Journal of Cancer 104:3, 520-523
CrossRef133
Guangyu Gu, Arthur R. Brothman. (2011) Cytogenomic aberrations associated with prostate cancer. Cancer Genetics 204:2, 57-67
CrossRef134
J W Ho, S-c Choi, Y-f Lee, T C Hui, S S Cherny, M-M Garcia-Barceló, L Carvajal-Carmona, R Liu, S-h To, T-k Yau, C C Chung, C C Yau, S M Hui, P Y Lau, C-h Yuen, Y-w Wong, S Ho, S S Fung, I P Tomlinson, R S Houlston, K K Cheng, P C Sham. (2011) Replication study of SNP associations for colorectal cancer in Hong Kong Chinese. British Journal of Cancer 104:2, 369-375
CrossRef135
Emma L. Turner, Janet Athene Lane, Jenny L. Donovan, Michael J. Davis, Chris Metcalfe, David E. Neal, Freddie C. Hamdy, Richard M. Martin. (2011) Association of diabetes mellitus with prostate cancer: Nested case-control study (Prostate testing for cancer and Treatment study). International Journal of Cancer 128:2, 440-446
CrossRef136
Jacqueline M Vink, Folkert J van Kemenade, Chris J L M Meijer, Mariel K Casparie, Gerrit A Meijer, Dorret I Boomsma. (2011) Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters. European Journal of Human Genetics 19:1, 108-111
CrossRef137
Haiming Sun, Jing Bai, Feng Chen, Yan Jin, Yang Yu, Lianhong Jin, Songbin Fu. (2011) RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects. Breast Cancer Research and Treatment 125:1, 157-161
CrossRef138
Nengjun Yi, Virginia G. Kaklamani, Boris Pasche. (2011) Bayesian Analysis of Genetic Interactions in Case-control Studies, with Application to Adiponectin Genes and Colorectal Cancer Risk. Annals of Human Genetics 75:1, 90-104
CrossRef139
Loreta Strumylaite, Algirdas Bogusevicius, Olegas Abdrachmanovas, Dale Baranauskiene, Rima Kregzdyte, Darius Pranys, Lina Poskiene. (2011) Cadmium concentration in biological media of breast cancer patients. Breast Cancer Research and Treatment 125:2, 511-517
CrossRef140
Renata Midori Hirosawa, Monica Marivo, Juliana de Moura Leite Luengo, Jose Vicente Tagliarini, Emanuel Cellice Castilho, Mariangela de Alencar Marques, Yoshio Kiy, Marilia Martins Silveira Marone, Liciana Vaz de Arruda Silveira, Glaucia Maria Ferreira da Silva Mazeto. (2011) Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?. ISRN Oncology 2011, 1-5
CrossRef141
Jesús Pérez-Losada, Andrés Castellanos-Martín, Jian-Hua Mao. (2011) Cancer evolution and individual susceptibility. Integrative Biology 3:4, 316
CrossRef142
Pei-Hua Lu, Mu-Xin Wei, Jie Yang, Xiao Liu, Guo-Qing Tao, Wei Shen, Min-Bin Chen. (2011) Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Research and Treatment 125:2, 537-543
CrossRef143
Gerd P Pfeifer, Pierre Hainaut. (2011) Next-generation sequencing: emerging lessons on the origins of human cancer. Current Opinion in Oncology 23:1, 62-68
CrossRef144
H. Surowy, A. Rinckleb, M. Luedeke, M. Stuber, A. Wecker, D. Varga, C. Maier, J. Hoegel, W. Vogel. (2011) Heritability of baseline and induced micronucleus frequencies. Mutagenesis 26:1, 111-117
CrossRef145
Sofia Carlsson, Tomas Andersson, Ulf de Faire, Paul Lichtenstein, Karl Michaëlsson, Anders Ahlbom. (2011) Using Twin Controls to Study the Effects of BMI on Mortality. Epidemiology 22:1, 107-108
CrossRef146
Bangshun He, Yuqin Pan, Ying Zhang, Qian Bao, Liping Chen, Zhenlin Nie, Ling Gu, Yeqiong Xu, Shukui Wang. (2011) Effects of genetic variations in the Adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Medical Genetics 12:1, 94
CrossRef147
Henna Mattila, Martin Schindler, Jarkko Isotalo, Tarja Ikonen, Mauno Vihinen, Hannu Oja, Teuvo LJ Tammela, Tiina Wahlfors, Johanna Schleutker. (2011) NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene. BMC Cancer 11:1, 327
CrossRef148
Giuseppe Colloca, Antonella Venturino. (2011) The evolving role of familial history for prostate cancer. Acta Oncologica 50:1, 14-24
CrossRef149
M. Fusser, G. J. Nesse, A. Khobta, N. Xia, H. Li, A. Klungland, B. Epe. (2011) Spontaneous mutagenesis in Csbm/mOgg1-/- mice is attenuated by dietary resveratrol. Carcinogenesis 32:1, 80-85
CrossRef150
Haiming Sun, Jing Bai, Feng Chen, Yan Jin, Yang Yu, Songbin Fu. (2011) Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects. Breast Cancer Research and Treatment 125:1, 175-179
CrossRef151
Charles C. Chung, Joseph Boland, Meredith Yeager, Kevin B. Jacobs, Xijun Zhang, Zuoming Deng, Casey Matthews, Sonja I. Berndt, Stephen J. Chanock. (2011) Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. The Prostaten/a-n/a
CrossRef152
Deborah W Neklason, Michelle W Done, Nykole R Sargent, Ann G Schwartz, Hoda Anton-Culver, Constance A Griffin, Dennis J Ahnen, Joellen M Schildkraut, Gail E Tomlinson, Louise C Strong, Alexander R Miller, Jill E Stopfer, Randall W Burt. (2011) Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer 11:1, 424
CrossRef153
Stephen M Rappaport. (2011) Implications of the exposome for exposure science. Journal of Exposure Science and Environmental Epidemiology 21:1, 5-9
CrossRef154
Fay Kastrinos, Sapna Syngal. (2011) Inherited Colorectal Cancer Syndromes. The Cancer Journal 17:6, 405-415
CrossRef155
Mark M. Pomerantz, Matthew L. Freedman. (2011) The Genetics of Cancer Risk. The Cancer Journal 17:6, 416-422
CrossRef156
Bernd Frank, Michael Hoffmeister, Norman Klopp, Thomas Illig, Jenny Chang-Claude, Hermann Brenner. (2010) Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk. International Journal of Cancer 127:12, 2822-2830
CrossRef157
2010. Toxicology and Risk Assessment of Coumarin: Focus on Human Data. , 272-360.
CrossRef158
Chee Seng Ku, Nasheen Naidoo, Mikael Hartman, Yudi Pawitan. 2010. Genome-wide Association Studies of Cancers. .
CrossRef159
Alexandra E. Gylfe, Johanna Sirkiä, Manuel Ahlsten, Heikki Järvinen, Jukka-Pekka Mecklin, Auli Karhu, Lauri A. Aaltonen. (2010) Somatic mutations and germline sequence variants in patients with familial colorectal cancer. International Journal of Cancer 127:12, 2974-2980
CrossRef160
Jeanna M McCuaig, Celia Greenwood, Cheryl Shuman, David Chitayat, K Joan Murphy, Barry Rosen, Susan Randall Armel. (2010) Breast and ovarian cancer: Y do we forget about dad?. The Lancet Oncology 11:12, 1115-1117
CrossRef161
, Mirjam A. G. Sprangers, Jeff A. Sloan, Andrea Barsevick, Cynthia Chauhan, Amylou C. Dueck, Hein Raat, Quiling Shi, Cornelis J. F. Noorden. (2010) Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Quality of Life Research 19:10, 1395-1403
CrossRef162
Petra G.A. van Boeckel, Hendriek C. Boshuizen, Peter D. Siersema, Alina Vrieling, Anton E. Kunst, Weimin Ye, Malin Sund, Dominique S. Michaud, Valentina Gallo, Elizabeth A. Spencer, Antonia Trichopoulou, Vasiliki Benetou, Philippos Orfanos, Lluis Cirera, Eric J. Duell, Sabine Rohrmann, Silke Hemann, Giovanni Masala, Jonas Manjer, Amalia Mattiello, Bjorn Lindkvist, María-José Sánchez, Valeria Pala, Petra H.M. Peeters, Tonje Braaten, Anne Tjonneland, Susanne Oksbjerg Dalton, Nerea Larranaga, Miren Dorronsoro, Kim Overvad, Anne-Kathrin Illner, Eva Ardanaz, M. Marron, K. Straif, E. Riboli, B. Bueno-de-Mesquita. (2010) No association between educational level and pancreatic cancer incidence in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology 34:6, 696-701
CrossRef163
Jess Tyson, Tamsin M.O. Majerus, Susan Walker, John A.L. Armour. (2010) Screening for common copy-number variants in cancer genes. Cancer Genetics and Cytogenetics 203:2, 316-323
CrossRef164
Luisa Adán, Ana Álvarez-Castro, Antoni Castells. (2010) Aproximación al cáncer colorrectal familiar. Gastroenterología y Hepatología 33:9, 652-659
CrossRef165
Yan Lu, Jianjian Chen, Yanbing Ding, Guangfu Jin, Juan Wu, Hua Huang, Bin Deng, Zhaolai Hua, Yan Zhou, Yongqian Shu, Ping Liu, Zhibin Hu, Jing Shen, Yaochu Xu, Hongbing Shen. (2010) Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population. International Journal of Cancer 127:9, 2183-2189
CrossRef166
Ad Geurts van Kessel. (2010) The ‘omics’ of cancer. Cancer Genetics and Cytogenetics 203:1, 37-42
CrossRef167
Charlotta Ryk, Gunnar Steineck, N. Peter Wiklund, Tommy Nyberg, Petra J. de Verdier. (2010) The (CCTTT)n Microsatellite Polymorphism in the Nitric Oxide Synthase 2 Gene May Influence Bladder Cancer Pathogenesis. The Journal of Urology 184:5, 2150-2157
CrossRef168
Ilir Agalliu, Suzanne M. Leanza, Lorie Smith, Jeffrey M. Trent, John D. Carpten, Joan E. Bailey-Wilson, Robert D. Burk. (2010) Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. The Prostate 70:15, 1716-1727
CrossRef169
Chenyou Jia, Yu Cai, Yushui Ma, Da Fu. (2010) Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. Breast Cancer Research and Treatment 124:2, 521-528
CrossRef170
Mark M. Pomerantz, Matthew L. Freedman. (2010) Genetics of Prostate Cancer Risk. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77:6, 643-654
CrossRef171
M.C.M. Goossens, Jacques De Grève. (2010) Individual cancer risk as a function of current age and risk profile. European Journal of Cancer Prevention 19:6, 485-495
CrossRef172
Li-Xin Qiu, Lei Yao, Jian Zhang, Xiao-Dong Zhu, Xin-Min Zhao, Kai Xue, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Xi-Chun Hu. (2010) XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast Cancer Research and Treatment 124:1, 229-235
CrossRef173
C. Zhang, Z. Fang, Y. Xiong, J. Li, L. Liu, M. Li, W. Zhang, J. Wan. (2010) Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression. Acta Biochimica et Biophysica Sinica 42:11, 834-838
CrossRef174
S. Akamatsu, R. Takata, K. Ashikawa, N. Hosono, N. Kamatani, T. Fujioka, O. Ogawa, M. Kubo, Y. Nakamura, H. Nakagawa. (2010) A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression. Human Molecular Genetics 19:21, 4265-4272
CrossRef175
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Shiang-Jiin Leaw, Bi-Yun Wang, Jia-Lei Wang, Zhi-Gang Cao, Jia-Li Gao, Xi-Chun Hu. (2010) Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment 124:2, 419-424
CrossRef176
Lei Yao, Fang Fang, Yang Zhong, Long Yu. (2010) The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment 124:1, 223-227
CrossRef177
Sima P. Porten, Damien A. Richardson, Anobel Y. Odisho, Jack W. McAninch, Peter R. Carroll, Matthew R. Cooperberg. (2010) Disproportionate Presentation of High Risk Prostate Cancer in a Safety Net Health System. The Journal of Urology 184:5, 1931-1936
CrossRef178
S. M. Rappaport, M. T. Smith. (2010) Environment and Disease Risks. Science 330:6003, 460-461
CrossRef179
Wei Yue, Ji-Ping Wang, Yuebai Li, Ping Fan, Guijian Liu, Nan Zhang, Mark Conaway, Hongkun Wang, Kenneth S. Korach, Wayne Bocchinfuso, Richard Santen. (2010) Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms. International Journal of Cancer 127:8, 1748-1757
CrossRef180
Ru-Yan Liao, Chen Mao, Li-Xin Qiu, Hong Ding, Qing Chen, Hai-Feng Pan. (2010) TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Molecular Biology Reports 37:7, 3227-3232
CrossRef181
Yongsheng Huang, Binghui Li, Ji Qian, Jingtian Xie, Long Yu. (2010) TGF-β1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects. Breast Cancer Research and Treatment 123:3, 863-868
CrossRef182
Zsofia K. Stadler, Joseph Vijai, Peter Thom, Tomas Kirchhoff, Nichole A.L. Hansen, Noah D. Kauff, Mark Robson, Kenneth Offit. (2010) Genome-wide Association Studies of Cancer Predisposition. Hematology/Oncology Clinics of North America 24:5, 973-996
CrossRef183
J. Tomsic, K. Guda, S. Liyanarachchi, H. Hampel, L. Natale, S. D. Markowitz, S. M. Tanner, A. de la Chapelle. (2010) Allele-specific expression of TGFBR1 in colon cancer patients. Carcinogenesis 31:10, 1800-1804
CrossRef184
David J. Gallagher, Andrew Feifer, Jonathan A. Coleman. (2010) Genitourinary Cancer Predisposition Syndromes. Hematology/Oncology Clinics of North America 24:5, 861-883
CrossRef185
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Jia-Lei Wang, Shuang-Shuang He, Xi-Chun Hu. (2010) NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Research and Treatment 123:3, 877-883
CrossRef186
Jane E. Churpek, Kenan Onel. (2010) Heritability of Hematologic Malignancies: From Pedigrees to Genomics. Hematology/Oncology Clinics of North America 24:5, 939-972
CrossRef187
A. Lasa, T. Ramón y Cajal, G. Llort, J. Suela, J. C. Cigudosa, M. Cornet, C. Alonso, A. Barnadas, M. Baiget. (2010) Copy number variations are not modifiers of phenotypic expression in a pair of identical twins carrying a BRCA1 mutation. Breast Cancer Research and Treatment 123:3, 901-905
CrossRef188
Gábor Lakatos, Zsolt Tulassay. (2010) A hasnyálmirigyrák epidemiológiája. Orvosi Hetilap 151:44, 1816-1822
CrossRef189
K. Sabitha, M. Vishnuvardhan Reddy, Kaiser Jamil. (2010) Smoking related risk involved in individuals carrying genetic variants of CYP1A1 gene in head and neck cancer. Cancer Epidemiology 34:5, 587-592
CrossRef190
Dongying Gu, Luhong Zhuang, Huaying Huang, Ping Cao, Danling Wang, Jinhai Tang, Jinfei Chen. (2010) TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls. Breast Cancer Research and Treatment 123:3, 857-861
CrossRef191
Manish A. Shah, Robert C. Kurtz. (2010) Upper Gastrointestinal Cancer Predisposition Syndromes. Hematology/Oncology Clinics of North America 24:5, 815-835
CrossRef192
Tara Bergren, Roschelle Heuberger. (2010) Vitamin D and Breast Cancer Prevention. Nursing for Women's Health 14:5, 368-375
CrossRef193
David J. Gallagher, James D. Smith, Kenneth Offit, Zsofia K. Stadler. (2010) Diagnosing Hereditary Colorectal Cancer. Clinical Colorectal Cancer 9:4, 205-211
CrossRef194
K F Newton, W Newman, J Hill. (2010) Review of Biomarkers in Colorectal Cancer. Colorectal Diseaseno-no
CrossRef195
Katherine S. Garman, Dawn Provenzale. 2010. Colorectal Cancer Screening. , 212-218.
CrossRef196
O. Bratt, H. Garmo, J. Adolfsson, A. Bill-Axelson, L. Holmberg, M. Lambe, P. Stattin. (2010) Effects of Prostate-Specific Antigen Testing on Familial Prostate Cancer Risk Estimates. JNCI Journal of the National Cancer Institute 102:17, 1336-1343
CrossRef197
J. Lascorz, A. Forsti, B. Chen, S. Buch, V. Steinke, N. Rahner, E. Holinski-Feder, M. Morak, H. K. Schackert, H. Gorgens, K. Schulmann, T. Goecke, M. Kloor, C. Engel, R. Buttner, N. Kunkel, M. Weires, M. Hoffmeister, B. Pardini, A. Naccarati, L. Vodickova, J. Novotny, S. Schreiber, M. Krawczak, C. D. Broring, H. Volzke, C. Schafmayer, P. Vodicka, J. Chang-Claude, H. Brenner, B. Burwinkel, P. Propping, J. Hampe, K. Hemminki. (2010) Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility. Carcinogenesis 31:9, 1612-1619
CrossRef198
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Xiang-Hua Wu, Xiao-Jian Liu, Bi-Yun Wang, Xi-Chun Hu. (2010) MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Research and Treatment 123:2, 549-555
CrossRef199
Ryo Takata, Shusuke Akamatsu, Michiaki Kubo, Atsushi Takahashi, Naoya Hosono, Takahisa Kawaguchi, Tatsuhiko Tsunoda, Johji Inazawa, Naoyuki Kamatani, Osamu Ogawa, Tomoaki Fujioka, Yusuke Nakamura, Hidewaki Nakagawa. (2010) Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nature Genetics 42:9, 751-754
CrossRef200
Li-Xin Qiu, Lei Yao, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Kai Xue, Jian Zhang, Xi-Chun Hu. (2010) Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects. Breast Cancer Research and Treatment 123:2, 543-547
CrossRef201
Li-Xin Qiu, Lei Yao, Kai Xue, Jian Zhang, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Xi-Chun Hu. (2010) BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects. Breast Cancer Research and Treatment 123:2, 487-490
CrossRef202
Krister Sjödahl, Jesper Lagergren. (2010) Epidemiological aspects of gastric adenocarcinoma: are predictive diagnostics and targeted preventive measures possible?. The EPMA Journal 1:3, 461-471
CrossRef203
Amreen Dinani, Amit Desai, Nina Kohn, Ellen Gutkin, Michel Nussbaum, Kaumudi Somnay. (2010) High Rates of Advanced Gastric Cancer in Community of Flushing, New York. Journal of Gastrointestinal Cancer
CrossRef204
Raju Kumar Mandal, Rama Devi Mittal. (2010) Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?. Urologic Oncology: Seminars and Original Investigations
CrossRef205
Li-Xin Qiu, Lei Yao, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Hui Yuan, Xi-Chun Hu. (2010) TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects. Breast Cancer Research and Treatment 123:2, 563-567
CrossRef206
S von Holst, S Picelli, D Edler, C Lenander, J Dalén, F Hjern, N Lundqvist, U Lindforss, L Påhlman, K Smedh, A Törnqvist, J Holm, M Janson, M Andersson, S Ekelund, L Olsson, S Ghazi, N Papadogiannakis, A Tenesa, S M Farrington, H Campbell, M G Dunlop, A Lindblom. (2010) Association studies on 11 published colorectal cancer risk loci. British Journal of Cancer 103:4, 575-580
CrossRef207
Nathaniel P. Hitt, Michael Hendryx. (2010) Ecological Integrity of Streams Related to Human Cancer Mortality Rates. EcoHealth 7:1, 91-104
CrossRef208
Haiming Sun, Yuandong Qiao, Xuelong Zhang, Lidan Xu, Xueyuan Jia, Donglin Sun, Chao Shen, An Liu, Yanling Zhao, Yan Jin, Yang Yu, Jing Bai, Songbin Fu. (2010) XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: A meta-analysis. Cancer Science 101:8, 1777-1782
CrossRef209
Li-Xin Qiu, Lei Yao, Hui Yuan, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Xi-Chun Hu. (2010) IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Breast Cancer Research and Treatment 122:3, 867-871
CrossRef210
Victor Enciso-Mora, Fay J Hosking, Richard S Houlston. (2010) Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations. European Journal of Human Genetics 18:8, 909-914
CrossRef211
Brian T. Helfand, Angela J. Fought, Stacy Loeb, Joshua J. Meeks, Donghui Kan, William J. Catalona. (2010) Genetic Prostate Cancer Risk Assessment: Common Variants in 9 Genomic Regions are Associated With Cumulative Risk. The Journal of Urology 184:2, 501-505
CrossRef212
B. Frank, M. Hoffmeister, N. Klopp, T. Illig, J. Chang-Claude, H. Brenner. (2010) Single nucleotide polymorphisms in Wnt signaling and cell death pathway genes and susceptibility to colorectal cancer. Carcinogenesis 31:8, 1381-1386
CrossRef213
Luciano Delgado-Plasencia, Vicente Medina-Arana, Ysamar Barrios del Pino, Antonia Fernández-Peralta, Juan J. González-Aguilera. (2010) Genealogical Tree Study as Screening Method in the Lynch Syndrome Prior to Genetic Test. American Journal of Clinical Oncology 33:4, 376-380
CrossRef214
R. Kvåle, B. Møller, A. Angelsen, O. Dahl, S.D. Fosså, O.J. Halvorsen, L. Hoem, A. Solberg, R. Wahlqvist, F. Bray. (2010) Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980–2007. Cancer Epidemiology 34:4, 359-367
CrossRef215
Abdulbari Bener, Hanadi Rafii El Ayoubi, Awab Ibrahim Ali, Aisha Al-Kubaisi, Haya Al-Sulaiti. (2010) Does consanguinity lead to decreased incidence of breast cancer?. Cancer Epidemiology 34:4, 413-418
CrossRef216
Lei Jiang, Ke-hu Yang, Jin-hui Tian, Quan-lin Guan, Nan Yao, Nong Cao, Deng-hai Mi, Jie Wu, Bin Ma, Sun-hu Yang. (2010) Efficacy of Antioxidant Vitamins and Selenium Supplement in Prostate Cancer Prevention: A Meta-Analysis of Randomized Controlled Trials. Nutrition and Cancer 62:6, 719-727
CrossRef217
James W. Holder. 2010. The Interplay of Cancer and Biology. , 97-167.
CrossRef218
Li-Xin Qiu, Chen Mao, Lei Yao, Ke-Da Yu, Ping Zhan, Bo Chen, Hai-Guang Liu, Hui Yuan, Jian Zhang, Kai Xue, Xi-Chun Hu. (2010) XRCC3 5′-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Breast Cancer Research and Treatment 122:2, 489-493
CrossRef219
Li-Xin Qiu, Lei Yao, Chen Mao, Ke-Da Yu, Ping Zhan, Bo Chen, Hui Yuan, Jian Zhang, Kai Xue, Xi-Chun Hu. (2010) Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. Breast Cancer Research and Treatment 122:2, 521-525
CrossRef220
William R. Carpenter, Daniel L. Howard, Yhenneko J. Taylor, Louie E. Ross, Sara E. Wobker, Paul A. Godley. (2010) Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes & Control 21:7, 1071-1080
CrossRef221
Chen Mao, Li-Xin Qiu, Ping Zhan, Kai Xue, Hong Ding, Fang-Bing Du, Jin Li, Qing Chen. (2010) MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 Subjects. Journal of Cancer Research and Clinical Oncology 136:7, 975-979
CrossRef222
Xiaowei Qi, Fan Zhang, Xinhua Yang, Linjun Fan, Yi Zhang, Li Chen, Yan Zhou, Xianchun Chen, Ling Zhong, Jun Jiang. (2010) Transforming growth factor-β1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case–control studies. Breast Cancer Research and Treatment 122:1, 273-279
CrossRef223
Xin-Min Pan, Lin-Bo Gao, Wei-Bo Liang, Yun Liu, Yi Zhu, Ming Tang, Ying-Bi Li, Lin Zhang. (2010) CD86 +1057 G/A Polymorphism and the Risk of Colorectal Cancer. DNA and Cell Biology 29:7, 381-386
CrossRef224
Lijun Shen, Hezhi Fang, Tao Chen, Jing He, Mei Zhang, Xiaosong Wei, Yijuan Xin, Yulin Jiang, Zhinan Ding, Jingzhang Ji, Jianxin Lu, Yidong Bai. (2010) Evaluating mitochondrial DNA in cancer occurrence and development. Annals of the New York Academy of Sciences 1201:1, 26-33
CrossRef225
Lei Yao, Fang Fang, Qi Wu, Zhen Yang, Yang Zhong, Long Yu. (2010) No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects. Breast Cancer Research and Treatment 122:1, 221-227
CrossRef226
Dongying Gu, Meilin Wang, Zhengdong Zhang, Jinfei Chen. (2010) Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case–control studies. Breast Cancer Research and Treatment 122:2, 527-531
CrossRef227
Ju-Hyun Park, Sholom Wacholder, Mitchell H Gail, Ulrike Peters, Kevin B Jacobs, Stephen J Chanock, Nilanjan Chatterjee. (2010) Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nature Genetics 42:7, 570-575
CrossRef228
Fang Fang, Lei Yao, Xiao Jia Yu, Lu Yu, Qi Wu, Long Yu. (2010) TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Research and Treatment 122:1, 267-271
CrossRef229
Lei Yao, Fang Fang, Qi Wu, Yang Zhong, Long Yu. (2010) No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects. Breast Cancer Research and Treatment 122:1, 237-242
CrossRef230
Steven J. Hawken, Celia M. T. Greenwood, Thomas J. Hudson, Rafal Kustra, John McLaughlin, Quanhe Yang, Brent W. Zanke, Julian Little. (2010) The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Human Genetics 128:1, 89-101
CrossRef231
Arturas Petronis. (2010) Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465:7299, 721-727
CrossRef232
Simon A Gayther, Paul DP Pharoah. (2010) The inherited genetics of ovarian and endometrial cancer. Current Opinion in Genetics & Development 20:3, 231-238
CrossRef233
Min Liu, Min Su, Dong-Ping Tian, Guo-Hong Zhang, He-Lin Yang, Yu-Xia Gao. (2010) Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China. Familial Cancer 9:2, 229-238
CrossRef234
Boris Pasche, Nengjun Yi. (2010) Candidate gene association studies: successes and failures. Current Opinion in Genetics & Development 20:3, 257-261
CrossRef235
Roland P Kuiper, Marjolijn JL Ligtenberg, Nicoline Hoogerbrugge, Ad Geurts van Kessel. (2010) Germline copy number variation and cancer risk. Current Opinion in Genetics & Development 20:3, 282-289
CrossRef236
Jajini Susan Varghese, Douglas F Easton. (2010) Genome-wide association studies in common cancers—what have we learnt?. Current Opinion in Genetics & Development 20:3, 201-209
CrossRef237
Li-Xin Qiu, Hui Yuan, Ke-Da Yu, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Xi-Chun Hu. (2010) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Research and Treatment 121:3, 703-708
CrossRef238
S Karami, K Schwartz, M P Purdue, F G Davis, J J Ruterbusch, S S Munuo, S Wacholder, B I Graubard, J S Colt, W-H Chow. (2010) Family history of cancer and renal cell cancer risk in Caucasians and African Americans. British Journal of Cancer 102:11, 1676-1680
CrossRef239
Rulla M. Tamimi, Pagona Lagiou, Kamila Czene, Jianjun Liu, Anders Ekbom, Chung-Cheng Hsieh, Hans-Olov Adami, Dimitrios Trichopoulos, Per Hall. (2010) Birth weight, breast cancer susceptibility loci, and breast cancer risk. Cancer Causes & Control 21:5, 689-696
CrossRef240
N. Obel, K. Christensen, I. Petersen, T. I. A. Sorensen, A. Skytthe. (2010) Genetic and Environmental Influences on Risk of Death due to Infections Assessed in Danish Twins, 1943-2001. American Journal of Epidemiology 171:9, 1007-1013
CrossRef241
Olivia Fletcher, Richard S. Houlston. (2010) Architecture of inherited susceptibility to common cancer. Nature Reviews Cancer 10:5, 353-361
CrossRef242
Sandra Demaria, Eli Pikarsky, Michael Karin, Lisa M. Coussens, Yen-Ching Chen, Emad M. El-Omar, Giorgio Trinchieri, Steven M. Dubinett, Jenny T. Mao, Eva Szabo, Arthur Krieg, George J. Weiner, Bernard A. Fox, George Coukos, Ena Wang, Robert T. Abraham, Michele Carbone, Michael T. Lotze. (2010) Cancer and Inflammation: Promise for Biologic Therapy. Journal of Immunotherapy 33:4, 335-351
CrossRef243
Raju K. Mandal, Ruchika Gangwar, Anil Mandhani, Rama Devi Mittal. (2010) DNA Repair Gene X-Ray Repair Cross-Complementing Group 1 and Xeroderma Pigmentosum Group D Polymorphisms and Risk of Prostate Cancer: A Study from North India. DNA and Cell Biology 29:4, 183-190
CrossRef244
Simone Picelli, Pawel Zajac, Xiao-Lei Zhou, David Edler, Claes Lenander, Johan Dalén, Fredrik Hjern, Nils Lundqvist, Ulrik Lindforss, Lars Påhlman, Kennet Smedh, Anders Törnqvist, Jörn Holm, Martin Janson, Magnus Andersson, Susanne Ekelund, Louise Olsson, Joakim Lundeberg, Annika Lindblom. (2010) Common variants in human CRC genes as low-risk alleles. European Journal of Cancer 46:6, 1041-1048
CrossRef245
David O Carpenter MD. (2010) Human health effects of EMFs: The cost of doing nothing. IOP Conference Series: Earth and Environmental Science 10, 012004
CrossRef246
(2010) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Research and Treatment 120:3, 727-736
CrossRef247
Uffe Birk Jensen, Lone Sunde, Susanne Timshel, Britta Halvarsson, Anja Nissen, Inge Bernstein, Mef Nilbert. (2010) Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome. Breast Cancer Research and Treatment 120:3, 777-782
CrossRef248
Ramal Moonesinghe, Tiebin Liu, Muin J Khoury. (2010) Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases. European Journal of Human Genetics 18:4, 485-489
CrossRef249
Yong Sung Choi, Jung Pil Suh, Doo Seok Lee, Eui Gon Youk, In Taek Lee, Suk Hee Lee, Do Sun Kim, Doo Han Lee. (2010) Colonoscopy screening for individuals aged 40–49 years with a family history of stomach cancer in Korea. International Journal of Colorectal Disease 25:4, 443-447
CrossRef250
Julia G.Brody,. (2010) Everyday Exposures and Breast Cancer. Reviews on Environmental Health 25:1, 1-8
CrossRef251
Bin Wang, Dan Wang, Gang Huang, Chao Zhang, Dong-hua Xu, Weiping Zhou. (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. International Journal of Colorectal Disease 25:3, 313-321
CrossRef252
Antonella Galvan, John P.A. Ioannidis, Tommaso A. Dragani. (2010) Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. Trends in Genetics 26:3, 132-141
CrossRef253
A. Galvan, F. S. Falvella, E. Frullanti, M. Spinola, M. Incarbone, M. Nosotti, L. Santambrogio, B. Conti, U. Pastorino, A. Gonzalez-Neira, T. A. Dragani. (2010) Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer. Carcinogenesis 31:3, 462-465
CrossRef254
Gayathri Sridhar, Saba W. Masho, Tilahun Adera, Viswanathan Ramakrishnan, John D. Roberts. (2010) Association between family history of cancers and risk of prostate cancer. Journal of Men's Health 7:1, 45-54
CrossRef255
Ilir Agalliu, Erika M. Kwon, Claudia A. Salinas, Joseph S. Koopmeiners, Elaine A. Ostrander, Janet L. Stanford. (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control 21:2, 289-300
CrossRef256
Toshikazu Ushijima, Kiyoshi Asada. (2010) Aberrant DNA methylation in contrast with mutations. Cancer Science 101:2, 300-305
CrossRef257
Yun Tian, Yi Li, Zhenhua Hu, Daqing Wang, Xiyang Sun, Changshan Ren. (2010) Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. International Journal of Colorectal Disease 25:2, 161-168
CrossRef258
Melissa S. Nise, Puran Falaturi, Thomas C. Erren. (2010) Epigenetics: Origins and implications for cancer epidemiology. Medical Hypotheses 74:2, 377-382
CrossRef259
Nobuko Mori. (2010) Two Loci Controlling Susceptibility to Radiation-Induced Lymphomagenesis on Mouse Chromosome 4: Cdkn2a , a Candidate for One Locus, and a Novel Locus Distinct from Cdkn2a. Radiation Research 173:2, 158-164
CrossRef260
Nilüfer Rahmioğlu, Kourosh R Ahmadi. (2010) Classical twin design in modern pharmacogenomics studies. Pharmacogenomics 11:2, 215-226
CrossRef261
Xing-xing XU, Wen-jun CHANG, Jian-guo HOU, Dan-feng XU, Xin-gang CUI, Yu-jia ZHAI, Guo-ping WANG, Hong-wei ZHANG, Guang-wen CAO. (2010) Relationship of GSTP1,RASSF1A polymorphisms and environmental agent with susceptibility to prostate cancer:a case-control study. Academic Journal of Second Military Medical University 30:1, 12-17
CrossRef262
Z Kote-Jarai, D Leongamornlert, M Tymrakiewicz, H Field, M Guy, A A Al Olama, J Morrison, L O'Brien, R Wilkinson, A Hall, E Sawyer, K Muir, F Hamdy, J Donovan, D Neal, D Easton, R Eeles. (2010) Mutation analysis of the MSMB gene in familial prostate cancer. British Journal of Cancer 102:2, 414-418
CrossRef263
I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger, T Hudson, T Koessler, P D Pharoah, I Niittymäkix, S Tuupanenx, L A Aaltonen, K Hemminki, A Lindblom, A Försti, O Sieber, L Lipton, T van Wezel, H Morreau, J T Wijnen, P Devilee, K Matsuda, Y Nakamura, S Castellví-Bel, C Ruiz-Ponte, A Castells, A Carracedo, J W C Ho, P Sham, R M W Hofstra, P Vodicka, H Brenner, J Hampe, C Schafmayer, J Tepel, S Schreiber, H Völzke, M M Lerch, C A Schmidt, S Buch, V Moreno, C M Villanueva, P Peterlongo, P Radice, M M Echeverry, A Velez, L Carvajal-Carmona, R Scott, S Penegar, P Broderick, A Tenesa, R S Houlston. (2010) COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British Journal of Cancer 102:2, 447-454
CrossRef264
M. Arora, J. Weuve, K. Fall, N. L. Pedersen, L. A. Mucci. (2010) An Exploration of Shared Genetic Risk Factors Between Periodontal Disease and Cancers: A Prospective Co-Twin Study. American Journal of Epidemiology 171:2, 253-259
CrossRef265
I. Kramer. (2010) Widespread Immunity to Breast and Prostate Cancers is Predicted by a Novel Model that also Determines Sporadic and Hereditary Susceptible Population Sizes. Mathematical Modelling of Natural Phenomena 5:3, 134-164
CrossRef266
Kojiro Yano. (2010) Gene expression correlation analysis predicts involvement of high- and low-confidence risk genes in different stages of prostate carcinogenesis. The Prostaten/a-n/a
CrossRef267
Hui Cao, Zhong Xu, Hao Long, Xiao-Qing Li, Shao-Lin Li. (2010) The -765C Allele of the Cyclooxygenase-2 Gene as a Potential Risk Factor of Colorectal Cancer: A Meta-Analysis. The Tohoku Journal of Experimental Medicine 222:1, 15-21
CrossRef268
Anneke Middeldorp, Shantie C. Jagmohan-Changur, Heleen M. van der Klift, Marjo van Puijenbroek, Jeanine J. Houwing-Duistermaat, Emily Webb, Richard Houlston, Carli Tops, Hans F. A. Vasen, Peter Devilee, Hans Morreau, Tom van Wezel, Juul Wijnen. (2010) Comprehensive genetic analysis of seven large families with mismatch repair proficient colorectal cancer. Genes, Chromosomes and CancerNA-NA
CrossRef269
Thomas E. Rohan, Lee-Jun Wong, Tao Wang, Jonathan Haines, Geoffrey C. Kabat. (2010) Do Alterations in Mitochondrial DNA Play a Role in Breast Carcinogenesis?. Journal of Oncology 2010, 1-11
CrossRef270
Seong-Tae Kim, Yu Cheng, Fang-Chi Hsu, Tao Jin, A. Karim Kader, S. Lilly Zheng, William B. Isaacs, Jianfeng Xu, Jielin Sun. (2010) Prostate cancer risk-associated variants reported from genome-wide association studies: Meta-analysis and their contribution to genetic Variation. The Prostaten/a-n/a
CrossRef271
Wendy K. Chung. 2010. Gender Differences in Hereditary Cancer SyndromesRisks, Management, and Testing for Inherited Predisposition to Cancer. , 481-494.
CrossRef272
Markowitz, Sanford D., Bertagnolli, Monica M., . (2009) Molecular Basis of Colorectal Cancer. New England Journal of Medicine 361:25, 2449-2460
Full Text273
M. Chen, A. Cassidy, J. Gu, G. L. Delclos, F. Zhen, H. Yang, M. A.T. Hildebrandt, J. Lin, Y. Ye, R. M. Chamberlain, C. P. Dinney, X. Wu. (2009) Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk. Carcinogenesis 30:12, 2047-2052
CrossRef274
Li-Xin Qiu, Bo Chen, Chen Mao, Ping Zhan, Hui Yuan, Kai Xue, Jin Li, Xi-Chun Hu. (2009) STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25,014 subjects. Breast Cancer Research and Treatment 118:3, 599-603
CrossRef275
Meredith Yeager, Zuoming Deng, Joseph Boland, Casey Matthews, Jennifer Bacior, Victor Lonsberry, Amy Hutchinson, Laura A. Burdett, Liqun Qi, Kevin B. Jacobs, Jesus Gonzalez-Bosquet, Sonja I. Berndt, Richard B. Hayes, Robert N. Hoover, Gilles Thomas, David J. Hunter, Michael Dean, Stephen J. Chanock. (2009) Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Human Genetics 126:6, 743-750
CrossRef276
Pravin Kesarwani, Anil Mandhani, Rama Devi Mittal. (2009) Polymorphisms in Tumor Necrosis Factor-A Gene and Prostate Cancer Risk in North Indian Cohort. The Journal of Urology 182:6, 2938-2943
CrossRef277
Sara Raimondi, Patrick Maisonneuve, Albert B. Lowenfels. (2009) Epidemiology of pancreatic cancer: an overview. Nature Reviews Gastroenterology & Hepatology 6:12, 699-708
CrossRef278
J E Elkahwaji, R J Hauke, C M Brawner. (2009) Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. British Journal of Cancer 101:10, 1740-1748
CrossRef279
Adrian Cassidy, Jessica Balsan, Aurélien Vesin, Xifeng Wu, Triantafillos Liloglou, Christian Brambilla, Jean-François Timsit, John K. Field. (2009) Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case–control study in Europe. European Journal of Cancer 45:17, 3047-3053
CrossRef280
William R. Carpenter, Paul A. Godley, Jack A. Clark, James A. Talcott, Timothy Finnegan, Merle Mishel, Jeannette Bensen, Walter Rayford, L. Joseph Su, Elizabeth T. H. Fontham, James L. Mohler. (2009) Racial differences in trust and regular source of patient care and the implications for prostate cancer screening use. Cancer 115:21, 5048-5059
CrossRef281
Rongxi Yang, Bowang Chen, Kari Hemminki, Barbara Wappenschmidt, Christoph Engel, Christian Sutter, Nina Ditsch, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Alfons Meindl, Claus R. Bartram, Rita K. Schmutzler, Barbara Burwinkel. (2009) Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk. Breast Cancer Research and Treatment 118:2, 407-413
CrossRef282
Matthew J Walter, Timothy A Graubert, John F DiPersio, Elaine R Mardis, Richard K Wilson, Timothy J Ley. (2009) Next-generation sequencing of cancer genomes: back to the future. Personalized Medicine 6:6, 653-662
CrossRef283
Emily Webb, Peter Broderick, Steven Lubbe, Ian Chandler, Ian Tomlinson, Richard S Houlston. (2009) A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk. European Journal of Human Genetics 17:11, 1507-1514
CrossRef284
Gordon Fehringer, Norman F. Boyd, Julia A. Knight, Andrew D. Paterson, Gillian S. Dite, Graham G. Giles, Melissa C. Southey, Irene L. Andrulis, John L. Hopper, Hilmi Ozcelik. (2009) Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk. Breast Cancer Research and Treatment 118:2, 415-424
CrossRef285
S. Bloethner, D. Scherer, M. Drechsel, K. Hemminki, R. Kumar. (2009) Malignant Melanoma–a Genetic Overview. Actas Dermo-Sifiliográficas 100, 38-51
CrossRef286
M.E. MCDOWELL, S. OCCHIPINTI, R.A. GARDINER, P.D. BAADE, S.K. STEGINGA. (2009) A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. European Journal of Cancer Care 18:6, 545-555
CrossRef287
Alan M. Pittman, Philip Twiss, Peter Broderick, Steven Lubbe, Ian Chandler, Steven Penegar, Richard S. Houlston. (2009) The CDH1 -160C>A polymorphism is a risk factor for colorectal cancer. International Journal of Cancer 125:7, 1622-1625
CrossRef288
Vincenzo Calvanese, Ester Lara, Arnold Kahn, Mario F. Fraga. (2009) The role of epigenetics in aging and age-related diseases. Ageing Research Reviews 8:4, 268-276
CrossRef289
Luigi Fontana. (2009) Modulating human aging and age-associated diseases. Biochimica et Biophysica Acta (BBA) - General Subjects 1790:10, 1133-1138
CrossRef290
Loïc Le Marchand. (2009) Genome-Wide Association Studies and Colorectal Cancer. Surgical Oncology Clinics of North America 18:4, 663-668
CrossRef291
Xiaoyong Wang, Jing Yang, Bo Ho, Yang Yang, Zuhu Huang, Zhihong Zhang, Guoxin Zhang. (2009) Interaction of Helicobacter pylori with Genetic Variants in the MDM2 Promoter, is Associated with Gastric Cancer Susceptibility in Chinese Patients. Helicobacter 14:5, 466-471
CrossRef292
Stacy Loeb, Edward M. Schaeffer. (2009) Risk Factors, Prevention and Early Detection of Prostate Cancer. Primary Care: Clinics in Office Practice 36:3, 603-621
CrossRef293
Xifeng Wu, Yuanqing Ye, Lambertus A Kiemeney, Patrick Sulem, Thorunn Rafnar, Giuseppe Matullo, Daniela Seminara, Teruhiko Yoshida, Norihisa Saeki, Angeline S Andrew, Colin P Dinney, Bogdan Czerniak, Zuo-feng Zhang, Anne E Kiltie, D Timothy Bishop, Paolo Vineis, Stefano Porru, Frank Buntinx, Eliane Kellen, Maurice P Zeegers, Rajiv Kumar, Peter Rudnai, Eugene Gurzau, Kvetoslava Koppova, Jose Ignacio Mayordomo, Manuel Sanchez, Berta Saez, Annika Lindblom, Petra de Verdier, Gunnar Steineck, Gordon B Mills, Alan Schned, Simonetta Guarrera, Silvia Polidoro, Shen-Chih Chang, Jie Lin, David W Chang, Katherine S Hale, Tadeusz Majewski, H Barton Grossman, Steinunn Thorlacius, Unnur Thorsteinsdottir, Katja K H Aben, J Alfred Witjes, Kari Stefansson, Christopher I Amos, Margaret R Karagas, Jian Gu. (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nature Genetics 41:9, 991-995
CrossRef294
Sri N Shekar, David L Duffy, Philippa Youl, Amanda J Baxter, Marina Kvaskoff, David C Whiteman, Adèle C Green, Maria C Hughes, Nicholas K Hayward, Marylon Coates, Nicholas G Martin. (2009) A Population-Based Study of Australian Twins with Melanoma Suggests a Strong Genetic Contribution to Liability. Journal of Investigative Dermatology 129:9, 2211-2219
CrossRef295
A Murad, S J Lewis, G Davey Smith, S M Collin, L Chen, F C Hamdy, D E Neal, J Donovan, R M Martin. (2009) PTGS2–899G>C and prostate cancer risk: a population-based nested case–control study (ProtecT) and a systematic review with meta-analysis. Prostate Cancer and Prostatic Diseases 12:3, 296-300
CrossRef296
Ross L Levine. (2009) Inherited susceptibility to pediatric acute lymphoblastic leukemia. Nature Genetics 41:9, 957-958
CrossRef297
Yan Liu, Qian-Jun Wen, You Yin, Xiao-Tong Lu, Shu-Hong Pu, Huai-Ping Tian, Yue-Fen Lou, Yue-Nian Tang, Xin Jiang, Gen-Sheng Lu, Jian Zhang. (2009) FASLG polymorphism is associated with cancer risk. European Journal of Cancer 45:14, 2574-2578
CrossRef298
Leon Mullenders, Mike Atkinson, Herwig Paretzke, Laure Sabatier, Simon Bouffler. (2009) Assessing cancer risks of low-dose radiation. Nature Reviews Cancer 9:8, 596-604
CrossRef299
J. Zabaleta, L. J. Su, H.-Y. Lin, R. A. Sierra, M. C. Hall, A. O. Sartor, P. E. Clark, J. J. Hu, A. C. Ochoa. (2009) Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30:8, 1358-1362
CrossRef300
Natalie Jones, Stefanie Vogt, Maartje Nielsen, Daria Christian, Petra A. Wark, Diana Eccles, Emma Edwards, D. Gareth Evans, Eamonn R. Maher, Hans F. Vasen, Frederik J. Hes, Stefan Aretz, Julian R. Sampson. (2009) Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH. Gastroenterology 137:2, 489-494.e1
CrossRef301
Mario F Fraga. (2009) Genetic and epigenetic regulation of aging. Current Opinion in Immunology 21:4, 446-453
CrossRef302
Petra A. Wark, Kana Wu, Pieter van 't Veer, Charles F. Fuchs, Edward L. Giovannucci. (2009) Family history of colorectal cancer: A determinant of advanced adenoma stage or adenoma multiplicity?. International Journal of Cancer 125:2, 413-420
CrossRef303
Andreas Meyer, Peter Schürmann, Maryam Ghahremani, Ertan Kocak, Maria-Jantje Brinkhaus, Michael Bremer, Johann H. Karstens, Jörn Hagemann, Stefan Machtens, Thilo Dörk. (2009) Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy. Urologic Oncology: Seminars and Original Investigations 27:4, 373-376
CrossRef304
Sharon A. Chung, Theresa K. Wolf, Colin M. Shapiro. (2009) Sleep and Health Consequences of Shift Work in Women. Journal of Women's Health 18:7, 965-977
CrossRef305
Zachary Klinghoffer, Brian Yang, Anil Kapoor, Jehonathan H Pinthus. (2009) Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations. Expert Review of Anticancer Therapy 9:7, 975-987
CrossRef306
Pravin Kesarwani, Dinesh Kumar Ahirwar, Anil Mandhani, Anand Narayan Singh, Divakar Dalela, Anand Narain Srivastava, Rama D. Mittal. (2009) IL-10 −1082 G>A: a risk for prostate cancer but may be protective against progression of prostate cancer in North Indian cohort. World Journal of Urology 27:3, 389-396
CrossRef307
Albert Tenesa, Malcolm G. Dunlop. (2009) New insights into the aetiology of colorectal cancer from genome-wide association studies. Nature Reviews Genetics 10:6, 353-358
CrossRef308
P. Hodek, J. Křížková, K. Burdová, M. Šulc, R. Kizek, J. Hudeček, M. Stiborová. (2009) Chemopreventive compounds—View from the other side. Chemico-Biological Interactions 180:1, 1-9
CrossRef309
Maya Ghoussaini, Paul DP Pharoah. (2009) Polygenic susceptibility to breast cancer: current state-of-the-art. Future Oncology 5:5, 689-701
CrossRef310
Shahjahan Kabir. (2009) Effect of Helicobacter pylori Eradication on Incidence of Gastric Cancer in Human and Animal Models: Underlying Biochemical and Molecular Events. Helicobacter 14:3, 159-171
CrossRef311
Gül Dölen, Mark F. Bear. (2009) Fragile x syndrome and autism: from disease model to therapeutic targets. Journal of Neurodevelopmental Disorders 1:2, 133-140
CrossRef312
Arnoud Templeton, Giancarlo Marra, Emanuele Valtorta, Karl Heinimann, Hansjakob Müller, Dieter Köberle, Silke Gillessen. (2009) Concordant colon tumors in monozygotic twins previously treated for prostate cancer. Familial Cancer 8:2, 167-171
CrossRef313
Daniel H. Kim, Beth Crawford, John Ziegler, Mary S. Beattie. (2009) Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations. Familial Cancer 8:2, 153-158
CrossRef314
J Skoglund Lundin, J Vandrovcova, B Song, X Zhou, M Zelada-Hedman, B Werelius, R S Houlston, A Lindblom. (2009) TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk. British Journal of Cancer 100:10, 1674-1679
CrossRef315
L. G. Carvajal-Carmona, S. Spain, , D. Kerr, R. Houlston, J.-B. Cazier, I. Tomlinson. (2009) Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Human Molecular Genetics 18:10, 1889-1892
CrossRef316
, , Sharon E. Johnatty, Jonathan Beesley, Xiaoqing Chen, John L. Hopper, Melissa C. Southey, Graham G. Giles, David E. Goldgar, Georgia Chenevix-Trench, Amanda B. Spurdle. (2009) The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis. Breast Cancer Research and Treatment 115:1, 145-150
CrossRef317
Li-Xin Qiu, Jian Shi, Hui Yuan, Xin Jiang, Kai Xue, Hai-Feng Pan, Jin Li, Ming-Hua Zheng. (2009) FAS −1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls. Human Genetics 125:4, 431-435
CrossRef318
Neil E. Fleshner, Nathan Lawrentschuk. (2009) Risk of Developing Prostate Cancer in the Future: Overview of Prognostic Biomarkers. Urology 73:5, S21-S27
CrossRef319
Pravin Kesarwani, Ranjana Singh, Rama Devi Mittal. (2009) Association of GSTM3 intron 6 variant with cigarette smoking, tobacco chewing and alcohol as modifier factors for prostate cancer risk. Archives of Toxicology 83:4, 351-356
CrossRef320
Kaarthik John, Narasimhan Ragavan, M. Margaret Pratt, Paras B. Singh, Salah Al-Buheissi, Shyam S. Matanhelia, David H. Phillips, Miriam C. Poirier, Francis L. Martin. (2009) Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. The Prostate 69:5, 505-519
CrossRef321
Dimitrios H. Roukos. (2009) Genome-Wide Association Studies and Aggressive Surgery Toward Individualized Prevention, and Improved Local Control and Overall Survival for Gastric Cancer. Annals of Surgical Oncology 16:4, 795-798
CrossRef322
Peter A. Fasching, Simon Gayther, Leigh Pearce, Joellen M. Schildkraut, Ellen Goode, Falk Thiel, Georgia Chenevix-Trench, Jenny Chang-Claude, Shan Wang-Gohrke, Susan Ramus, Paul Pharoah, Andrew Berchuck. (2009) Role of genetic polymorphisms and ovarian cancer susceptibility. Molecular Oncology 3:2, 171-181
CrossRef323
Sara E. Wagner, James B. Burch, Jim Hussey, Tom Temples, Susan Bolick-Aldrich, Catishia Mosley-Broughton, Yuan Liu, James R. Hebert. (2009) Soil zinc content, groundwater usage, and prostate cancer incidence in South Carolina. Cancer Causes & Control 20:3, 345-353
CrossRef324
Carli M.J. Tops, Juul Th. Wijnen, Frederik J. Hes. (2009) Introduction to molecular and clinical genetics of colorectal cancer syndromes. Best Practice & Research Clinical Gastroenterology 23:2, 127-146
CrossRef325
Bhalchandra A. Diwan, Olga Timofeeva, Jerry M. Rice, Yili Yang, Nirmala Sharma, Mark E. Fortini, Honghe Wang, Alan O. Perantoni. (2009) Inheritance of susceptibility to induction of nephroblastomas in the Noble rat. Differentiation 77:4, 424-432
CrossRef326
L Quaye, H Song, S J Ramus, A Gentry-Maharaj, E Høgdall, R A DiCioccio, V McGuire, A H Wu, D J Van Den Berg, M C Pike, E Wozniak, J A Doherty, M A Rossing, R B Ness, K B Moysich, C Høgdall, J Blaakaer, D F Easton, B A J Ponder, I J Jacobs, U Menon, A S Whittemore, S Krüger-Kjaer, C L Pearce, P D P Pharoah, S A Gayther. (2009) Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer 100:6, 993-1001
CrossRef327
Ruchika Gangwar, Dinesh Ahirwar, Anil Mandhani, Rama Devi Mittal. (2009) Influence of XPD and APE1 DNA Repair Gene Polymorphism on Bladder Cancer Susceptibility in North India. Urology 73:3, 675-680
CrossRef328
Stefano Landi. (2009) Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature. Mutation Research/Reviews in Mutation Research 681:2-3, 299-307
CrossRef329
Andrea V. Burri, Lynn M. Cherkas, Tim D. Spector. (2009) The Genetics and Epidemiology of Female Sexual Dysfunction: A Review. Journal of Sexual Medicine 6:3, 646-657
CrossRef330
Jie Shen, Christine B. Ambrosone, Hua Zhao. (2009) Novel genetic variants in microRNA genes and familial breast cancer. International Journal of Cancer 124:5, 1178-1182
CrossRef331
Steven C. Moore, Michael F. Leitzmann, Demetrius Albanes, Stephanie J. Weinstein, Kirk Snyder, Jarmo Virtamo, Jiyoung Ahn, Susan T. Mayne, Herbert Yu, Ulrike Peters, Marc J. Gunter. (2009) Adipokine genes and prostate cancer risk. International Journal of Cancer 124:4, 869-876
CrossRef332
J. Martellucci, S. Civitelli, A. Dhamo, G. Tanzini. (2009) Familial colorectal cancer: a concept revisited. Colorectal Disease 11:2, 133-137
CrossRef333
Li-Xin Qiu, Ru-Tian Li, Jian-Bing Zhang, Wen-Zhao Zhong, Jian-Ling Bai, Bao-Rui Liu, Ming-Hua Zheng, Xiao-Ping Qian. (2009) The E-cadherin (CDH1) −160 C/A polymorphism and prostate cancer risk: a meta-analysis. European Journal of Human Genetics 17:2, 244-249
CrossRef334
C L Pearce, A M Near, D J Van Den Berg, S J Ramus, A Gentry-Maharaj, U Menon, S A Gayther, A R Anderson, C K Edlund, A H Wu, X Chen, J Beesley, P M Webb, S K Holt, C Chen, J A Doherty, M A Rossing, A S Whittemore, V McGuire, R A DiCioccio, M T Goodman, G Lurie, M E Carney, L R Wilkens, R B Ness, K B Moysich, R Edwards, E Jennison, S K Kjaer, E Hogdall, C K Hogdall, E L Goode, T A Sellers, R A Vierkant, J C Cunningham, J M Schildkraut, A Berchuck, P G Moorman, E S Iversen, D W Cramer, K L Terry, A F Vitonis, L Titus-Ernstoff, H Song, P D P Pharoah, A B Spurdle, H Anton-Culver, A Ziogas, W Brewster, V Galitovskiy, G Chenevix-Trench. (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer 100:2, 412-420
CrossRef335
A. Wienke, S. Ripatti, J. Palmgren, A. Yashin. (2009) A bivariate survival model with compound Poisson frailty. Statistics in Medicinen/a-n/a
CrossRef336
Tiva T. VanCleave, Jason H. Moore, Marnita L. Benford, Guy N. Brock, Ted Kalbfleisch, Richard N. Baumgartner, James W. Lillard, Rick A. Kittles, La Creis R. Kidd. (2009) Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. The Prostaten/a-n/a
CrossRef337
Jānis Gardovskis, Ilze Štrumfa, Edvīns Miklaševičs, Arvīds Irmejs, Genādijs Trofimovičs, Egils Vjaters, Viktors Borošenko, Inga Melbārde-Gorkuša, Andris Gardovskis, Andrejs Vanags, Andris Ābele, Signe Subatniece, Marianna Bitiņa, Liāna Švampāne, Jekaterina Žestkova, Dace Bērziņa, Karina Aksenoka, Viesturs Boka, Aldis Puķītis, Aiga Stāka, Laima Tihomirova. (2009) Epidemiological, Clinical, Molecular Features and Early Detection Strategy of Most Frequent Hereditary Cancers in Latvia. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 63:4, 131-140
CrossRef338
Dimitrios H Roukos. (2009) Assessing both genetic variation (SNPs/CNVs) and gene–environment interactions may lead to personalized gastric cancer prevention. Expert Review of Molecular Diagnostics 9:1, 1-6
CrossRef339
Nick M. Makridakis, Lúcio Fábio Caldas Ferraz, Juergen K.V. Reichardt. (2009) Genomic analysis of cancer tissue reveals that somatic mutations commonly occur in a specific motif. Human Mutation 30:1, 39-48
CrossRef340
Yanhua Chen, Ruiping Zhang, Yongmei Song, Jiuming He, Jianghao Sun, Jinfa Bai, Zhuoling An, Lijia Dong, Qimin Zhan, Zeper Abliz. (2009) RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. The Analyst 134:10, 2003
CrossRef341
Sana Sfar, Hamadi Saad, Faouzi Mosbah, Lotfi Chouchane. (2009) Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness. Molecular Biology Reports 36:1, 37-45
CrossRef342
Peh Yean Cheah. (2009) Recent advances in colorectal cancer genetics and diagnostics. Critical Reviews in Oncology/Hematology 69:1, 45-55
CrossRef343
Jessica Lubahn, Sonja I. Berndt, Carol H. Jin, Aleksandra Klim, Jason Luly, William S. Wu, Sarah Isaacs, Kathleen Wiley, William B. Isaacs, Brian K. Suarez, Richard B. Hayes, Adam S. Kibel. (2009) Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. The Prostaten/a-n/a
CrossRef344
M. Greaves. (2009) Darwin and evolutionary tales in leukemia. Hematology 2009:1, 3-12
CrossRef345
Richard J. Santen. 2009. Breast Cancer. , 659-686.
CrossRef346
Gareth Evans. 2009. Risk assessment and management. , 327-337.
CrossRef347
E Webb, P Broderick, I Chandler, S Lubbe, S Penegar, I P M Tomlinson, R S Houlston. (2008) Comprehensive analysis of common mitochondrial DNA variants and colorectal cancer risk. British Journal of Cancer 99:12, 2088-2093
CrossRef348
A.-C. Hoffmann, M. Schuler. (2008) Biomarker in der Onkologie. best practice onkologie 3:6, 48-58
CrossRef349
Richard S Houlston, Emily Webb, Peter Broderick, Alan M Pittman, Maria Chiara Di Bernardo, Steven Lubbe, Ian Chandler, Jayaram Vijayakrishnan, Kate Sullivan, Steven Penegar, Luis Carvajal-Carmona, Kimberley Howarth, Emma Jaeger, Sarah L Spain, Axel Walther, Ella Barclay, Lynn Martin, Maggie Gorman, Enric Domingo, Ana S Teixeira, David Kerr, Jean-Baptiste Cazier, Iina Niittymäki, Sari Tuupanen, Auli Karhu, Lauri A Aaltonen, Ian P M Tomlinson, Susan M Farrington, Albert Tenesa, James G D Prendergast, Rebecca A Barnetson, Roseanne Cetnarskyj, Mary E Porteous, Paul D P Pharoah, Thibaud Koessler, Jochen Hampe, Stephan Buch, Clemens Schafmayer, Jurgen Tepel, Stefan Schreiber, Henry Völzke, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Brent W Zanke, Alexandre Montpetit, Thomas J Hudson, Steven Gallinger, Harry Campbell, Malcolm G Dunlop. (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nature Genetics 40:12, 1426-1435
CrossRef350
Bernd Frank, Barbara Burwinkel, Justo Lorenzo Bermejo, Asta Försti, Kari Hemminki, Richard Houlston, Elisabeth Mangold, Nils Rahner, Waltraut Friedl, Nicolaus Friedrichs, Reinhard Buettner, Christoph Engel, Markus Loeffler, Elke Holinski-Feder, Monika Morak, Gisela Keller, Hans K. Schackert, Stefan Krüger, Timm Goecke, Gabriela Moeslein, Matthias Kloor, Johannes Gebert, Erdmute Kunstmann, Karsten Schulmann, Josef Rüschoff, Peter Propping. (2008) Ten recently identified associations between nsSNPs and colorectal cancer could not be replicated in German families. Cancer Letters 271:1, 153-157
CrossRef351
Jennifer R. Brown, Donna Neuberg, Kimberly Phillips, Hazel Reynolds, Jason Silverstein, Jennifer C. Clark, Megan Ash, Christina Thompson, David C. Fisher, Eric Jacobsen, Ann S. LaCasce, Arnold S. Freedman. (2008) Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders. British Journal of Haematology 143:3, 361-368
CrossRef352
Naoki Terada, Norihiko Tsuchiya, Zhiyong Ma, Yosuke Shimizu, Takashi Kobayashi, Eijiro Nakamura, Toshiyuki Kamoto, Tomonori Habuchi, Osamu Ogawa. (2008) Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population. The Prostate 68:15, 1689-1695
CrossRef353
D. F. Easton, R. A. Eeles. (2008) Genome-wide association studies in cancer. Human Molecular Genetics 17:R2, R109-R115
CrossRef354
Marc D. Tischkowitz, Ahmet Yilmaz, Long Q. Chen, Danielle M. Karyadi, David Novak, Tomas Kirchhoff, Nancy Hamel, Sean V. Tavtigian, Suzanne Kolb, Tarek A. Bismar, Raquel Aloyz, Peter S. Nelson, Lee Hood, Steven A. Narod, Kirsten A. White, Elaine A. Ostrander, William B. Isaacs, Kenneth Offit, Kathleen A. Cooney, Janet L. Stanford, William D. Foulkes. (2008) Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Letters 270:1, 173-180
CrossRef355
Faysal A Yafi, Armen G Aprikian, Wassim Kassouf. (2008) Chemoprevention of prostate cancer: agents, studies and future prospects. Aging Health 4:5, 469-479
CrossRef356
Rustam Ibragimov. (2008) A tale of two tails: peakedness properties in inheritance models of evolutionary theory. Journal of Evolutionary Economics 18:5, 597-613
CrossRef357
Deborah W. Neklason, Brett L. Thorpe, Angel Ferrandez, Anil Tumbapura, Kenneth Boucher, Gilda Garibotti, Richard A. Kerber, Cindy H. Solomon, Wade S. Samowitz, John C. Fang, Geraldine P. Mineau, Mark F. Leppert, Randall W. Burt, Scott K. Kuwada. (2008) Colonic Adenoma Risk in Familial Colorectal Cancer-A Study of Six Extended Kindreds. The American Journal of Gastroenterology 103:10, 2577-2584
CrossRef358
Yen-Ching Chen, John H. Page, Rong Chen, Edward Giovannucci. (2008) Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. The Prostate 68:14, 1582-1591
CrossRef359
Robert J. Allen, Maria M. LoTempio, James E. Craigie, Robert J. Allen. (2008) Transplantation in Identical Twins: Another Option for Breast Reconstruction. Plastic and Reconstructive Surgery 122:4, 1019-1023
CrossRef360
Kokichi Sugano, Seigo Nakamura, Jiro Ando, Shin Takayama, Hiroyuki Kamata, Isao Sekiguchi, Megumi Ubukata, Tetsuro Kodama, Masami Arai, Fujio Kasumi, Yasuo Hirai, Tadashi Ikeda, Hiromitsu Jinno, Masaki Kitajima, Daisuke Aoki, Akira Hirasawa, Yuko Takeda, Kumiko Yazaki, Takashi Fukutomi, Takayuki Kinoshita, Ryuichiro Tsunematsu, Teruhiko Yoshida, Masako Izumi, Shino Umezawa, Hiroshi Yagata, Hiroko Komatsu, Naoko Arimori, Noriko Matoba, Nobuhisa Gondo, Shiro Yokoyama, Yoshio Miki. (2008) Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. Cancer Science 99:10, 1967-1976
CrossRef361
Preetha Anand, Ajaikumar B. Kunnumakara, Chitra Sundaram, Kuzhuvelil B. Harikumar, Sheeja T. Tharakan, Oiki S. Lai, Bokyung Sung, Bharat B. Aggarwal. (2008) Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharmaceutical Research 25:9, 2097-2116
CrossRef362
Charles L. Wiggins, David G. Perdue, Jeffrey A. Henderson, Michael G. Bruce, Anne P. Lanier, Janet J. Kelley, Brenda F. Seals, David K. Espey. (2008) Gastric cancer among American Indians and Alaska Natives in the United States, 1999-2004. Cancer 113:S5, 1225-1233
CrossRef363
Clare Turnbull, Nazneen Rahman. (2008) Genetic Predisposition to Breast Cancer: Past, Present, and Future. Annual Review of Genomics and Human Genetics 9:1, 321-345
CrossRef364
Jiyoung Ahn, Roxana Moslehi, Stephanie J. Weinstein, Kirk Snyder, Jarmo Virtamo, Demetrius Albanes. (2008) Family history of prostate cancer and prostate cancer risk in the Alpha‐Tocopherol, Beta‐Carotene Cancer Prevention (ATBC) Study. International Journal of Cancer 123:5, 1154-1159
CrossRef365
Sana Sfar, Hamadi Saad, Faouzi Mosbah, Lotfi Chouchane. (2008) Association of HSP70-hom genetic variant with prostate cancer risk. Molecular Biology Reports 35:3, 459-464
CrossRef366
A. M. Pittman, E. Webb, L. Carvajal-Carmona, K. Howarth, M. C. Di Bernardo, P. Broderick, S. Spain, A. Walther, A. Price, K. Sullivan, P. Twiss, S. Fielding, A. Rowan, E. Jaeger, J. Vijayakrishnan, I. Chandler, S. Penegar, M. Qureshi, S. Lubbe, E. Domingo, Z. Kemp, E. Barclay, W. Wood, L. Martin, M. Gorman, H. Thomas, J. Peto, T. Bishop, R. Gray, E. R. Maher, A. Lucassen, D. Kerr, G. R. Evans, , T. van Wezel, H. Morreau, J. T. Wijnen, J. L. Hopper, M. C. Southey, G. G. Giles, G. Severi, S. Castellvi-Bel, C. Ruiz-Ponte, A. Carracedo, A. Castells, , A. Forsti, K. Hemminki, P. Vodicka, A. Naccarati, L. Lipton, J. W.C. Ho, K.K. Cheng, P. C. Sham, J. Luk, J. A.G. Agundez, J. M. Ladero, M. de la Hoya, T. Caldes, I. Niittymaki, S. Tuupanen, A. Karhu, L. A. Aaltonen, J.-B. Cazier, I. P.M. Tomlinson, R. S. Houlston. (2008) Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Human Molecular Genetics 17:23, 3720-3727
CrossRef367
T. J. Murtola, T. L. J. Tammela, J. Lahtela, A. Auvinen. (2008) Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study. American Journal of Epidemiology 168:8, 925-931
CrossRef368
Taro Iguchi, Ching Y. Wang, Nicolas B. Delongchamps, Robert Sunheimer, Tatsuya Nakatani, Gustavo de la Roza, Gabriel P. Haas. (2008) Association of Prostate Cancer and Manganese Superoxide Dismutase AA Genotype Influenced by Presence of Occult Cancer in Control Group. Urology 72:2, 238-241
CrossRef369
Adam S. Kibel, Carol H. Jin, Aleksandra Klim, Jason Luly, Kimberly A. Roehl, William S. Wu, Brian K. Suarez. (2008) Association between polymorphisms in cell cycle genes and advanced prostate carcinoma. The Prostate 68:11, 1179-1186
CrossRef370
Sanna Siltanen, Kirsi Syrjäkoski, Rainer Fagerholm, Tarja Ikonen, Peter Lipman, Jacob Mallott, Kaija Holli, Teuvo L J Tammela, Heikki J Järvinen, Jukka-Pekka Mecklin, Kristiina Aittomäki, Carl Blomqvist, Joan E Bailey-Wilson, Heli Nevanlinna, Lauri A Aaltonen, Johanna Schleutker, Pia Vahteristo. (2008) ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer. European Journal of Human Genetics 16:8, 983-991
CrossRef371
Jeff M.P. Holly, Claire M. Perks. (2008) Cancer as an endocrine problem. Best Practice & Research Clinical Endocrinology & Metabolism 22:4, 539-550
CrossRef372
James M Crawford. (2008) The origins of bladder cancer. Laboratory Investigation 88:7, 686-693
CrossRef373
Pharoah, Paul D.P., Antoniou, Antonis C., Easton, Douglas F., Ponder, Bruce A.J., . (2008) Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer. New England Journal of Medicine 358:26, 2796-2803
Full Text374
J. Beuten, J. A.L. Gelfond, J. J. Byrne, I. Balic, A. C. Crandall, T. L. Johnson-Pais, I. M. Thompson, D. K. Price, R. J. Leach. (2008) CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians. Carcinogenesis 29:9, 1751-1757
CrossRef375
Ole Johan Halvorsen. (2008) Molecular and prognostic markers in prostate cancer. APMIS 116, 1-62
CrossRef376
Nalin Siriwardhana, Shambhunath Choudhary, Hwa-Chain Robert Wang. (2008) Precancerous model of human breast epithelial cells induced by NNK for prevention. Breast Cancer Research and Treatment 109:3, 427-441
CrossRef377
Jamey A Sarvis, Ian M Thompson. (2008) Androgens and prevention of prostate cancer. Current Opinion in Endocrinology, Diabetes and Obesity 15:3, 271-277
CrossRef378
Paul Finnon, Naomi Robertson, Sylwia Dziwura, Claudine Raffy, Wei Zhang, Liz Ainsbury, Jaakko Kaprio, Christophe Badie, Simon Bouffler. (2008) Evidence for significant heritability of apoptotic and cell cycle responses to ionising radiation. Human Genetics 123:5, 485-493
CrossRef379
Hiromi Sakamoto, Kimio Yoshimura, Norihisa Saeki, Hitoshi Katai, Tadakazu Shimoda, Yoshihiro Matsuno, Daizo Saito, Haruhiko Sugimura, Fumihiko Tanioka, Shunji Kato, Norio Matsukura, Noriko Matsuda, Tsuneya Nakamura, Ichinosuke Hyodo, Tomohiro Nishina, Wataru Yasui, Hiroshi Hirose, Matsuhiko Hayashi, Emi Toshiro, Sumiko Ohnami, Akihiro Sekine, Yasunori Sato, Hirohiko Totsuka, Masataka Ando, Ryo Takemura, Yoriko Takahashi, Minoru Ohdaira, Kenichi Aoki, Izumi Honmyo, Suenori Chiku, Kazuhiko Aoyagi, Hiroki Sasaki, Shumpei Ohnami, Kazuyoshi Yanagihara, Kyong-Ah Yoon, Myeong-Cherl Kook, Yeon-Su Lee, Sook Ryun Park, Chan Gyoo Kim, Il Ju Choi, Teruhiko Yoshida, Yusuke Nakamura, Setsuo Hirohashi. (2008) Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nature Genetics 40:6, 730-740
CrossRef380
Di Qiao, Long Yi, Lixin Hua, Zheng Xu, Yi Ding, Dongquan Shi, Ligang Ni, Ninghong Song, Yong Wang, Hongfei Wu. (2008) Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: A case-control study in Chinese Han population. Journal of Cystic Fibrosis 7:3, 210-214
CrossRef381
R. Monier, M. Tubiana. (2008) Cancérogenèse. Accroissement des connaissances et évolution des concepts. Oncologie 10:5, 319-347
CrossRef382
Albert Tenesa, Susan M Farrington, James G D Prendergast, Mary E Porteous, Marion Walker, Naila Haq, Rebecca A Barnetson, Evropi Theodoratou, Roseanne Cetnarskyj, Nicola Cartwright, Colin Semple, Andrew J Clark, Fiona J L Reid, Lorna A Smith, Kostas Kavoussanakis, Thibaud Koessler, Paul D P Pharoah, Stephan Buch, Clemens Schafmayer, Jürgen Tepel, Stefan Schreiber, Henry Völzke, Carsten O Schmidt, Jochen Hampe, Jenny Chang-Claude, Michael Hoffmeister, Hermann Brenner, Stefan Wilkening, Federico Canzian, Gabriel Capella, Victor Moreno, Ian J Deary, John M Starr, Ian P M Tomlinson, Zoe Kemp, Kimberley Howarth, Luis Carvajal-Carmona, Emily Webb, Peter Broderick, Jayaram Vijayakrishnan, Richard S Houlston, Gad Rennert, Dennis Ballinger, Laura Rozek, Stephen B Gruber, Koichi Matsuda, Tomohide Kidokoro, Yusuke Nakamura, Brent W Zanke, Celia M T Greenwood, Jagadish Rangrej, Rafal Kustra, Alexandre Montpetit, Thomas J Hudson, Steven Gallinger, Harry Campbell, Malcolm G Dunlop. (2008) Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature Genetics 40:5, 631-637
CrossRef383
Shu-Fang Chang. (2008) Knowledge, health beliefs and health-related behaviours of first-degree relatives of women suffering from osteoporosis in Taiwan: a questionnaire survey. Journal of Clinical Nursing 17:10, 1280-1286
CrossRef384
Nalin Siriwardhana, Hwa-Chain Robert Wang. (2008) Precancerous carcinogenesis of human breast epithelial cells by chronic exposure to benzo[a]pyrene. Molecular Carcinogenesis 47:5, 338-348
CrossRef385
Marc Tischkowitz, Nelly Sabbaghian, Anna M. Ray, Ethan M. Lange, William D. Foulkes, Kathleen A. Cooney. (2008) Analysis of the gene coding for the BRCA2-Interacting protein PALB2 in hereditary prostate cancer. The Prostate 68:6, 675-678
CrossRef386
Sharon E. Johnatty, Amanda B. Spurdle, Jonathan Beesley, Xiaoqing Chen, John L. Hopper, David L. Duffy, Georgia Chenevix-Trench, . (2008) Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies. Breast Cancer Research and Treatment 109:1, 91-99
CrossRef387
Paras B. Singh, Shyam S. Matanhelia, Francis L. Martin. (2008) A potential paradox in prostate adenocarcinoma progression: Oestrogen as the initiating driver. European Journal of Cancer 44:7, 928-936
CrossRef388
R. E. Ricklefs, C. D. Cadena. (2008) Heritability of Longevity in Captive Populations of Nondomesticated Mammals and Birds. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63:5, 435-446
CrossRef389
A M Pittman, P Broderick, K Sullivan, S Fielding, E Webb, S Penegar, I Tomlinson, R S Houlston. (2008) CASP8 variants D302H and −652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. British Journal of Cancer 98:8, 1434-1436
CrossRef390
S. Wilkening, B. Tavelin, F. Canzian, K. Enquist, R. Palmqvist, A. Altieri, G. Hallmans, K. Hemminki, P. Lenner, A. Forsti. (2008) Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis 29:6, 1202-1206
CrossRef391
A. Tsezou, M. Tzetis, C. Gennatas, E. Giannatou, A. Pampanos, G. Malamis, E. Kanavakis, S. Kitsiou. (2008) Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer. The Breast 17:2, 159-166
CrossRef392
Jordan W. Smoller, Erica Gardner-Schuster, Mirella Misiaszek. (2008) Genetics of anxiety: Would the genome recognize the DSM?. Depression and Anxiety 25:4, 368-377
CrossRef393
A Zlotta, NE Fleshner, CC Schulman. 2008. Prostate cancer prevention. , 137-144.
CrossRef394
Babar K Rao, Omar Noor, Maya-Kolipakam Thosani. (2008) Identical Twins With Primary Cutaneous Melanoma Presenting at the Same Time and Location. The American Journal of Dermatopathology 30:2, 182-184
CrossRef395
Maren Weischer, Stig E. Bojesen, Børge G. Nordestgaard. (2008) CHEK2 in the Clinical Management of Breast Cancer. Breast Diseases: A Year Book Quarterly 19:1, 33-34
CrossRef396
Mats Olsson, Sara Lindström, Benjamin Häggkvist, Hans-Olov Adami, Katarina Bälter, Pär Stattin, Birgitta Ask, Anders Rane, Lena Ekström, Henrik Grönberg. (2008) TheUGT2B17 gene deletion is not associated with prostate cancer risk. The Prostate 68:5, 571-575
CrossRef397
B. Gold, T. Kirchhoff, S. Stefanov, J. Lautenberger, A. Viale, J. Garber, E. Friedman, S. Narod, A. B. Olshen, P. Gregersen, K. Kosarin, A. Olsh, J. Bergeron, N. A. Ellis, R. J. Klein, A. G. Clark, L. Norton, M. Dean, J. Boyd, K. Offit. (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proceedings of the National Academy of Sciences 105:11, 4340-4345
CrossRef398
Adam J. Bass, Jeffrey A. Meyerhardt, Jennifer A. Chan, Edward L. Giovannucci, Charles S. Fuchs. (2008) Family history and survival after colorectal cancer diagnosis. Cancer 112:6, 1222-1229
CrossRef399
J. Shen, C. B. Ambrosone, R. A. DiCioccio, K. Odunsi, S. B. Lele, H. Zhao. (2008) A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 29:10, 1963-1966
CrossRef400
Marie Plourde, Carolle Samson, Francine Durocher, Olga Sinilnokova, Jacques Simard. (2008) Characterization of HSD17B1 sequence variants in breast cancer cases from French Canadian families with high risk of breast and ovarian cancer. The Journal of Steroid Biochemistry and Molecular Biology 109:1-2, 115-128
CrossRef401
Jacqueline S. Drouin, Jerome Beeler. (2008) Exercise and urologic cancers. Urologic Oncology: Seminars and Original Investigations 26:2, 205-212
CrossRef402
Denise Daley, Susan Lewis, Petra Platzer, Melissa MacMillen, Joseph Willis, Robert C. Elston, Sanford D. Markowitz, Georgia L. Wiesner. (2008) Identification of Susceptibility Genes for Cancer in a Genome-wide Scan: Results from the Colon Neoplasia Sibling Study. The American Journal of Human Genetics 82:3, 723-736
CrossRef403
Kari Hemminki, Xinjun Li, Kristina Sundquist, Jan Sundquist. (2008) Familial risks for common diseases: Etiologic clues and guidance to gene identification. Mutation Research/Reviews in Mutation Research 658:3, 247-258
CrossRef404
Annie J. Sasco. (2008) Cancer and globalization. Biomedicine & Pharmacotherapy 62:2, 110-121
CrossRef405
A. M. González-Zuloeta Ladd, A. Arias Vásquez, F. Rivadeneira, C. Siemes, A. Hofman, B. H. Ch. Stricker, H. A. P. Pols, A. G. Uitterlinden, C. M. Duijn. (2008) Estrogen receptor α polymorphisms and postmenopausal breast cancer risk. Breast Cancer Research and Treatment 107:3, 415-419
CrossRef406
Aslihan Avci, Ilker Durak. 2008. Tomato Juice, Prostate Cancer and Adenosine Deaminase Enzyme. , 457-474.
CrossRef407
Dayna S. Early, Luigi Fontana, Nicholas O. Davidson. (2008) Translational approaches to addressing complex genetic pathways in colorectal cancer. Translational Research 151:1, 10-16
CrossRef408
Bradley A. Arrick. 2008. Breast Cancer. , 423-429.
CrossRef409
H. Lango, M. N. Weedon. (2008) What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?. Journal of Internal Medicine 263:1, 16-27
CrossRef410
Jayne Lucke, Wayne Hall, Bree Ryan, Neville Owen. (2008) The Implications of Genetic Susceptibility for the Prevention of Colorectal Cancer: A Qualitative Study of Older Adults’ Understanding. Community Genetics 11:5, 283-288
CrossRef411
Teresa Chiaverotti, Suzana S. Couto, Annemarie Donjacour, Jian-Hua Mao, Hiroki Nagase, Robert D. Cardiff, Gerald R. Cunha, Allan Balmain. (2008) Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer. The American Journal of Pathology 172:1, 236-246
CrossRef412
Betty A. Ingraham, Beth Bragdon, Anja Nohe. (2008) Molecular basis of the potential of vitamin D to prevent cancer. Current Medical Research and Opinion 24:1, 139-149
CrossRef413
Giorgia Randi, Claudio Pelucchi, Eva Negri, Renato Talamini, Carlotta Galeone, Silvia Franceschi, Carlo La Vecchia. (2007) Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers. International Journal of Cancer 121:12, 2748-2752
CrossRef414
Daphne W. Bell, Sang H. Kim, Andrew K. Godwin, Taryn A. Schiripo, Patricia L. Harris, Sara M. Haserlat, Doke C.R. Wahrer, Christopher A. Haiman, Mary B. Daly, Kristin B. Niendorf, Matthew R. Smith, Dennis C. Sgroi, Judy E. Garber, Olufunmilayo I. Olopade, Loic Le Marchand, Brian E. Henderson, David Altshuler, Daniel A. Haber, Matthew L. Freedman. (2007) Genetic and functional analysis ofCHEK2 (CHK2) variants in multiethnic cohorts. International Journal of Cancer 121:12, 2661-2667
CrossRef415
Cynthia Thomson, Bette Caan. 2007. Breast and Ovarian Cancer. .
CrossRef416
Randall Burt. (2007) Inheritance of colorectal cancer. Drug Discovery Today: Disease Mechanisms 4:4, 293-300
CrossRef417
P. Irigaray, J.A. Newby, R. Clapp, L. Hardell, V. Howard, L. Montagnier, S. Epstein, D. Belpomme. (2007) Lifestyle-related factors and environmental agents causing cancer: An overview. Biomedicine & Pharmacotherapy 61:10, 640-658
CrossRef418
Noah M Hahn, Mark R Kelley, James E Klaunig, Michael O Koch, Lang Li, Christopher J Sweeney. (2007) Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications. Future Oncology 3:6, 665-682
CrossRef419
S Z Pavletic, G Zhou, K Sobocinski, G Marti, K Doney, J DiPersio, W Feremans, L Foroni, S Goodman, G Prentice, C LeMaistre, G Bandini, A Ferrant, N Jacobsen, I Khouri, R P Gale, A Wiestner, S Giralt, E Montserrat, W C Chan, C Bredeson. (2007) Genetically identical twin transplantation for chronic lymphocytic leukemia. Leukemia 21:12, 2452-2455
CrossRef420
Devra Lee Davis, Maryann Donovan, Ronald Herberman, Mitchell Gaynor, Deborah Axelrod, Nik van Larebeke, Annie J. Sasco. (2007) The need to develop centers for environmental oncology. Biomedicine & Pharmacotherapy 61:10, 614-622
CrossRef421
Ingemar Turesson, Martha S. Linet, Magnus Björkholm, Sigurdur Y. Kristinsson, Lynn R. Goldin, Neil E. Caporaso, Ola Landgren. (2007) Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003. International Journal of Cancer 121:10, 2260-2266
CrossRef422
S Penegar, W Wood, S Lubbe, I Chandler, P Broderick, E Papaemmanuil, G Sellick, R Gray, J Peto, R Houlston. (2007) National study of colorectal cancer genetics. British Journal of Cancer 97:9, 1305-1309
CrossRef423
F. Blachier, F. Mariotti, J. F. Huneau, D. Tomé. (2007) Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33:4, 547-562
CrossRef424
Peter Broderick, Luis Carvajal-Carmona, Alan M Pittman, Emily Webb, Kimberley Howarth, Andrew Rowan, Steven Lubbe, Sarah Spain, Kate Sullivan, Sarah Fielding, Emma Jaeger, Jayaram Vijayakrishnan, Zoe Kemp, Maggie Gorman, Ian Chandler, Elli Papaemmanuil, Steven Penegar, Wendy Wood, Gabrielle Sellick, Mobshra Qureshi, Ana Teixeira, Enric Domingo, Ella Barclay, Lynn Martin, Oliver Sieber, David Kerr, Richard Gray, Julian Peto, Jean-Baptiste Cazier, Ian Tomlinson, Richard S Houlston. (2007) A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nature Genetics 39:11, 1315-1317
CrossRef425
Neil Fleshner, Alexandre R. Zlotta. (2007) Prostate cancer prevention. Cancer 110:9, 1889-1899
CrossRef426
Q. Xu, P. K. Majumder, K. Ross, Y. Shim, T. R. Golub, M. Loda, W. R. Sellers. (2007) Identification of prostate cancer modifier pathways using parental strain expression mapping. Proceedings of the National Academy of Sciences 104:45, 17771-17776
CrossRef427
S. L. Zheng, J. Sun, Y. Cheng, G. Li, F.-C. Hsu, Y. Zhu, B.-L. Chang, W. Liu, J. W. Kim, A. R. Turner, M. Gielzak, G. Yan, S. D. Isaacs, K. E. Wiley, J. Sauvageot, H.-S. Chen, R. Gurganus, L. A. Mangold, B. J. Trock, H. Gronberg, D. Duggan, J. D. Carpten, A. W. Partin, P. C. Walsh, J. Xu, W. B. Isaacs. (2007) Association Between Two Unlinked Loci at 8q24 and Prostate Cancer Risk Among European Americans. JNCI Journal of the National Cancer Institute 99:20, 1525-1533
CrossRef428
Prodipto Pal, Huifeng Xi, Guangyun Sun, Ritesh Kaushal, Joshua J. Meeks, C. Shad Thaxton, Saurav Guha, Carol H. Jin, Brian K. Suarez, William J. Catalona, Ranjan Deka. (2007) Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin. Human Genetics 122:3-4, 251-259
CrossRef429
Sarah Spain, Ian P. M. Tomlinson. 2007. Genetic Susceptibility to Cancer. .
CrossRef430
Anjali Jain, Surabhi Vashistha, Mitchell E. Gross, David B. Agus. 2007. Models for Prostate Cancer. .
CrossRef431
Fay Kastrinos, Sapna Syngal. (2007) Recently Identified Colon Cancer Predispositions: MYH and MSH6 Mutations. Seminars in Oncology 34:5, 418-424
CrossRef432
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Dean A. Troyer, Betsy Higgins, Donna Pauler Ankerst, Ian M. Thompson, Robin J. Leach, Dipen J. Parekh. (2007) Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL. Urology 70:4, 748-752
CrossRef433
Florian M.E. Wagenlehner, Johny E. Elkahwaji, Ferran Algaba, Truls Bjerklund-Johansen, Kurt G. Naber, Rudolf Hartung, Wolfgang Weidner. (2007) The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU International 100:4, 733-737
CrossRef434
Ian M. Thompson. (2007) Chemoprevention of Prostate Cancer: Agents and Study Designs. The Journal of Urology 178:3, S9-S13
CrossRef435
M. L. Bisgaard. (2007) Young age colorectal cancer and identification of hereditary non-polyposis colorectal cancer cohorts. British Journal of Surgery 94:9, 1055-1056
CrossRef436
John Mathers. 2007. Toward Personalized Nutrition for the Prevention and Treatment of Cancer. , 75-87.
CrossRef437
Ellen Lundqvist, Jaakko Kaprio, Pia K. Verkasalo, Eero Pukkala, Markku Koskenvuo, Karin C. Söderberg, Maria Feychting. (2007) Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. International Journal of Cancer 121:4, 810-818
CrossRef438
Diana S. Rosman, Virginia Kaklamani, Boris Pasche. (2007) New Insights into Breast Cancer Genetics and Impact on Patient Management. Current Treatment Options in Oncology 8:1, 61-73
CrossRef439
Kerstin Wagner, Kari Hemminki, Asta Försti. (2007) The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Research and Treatment 104:3, 233-248
CrossRef440
R.A. Oldenburg, H. Meijers-Heijboer, C.J. Cornelisse, P. Devilee. (2007) Genetic susceptibility for breast cancer: How many more genes to be found?. Critical Reviews in Oncology/Hematology 63:2, 125-149
CrossRef441
Nicholas J. Rukin, Richard C. Strange. (2007) What Are the Frequency, Distribution, and Functional Effects of Vitamin D Receptor Polymorphisms as Related to Cancer Risk?. Nutrition Reviews 65, S96-S101
CrossRef442
E. Rapley. (2007) Susceptibility alleles for testicular germ cell tumour: a review. International Journal of Andrology 30:4, 242-250
CrossRef443
Brent W Zanke, Celia MT Greenwood, Jagadish Rangrej, Rafal Kustra, Albert Tenesa, Susan M Farrington, James Prendergast, Sylviane Olschwang, Theodore Chiang, Edgar Crowdy, Vincent Ferretti, Philippe Laflamme, Saravanan Sundararajan, Stéphanie Roumy, Jean-François Olivier, Frédérick Robidoux, Robert Sladek, Alexandre Montpetit, Peter Campbell, Stephane Bezieau, Anne Marie O'Shea, George Zogopoulos, Michelle Cotterchio, Polly Newcomb, John McLaughlin, Ban Younghusband, Roger Green, Jane Green, Mary E M Porteous, Harry Campbell, Helene Blanche, Mourad Sahbatou, Emmanuel Tubacher, Catherine Bonaiti-Pellié, Bruno Buecher, Elio Riboli, Sebastien Kury, Stephen J Chanock, John Potter, Gilles Thomas, Steven Gallinger, Thomas J Hudson, Malcolm G Dunlop. (2007) Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nature Genetics 39:8, 989-994
CrossRef444
M. Laakso, S. Tuupanen, A. Karhu, R. Lehtonen, L. A. Aaltonen, S. Hautaniemi. (2007) Computational identification of candidate loci for recessively inherited mutation using high-throughput SNP arrays. Bioinformatics 23:15, 1952-1961
CrossRef445
Mark M. Pomerantz, Matthew L. Freedman, Philip W. Kantoff. (2007) GENETIC DETERMINANTS OF PROSTATE CANCER RISK. BJU International 100:2, 241-243
CrossRef446
Timothy C. Wang. (2007) Gastroenterologists as Preventionists: How Are We Doing?. Gastroenterology 133:2, 383-384
CrossRef447
Ian Tomlinson, Emily Webb, Luis Carvajal-Carmona, Peter Broderick, Zoe Kemp, Sarah Spain, Steven Penegar, Ian Chandler, Maggie Gorman, Wendy Wood, Ella Barclay, Steven Lubbe, Lynn Martin, Gabrielle Sellick, Emma Jaeger, Richard Hubner, Ruth Wild, Andrew Rowan, Sarah Fielding, Kimberley Howarth, Andrew Silver, Wendy Atkin, Kenneth Muir, Richard Logan, David Kerr, Elaine Johnstone, Oliver Sieber, Richard Gray, Huw Thomas, Julian Peto, Jean-Baptiste Cazier, Richard Houlston. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nature Genetics 39:8, 984-988
CrossRef448
Richard G. Stevens, Helen Swede, Daniel W. Rosenberg. (2007) Epidemiology of colonic aberrant crypt foci: Review and analysis of existing studies. Cancer Letters 252:2, 171-183
CrossRef449
Ian M. Thompson. (2007) Chemoprevention of prostate cancer: lessons learned. BJU International 100:s2 Prostate Can, 15-17
CrossRef450
Simon N Stacey, Andrei Manolescu, Patrick Sulem, Thorunn Rafnar, Julius Gudmundsson, Sigurjon A Gudjonsson, Gisli Masson, Margret Jakobsdottir, Steinunn Thorlacius, Agnar Helgason, Katja K Aben, Luc J Strobbe, Marjo T Albers-Akkers, Dorine W Swinkels, Brian E Henderson, Laurence N Kolonel, Loic Le Marchand, Esther Millastre, Raquel Andres, Javier Godino, Maria Dolores Garcia-Prats, Eduardo Polo, Alejandro Tres, Magali Mouy, Jona Saemundsdottir, Valgerdur M Backman, Larus Gudmundsson, Kristleifur Kristjansson, Jon T Bergthorsson, Jelena Kostic, Michael L Frigge, Frank Geller, Daniel Gudbjartsson, Helgi Sigurdsson, Thora Jonsdottir, Jon Hrafnkelsson, Jakob Johannsson, Thorarinn Sveinsson, Gardar Myrdal, Hlynur Niels Grimsson, Thorvaldur Jonsson, Susanna von Holst, Barbro Werelius, Sara Margolin, Annika Lindblom, Jose I Mayordomo, Christopher A Haiman, Lambertus A Kiemeney, Oskar Th Johannsson, Jeffrey R Gulcher, Unnur Thorsteinsdottir, Augustine Kong, Kari Stefansson. (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer. Nature Genetics 39:7, 865-869
CrossRef451
Julia Green Brody, Ruthann A. Rudel, Karin B. Michels, Kirsten B. Moysich, Leslie Bernstein, Kathleen R. Attfield, Sharon Gray. (2007) Environmental pollutants, diet, physical activity, body size, and breast cancer. Cancer 109:S12, 2627-2634
CrossRef452
Cristiane Murta-Nascimento, Bernd J. Schmitz-Dräger, Maurice P. Zeegers, Gunnar Steineck, Manolis Kogevinas, Francisco X. Real, Núria Malats. (2007) Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World Journal of Urology 25:3, 285-295
CrossRef453
E Couto, K Hemminki. (2007) Estimates of heritable and environmental components of familial breast cancer using family history information. British Journal of Cancer 96:11, 1740-1742
CrossRef454
C. Maier, W. Vogel. (2007) Genetik des Prostatakarzinoms. medizinische genetik 19:2, 210-215
CrossRef455
Guangfu Jin, Ruifen Miao, Yimei Deng, Zhibin Hu, Yan Zhou, Yongfei Tan, Jianming Wang, Zhaolai Hua, Weiliang Ding, Lina Wang, Wensen Chen, Jing Shen, Xinru Wang, Yaochu Xu, Hongbing Shen. (2007) Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Science 98:6, 864-868
CrossRef456
Anneke C. Blackburn, Linda Z. Hill, Amy L. Roberts, Jun Wang, Dee Aud, Jimmy Jung, Tania Nikolcheva, John Allard, Gary Peltz, Christopher N. Otis, Qing J. Cao, Reva St. J. Ricketts, Stephen P. Naber, Jan Mollenhauer, Annemarie Poustka, Daniel Malamud, D. Joseph Jerry. (2007) Genetic Mapping in Mice Identifies DMBT1 as a Candidate Modifier of Mammary Tumors and Breast Cancer Risk. The American Journal of Pathology 170:6, 2030-2041
CrossRef457
M GENC, J SCHANTZDUNN. (2007) The role of gene–environment interaction in predicting adverse pregnancy outcome. Best Practice & Research Clinical Obstetrics & Gynaecology 21:3, 491-504
CrossRef458
Bo Johanneson, Kerry Deutsch, Laura McIntosh, Danielle M. Friedrichsen-Karyadi, Marta Janer, Erika M. Kwon, Lori Iwasaki, Leroy Hood, Elaine A. Ostrander, Janet L. Stanford. (2007) Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer. The Prostate 67:7, 732-742
CrossRef459
Jielin Sun, Aubrey Turner, Jianfeng Xu, Henrik Grönberg, William Isaacs. (2007) Genetic variability in inflammation pathways and prostate cancer risk. Urologic Oncology: Seminars and Original Investigations 25:3, 250-259
CrossRef460
Julius Gudmundsson, Patrick Sulem, Andrei Manolescu, Laufey T Amundadottir, Daniel Gudbjartsson, Agnar Helgason, Thorunn Rafnar, Jon T Bergthorsson, Bjarni A Agnarsson, Adam Baker, Asgeir Sigurdsson, Kristrun R Benediktsdottir, Margret Jakobsdottir, Jianfeng Xu, Thorarinn Blondal, Jelena Kostic, Jielin Sun, Shyamali Ghosh, Simon N Stacey, Magali Mouy, Jona Saemundsdottir, Valgerdur M Backman, Kristleifur Kristjansson, Alejandro Tres, Alan W Partin, Marjo T Albers-Akkers, Javier Godino-Ivan Marcos, Patrick C Walsh, Dorine W Swinkels, Sebastian Navarrete, Sarah D Isaacs, Katja K Aben, Theresa Graif, John Cashy, Manuel Ruiz-Echarri, Kathleen E Wiley, Brian K Suarez, J Alfred Witjes, Mike Frigge, Carole Ober, Eirikur Jonsson, Gudmundur V Einarsson, Jose I Mayordomo, Lambertus A Kiemeney, William B Isaacs, William J Catalona, Rosa B Barkardottir, Jeffrey R Gulcher, Unnur Thorsteinsdottir, Augustine Kong, Kari Stefansson. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nature Genetics 39:5, 631-637
CrossRef461
William G Nelson. (2007) Prostate cancer prevention. Current Opinion in Urology 17:3, 157-167
CrossRef462
K Hemminki, J Sundquist, J Ji. (2007) Familial risk for gastric carcinoma: an updated study from Sweden. British Journal of Cancer 96:8, 1272-1277
CrossRef463
James A. Talcott, Pamela Spain, Jack A. Clark, William R. Carpenter, Young Kyung Do, Robert J. Hamilton, Joseph A. Galanko, Anne Jackman, Paul A. Godley. (2007) Hidden barriers between knowledge and behavior. Cancer 109:8, 1599-1606
CrossRef464
Stacey Gabriel. (2007) Population Genetic Tools: Application to Cancer. Seminars in Oncology 34, S21-S24
CrossRef465
Ghislaine Scélo, Paul Brennan. (2007) The epidemiology of bladder and kidney cancer. Nature Clinical Practice Urology 4:4, 205-217
CrossRef466
Ola Bratt. (2007) What should a urologist know about hereditary predisposition to prostate cancer?. BJU International 99:4, 743-748
CrossRef467
Fei Ye, Yuan Chen, Thomas Knösel, Karsten Schlüns, Manuela Pacyna-Gengelbach, Nicole Deutschmann, Maode Lai, Iver Petersen. (2007) Decreased expression of insulin-like growth factor binding protein 7 in human colorectal carcinoma is related to DNA methylation. Journal of Cancer Research and Clinical Oncology 133:5, 305-314
CrossRef468
Guangfu Jin, Lina Wang, Wensen Chen, Zhibin Hu, Yan Zhou, Yongfei Tan, Jianming Wang, Zhaolai Hua, Weiliang Ding, Jing Shen, Zuofeng Zhang, Xinru Wang, Yaochu Xu, Hongbing Shen. (2007) Variant alleles ofTGFB1 andTGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. International Journal of Cancer 120:6, 1330-1335
CrossRef469
Isabelle Soerjomataram, Esther de Vries, Eero Pukkala, Jan Willem Coebergh. (2007) Excess of cancers in Europe: A study of eleven major cancers amenable to lifestyle change. International Journal of Cancer 120:6, 1336-1343
CrossRef470
Sanna Pakkanen, Agnes B. Baffoe-Bonnie, Mika P. Matikainen, Pasi A. Koivisto, Teuvo L. J. Tammela, Snehal Deshmukh, Liang Ou, Joan E. Bailey-Wilson, Johanna Schleutker. (2007) Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Human Genetics 121:2, 257-267
CrossRef471
Sandrine Tchatchou, Michael Wirtenberger, Kari Hemminki, Christian Sutter, Alfons Meindl, Barbara Wappenschmidt, Marion Kiechle, Peter Bugert, Rita K. Schmutzler, Claus R. Bartram, Barbara Burwinkel. (2007) Aurora kinases A and B and familial breast cancer risk. Cancer Letters 247:2, 266-272
CrossRef472
Richard A. Hubner, Richard S. Houlston. (2007) MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. International Journal of Cancer 120:5, 1027-1035
CrossRef473
Nicholas J. Rukin, Christopher Luscombe, Sam Moon, Dhaval Bodiwala, Samson Liu, Mark F. Saxby, Anthony A. Fryer, Julie Alldersea, Paul R. Hoban, Richard C. Strange. (2007) Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5′ haplotype block of the vitamin D receptor gene. Cancer Letters 247:2, 328-335
CrossRef474
N J Rukin, M P Zeegers, S Ramachandran, C J Luscombe, S Liu, M Saxby, J Lear, R C Strange. (2007) A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma. British Journal of Cancer 96:3, 523-528
CrossRef475
Timothy C. Brand, Javier Hernandez, Edith D. Canby-Hagino, Joseph W. Basler, Ian M. Thompson. (2007) Prostate cancer detection strategies. Current Prostate Reports 5:1, 13-17
CrossRef476
Stephan Morgenthaler, William G. Thilly. (2007) A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: A cohort allelic sums test (CAST). Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 615:1-2, 28-56
CrossRef477
Kristin Shrader-Frechette. (2007) Human Rights and Duties to Alleviate Environmental Injustice: The Domestic Case. Journal of Human Rights 6:1, 107-130
CrossRef478
Magda J.A.M. Vandeloo, Liesbeth M. Bruckers, Jaak Ph. Janssens. (2007) Effects of lifestyle on the onset of puberty as determinant for breast cancer. European Journal of Cancer Prevention 16:1, 17-25
CrossRef479
Michael Nasterlack, Gerhard Hoffmann, Peter Messerer, Marvin Gerald Ott, Dirk Pallapies, Marcus Wrede, Andreas Zober. (2007) Epidemiological and clinical investigations among employees in a former herbicide production process. International Archives of Occupational and Environmental Health 80:3, 234-238
CrossRef480
Nicholas John Rukin, Christopher J. Luscombe, Richard C. Strange. (2007) Re: A Systematic Review of Vitamin D Receptor Gene Polymorphisms and Prostate Cancer Risk. The Journal of Urology 177:1, 404
CrossRef481
Jeffrey S. Mogil, Mitchell B. Max. 2007. Genética del dolor. , 161-176.
CrossRef482
Neung Hwa Park, Young-Hwa Chung. (2007) Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma. The Korean Journal of Hepatology 13:3, 320
CrossRef483
Johny E. Elkahwaji, Weixiong Zhong, Walter J. Hopkins, Wade Bushman. (2007) Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. The Prostate 67:1, 14-21
CrossRef484
Anita Y. Kinney, Bret Hicken, Sara E. Simonsen, Vickie Venne, Katrina Lowstuter, Jonathan Balzotti, Randall W. Burt. (2007) Colorectal Cancer Surveillance Behaviors Among Members of Typical and Attenuated FAP Families. The American Journal of Gastroenterology 102:1, 153-162
CrossRef485
Neung Hwa Park, Il Han Song, Young-Hwa Chung. (2007) Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut and Liver 1:2, 101
CrossRef486
Paloma Sánchez-Fayos, María Jesús Martín Relloso, Agustina González Guirado, Juan Carlos Porres Cubero. (2007) Adenocarcinoma gástrico: intento de aproximación a una realidad biológica compleja. Medicina Clínica 128:1, 21-30
CrossRef487
Adrian Cassidy, Stephen W. Duffy, Jonathan P. Myles, Triantafillos Liloglou, John K. Field. (2007) Lung cancer risk prediction: A tool for early detection. International Journal of Cancer 120:1, 1-6
CrossRef488
Sara Margolin, Hemming Johansson, Lars Erik Rutqvist, Annika Lindblom, Tommy Fornander. (2006) Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County. Familial Cancer 5:4, 309-321
CrossRef489
Bernd Frank, Kari Hemminki, Hermann Brenner, Michael Hoffmeister, Jenny Chang-Claude, Barbara Burwinkel. (2006) ARLTS1 variants and risk of colorectal cancer. Cancer Letters 244:2, 172-175
CrossRef490
Charlotta Ryk, Rajiv Kumar, Ranjit K. Thirumaran, Sai-Mei Hou. (2006) Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 54:3, 285-292
CrossRef491
Elisabeth Couto, Kari Hemminki. (2006) Heritable and environmental components in cervical tumors. International Journal of Cancer 119:11, 2699-2701
CrossRef492
Kari Hemminki, Justo Lorenzo Bermejo, Asta Försti. (2006) The balance between heritable and environmental aetiology of human disease. Nature Reviews Genetics 7:12, 958-965
CrossRef493
Beverly S. Kingsley, Karen L. Schmeichel, Carol H. Rubin. (2006) An Update on Cancer Cluster Activities at the Centers for Disease Control and Prevention. Environmental Health Perspectives 115:1, 165-171
CrossRef494
Louise Schmidt Arenholt Thomsen, Kirsten Marie Jochumsen, Ole Mogensen. (2006) Carcinoma in situ cervicis uteri and inheritance—A Danish twin study. Gynecologic Oncology 103:2, 688-691
CrossRef495
Andrei Anghel, Marius Raica, Catalin Marian, Sorin Ursoniu, Oana Mitrasca. (2006) Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer. Journal of Cancer Research and Clinical Oncology 132:11, 727-733
CrossRef496
David A Schwartz. (2006) The importance of gene–environment interactions and exposure assessment in understanding human diseases. Journal of Exposure Science and Environmental Epidemiology 16:6, 474-476
CrossRef497
H Naseem, J Boylan, D Speake, K Leask, A Shenton, F Lalloo, J Hill, D Trump, DGR Evans. (2006) Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes. Clinical Genetics 70:5, 388-395
CrossRef498
J. P. A. Ioannidis. (2006) Common Genetic Variants for Breast Cancer: 32 Largely Refuted Candidates and Larger Prospects. JNCI Journal of the National Cancer Institute 98:19, 1350-1353
CrossRef499
(2006) Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium. JNCI Journal of the National Cancer Institute 98:19, 1382-1396
CrossRef500
Emmanuel E. Zervos, Stephan M. Tanner, Dana A. Osborne, Mark Bloomston, Alexander S. Rosemurgy, E. Christopher Ellison, W. Scott Melvin, Albert de la Chapelle. (2006) Differential Gene Expression in Patients Genetically Predisposed to Pancreatic Cancer. Journal of Surgical Research 135:2, 317-322
CrossRef501
S. Lilly Zheng, Wennuan Liu, Fredrik Wiklund, Latchezar Dimitrov, Katarina Bälter, Jielin Sun, Hans-Olov Adami, Jan-Erik Johansson, Jishan Sun, Baoli Chang, Matthew Loza, Aubrey R. Turner, Eugene R. Bleecker, Deborah A. Meyers, John D. Carpten, David Duggan, William B. Isaacs, Jianfeng Xu, Henrik Grönberg. (2006) A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. The Prostate 66:14, 1556-1564
CrossRef502
William G. Nelson, Angelo M. De Marzo. 2006. The Molecular Pathogenesis and Pathophysiology of Prostate Cancer. , 1-25.
CrossRef503
Maria Hedelin, Katarina Augustsson Bälter, Ellen T. Chang, Rino Bellocco, Åsa Klint, Jan-Erik Johansson, Fredrik Wiklund, Camilla Thellenberg-Karlsson, Hans-Olov Adami, Henrik Grönberg. (2006) Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. The Prostate 66:14, 1512-1520
CrossRef504
L. Lindström, Y. Pawitan, M. Reilly, K. Hemminki, P. Lichtenstein, K. Czene. (2006) Estimation of genetic and environmental factors for melanoma onset using population-based family data. Statistics in Medicine 25:18, 3110-3123
CrossRef505
A C Antoniou, D F Easton. (2006) Models of genetic susceptibility to breast cancer. Oncogene 25:43, 5898-5905
CrossRef506
Sue-Min Lai, Kevin B. Zhang, Robert J. Uhler, Jovanka N. Harrison, Gayle G. Clutter, Melanie A. Williams. (2006) Geographic variation in the incidence of colorectal cancer in the United States, 1998–2001. Cancer 107:S5, 1172-1180
CrossRef507
K. Eto, S. Ohyama, T. Yamaguchi, T. Wada, Y. Suzuki, N. Mitsumori, H. Kashiwagi, S. Anazawa, K. Yanaga, M. Urashima. (2006) Familial clustering in subgroups of gastric cancer stratified by histology, age group and location. European Journal of Surgical Oncology (EJSO) 32:7, 743-748
CrossRef508
Ana Maria Quinteiro Ribeiro, Maria Paula Curado, Jales Benevides Santana Filho. (2006) Cutaneous squamous cell carcinoma of the lower limbs in Goi
nia, Goi
CrossRef509
Neely Kazerouni, Mark H. Greene, James V. Lacey, Pamela J. Mink, Catherine Schairer. (2006) Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer 107:5, 1075-1083
CrossRef510
Prodipto Pal, Huifeng Xi, Ritesh Kaushal, Guangyun Sun, Carol H. Jin, Li Jin, Brian K. Suarez, William J. Catalona, Ranjan Deka. (2006) Variants in the HEPSIN gene are associated with prostate cancer in men of European origin. Human Genetics 120:2, 187-192
CrossRef511
M Z Oestergaard, J Tyrer, A Cebrian, M Shah, A M Dunning, B A J Ponder, D F Easton, P D P Pharoah. (2006) Interactions between genes involved in the antioxidant defence system and breast cancer risk. British Journal of Cancer 95:4, 525-531
CrossRef512
M S Cotroneo, G M Merry, J D Haag, H Lan, L A Shepel, M N Gould. (2006) The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance. Oncogene 25:36, 5011-5017
CrossRef513
Jie Lin, Margaret R. Spitz, Colin P. Dinney, Carol J. Etzel, H. Barton Grossman, Xifeng Wu. (2006) Bladder cancer risk as modified by family history and smoking. Cancer 107:4, 705-711
CrossRef514
Timothy C. Brand, Edith D. Canby-Hagino, A. Pratap Kumar, Rita Ghosh, Robin J. Leach, Ian M. Thompson. (2006) Chemoprevention of Prostate Cancer. Hematology/Oncology Clinics of North America 20:4, 831-843
CrossRef515
Eero Pukkala, Ausra Kesminiene, Semion Poliakov, Anton Ryzhov, Vladimir Drozdovitch, Lina Kovgan, Pentti Kyyrönen, Irina V Malakhova, Liudmila Gulak, Elisabeth Cardis. (2006) Breast cancer in Belarus and Ukraine after the Chernobyl accident. International Journal of Cancer 119:3, 651-658
CrossRef516
Vineet Bhandari, Jeffrey R. Gruen. (2006) The Genetics of Bronchopulmonary Dysplasia. Seminars in Perinatology 30:4, 185-191
CrossRef517
Sana Sfar, Elham Hassen, Hamadi Saad, Faouzi Mosbah, Lotfi Chouchane. (2006) Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35:1-2, 21-28
CrossRef518
James M. Flanagan, Violeta Popendikyte, Natalija Pozdniakovaite, Martha Sobolev, Abbas Assadzadeh, Axel Schumacher, Masood Zangeneh, Lynette Lau, Carl Virtanen, Sun-Chong Wang, Arturas Petronis. (2006) Intra- and Interindividual Epigenetic Variation in Human Germ Cells. The American Journal of Human Genetics 79:1, 67-84
CrossRef519
Anne-Marie Moisan, Jessyka Fortin, Martine Dumont Moisan, Carolle Samson, Paul Bessette, Jocelyne Chiquette, Rachel Laframboise, Jean Lépine, Bernard Lespérance, Roxane Pichette, Marie Plante, Louise Provencher, Patricia Voyer, David Goldgar, Peter Bridge, Jacques Simard. (2006) No Evidence of BRCA1/2 Genomic Rearrangements in High-Risk French-Canadian Breast/Ovarian Cancer Families. Genetic Testing 10:2, 104-115
CrossRef520
Laufey T Amundadottir, Patrick Sulem, Julius Gudmundsson, Agnar Helgason, Adam Baker, Bjarni A Agnarsson, Asgeir Sigurdsson, Kristrun R Benediktsdottir, Jean-Baptiste Cazier, Jesus Sainz, Margret Jakobsdottir, Jelena Kostic, Droplaug N Magnusdottir, Shyamali Ghosh, Kari Agnarsson, Birgitta Birgisdottir, Louise Le Roux, Adalheidur Olafsdottir, Thorarinn Blondal, Margret Andresdottir, Olafia Svandis Gretarsdottir, Jon T Bergthorsson, Daniel Gudbjartsson, Arnaldur Gylfason, Gudmar Thorleifsson, Andrei Manolescu, Kristleifur Kristjansson, Gudmundur Geirsson, Helgi Isaksson, Julie Douglas, Jan-Erik Johansson, Katarina Bälter, Fredrik Wiklund, James E Montie, Xiaoying Yu, Brian K Suarez, Carole Ober, Kathleen A Cooney, Henrik Gronberg, William J Catalona, Gudmundur V Einarsson, Rosa B Barkardottir, Jeffrey R Gulcher, Augustine Kong, Unnur Thorsteinsdottir, Kari Stefansson. (2006) A common variant associated with prostate cancer in European and African populations. Nature Genetics 38:6, 652-658
CrossRef521
Timothy C. Brand, Javier Hernandez, Edith D. Canby-Hagino, Joseph W. Basler, Ian M. Thompson. (2006) Prostate cancer detection strategies. Current Urology Reports 7:3, 181-185
CrossRef522
Jielin Sun, Fang-Chi Hsu, Aubrey R. Turner, S Lilly Zheng, Bao-Li Chang, Wennuan Liu, William B. Isaacs, Jianfeng Xu. (2006) Meta-analysis of association of rare mutations and common sequence variants in theMSR1 gene and prostate cancer risk. The Prostate 66:7, 728-737
CrossRef523
Bernd Frank, Kari Hemminki, Alfons Meindl, Barbara Wappenschmidt, Rüdiger Klaes, Rita K. Schmutzler, Michael Untch, Peter Bugert, Claus R. Bartram, Barbara Burwinkel. (2006) Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk. International Journal of Cancer 118:10, 2505-2508
CrossRef524
F. Eissinger. (2006) Interactions génome-environnement dans les cancers liés aux expositions professionnelles. Archives des Maladies Professionnelles et de l'Environnement 67:2, 297-298
CrossRef525
Jacob vB. Hjelmborg, Ivan Iachine, Axel Skytthe, James W. Vaupel, Matt McGue, Markku Koskenvuo, Jaakko Kaprio, Nancy L. Pedersen, Kaare Christensen. (2006) Genetic influence on human lifespan and longevity. Human Genetics 119:3, 312-321
CrossRef526
Albert B. Lowenfels, Patrick Maisonneuve. (2006) Epidemiology and risk factors for pancreatic cancer. Best Practice & Research Clinical Gastroenterology 20:2, 197-209
CrossRef527
Todd Thornburg, Aubrey R Turner, Yong Q Chen, Mara Vitolins, Baoli Chang, Jianfeng Xu. (2006) Phytanic acid, AMACR and prostate cancer risk. Future Oncology 2:2, 213-223
CrossRef528
Stijn Roemeling, Monique J. Roobol, Stijn H. de Vries, Claartje Gosselaar, Theo H. van der Kwast, Fritz H. Schröder. (2006) Prevalence, Treatment Modalities and Prognosis of Familial Prostate Cancer in a Screened Population. The Journal of Urology 175:4, 1332-1336
CrossRef529
Lata Vadlamudi, Marianne J. Kjeldsen, Linda A. Corey, Marit H. Solaas, Mogen L. Friis, John M. Pellock, Karl O. Nakken, Roger L. Milne, Ingrid E. Scheffer, A. Simon Harvey, John L. Hopper, Samuel F. Berkovic. (2006) Analyzing the Etiology of Benign Rolandic Epilepsy: A Multicenter Twin Collaboration. Epilepsia 47:3, 550-555
CrossRef530
Prasanna Sooriakumaran. (2006) Management of prostate cancer. Part 1: chemoprevention. Expert Review of Anticancer Therapy 6:3, 419-425
CrossRef531
P.D. Ottewell, R.E. Coleman, I. Holen. (2006) From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Research and Treatment 96:2, 101-113
CrossRef532
D C Gould, R S Kirby. (2006) Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?. Prostate Cancer and Prostatic Diseases 9:1, 14-18
CrossRef533
Tina Heine, Hansruedi Glatt, Bernd Epe. (2006) Human cytochrome P450 reductase can act as a source of endogenous oxidative DNA damage and genetic instability. Free Radical Biology and Medicine 40:5, 801-807
CrossRef534
Marco Bernini, Stefano Barbi, Franco Roviello, Aldo Scarpa, Patrick Moore, Corrado Pedrazzani, Stefania Beghelli, Daniele Marrelli, Giovanni de Manzoni. (2006) Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer 9:1, 9-13
CrossRef535
V. A. Kirsh, R. B. Hayes, S. T. Mayne, N. Chatterjee, A. F. Subar, L. B. Dixon, D. Albanes, G. L. Andriole, D. A. Urban, U. Peters. (2006) Supplemental and Dietary Vitamin E, beta-Carotene, and Vitamin C Intakes and Prostate Cancer Risk. JNCI Journal of the National Cancer Institute 98:4, 245-254
CrossRef536
Jeffrey Bland. 2006. Nutrigenomics. , 27-41.
CrossRef537
M. Wagenius, Å. Borg, L. Johansson, A. Giwercman, O. Bratt. (2006) CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden. Scandinavian Journal of Urology and Nephrology 40:1, 23-25
CrossRef538
Alfredo Ortega-Alonso. (2006) Influencias genéticas en la movilidad y capacidad funcional de mujeres mayores: introducción metodológica y resultados preliminares del estudio de hermanas gemelas FITSA. Revista Española de Geriatría y Gerontología 41, 25-32
CrossRef539
Simon N. Stacey, Patrick Sulem, Oskar T. Johannsson, Agnar Helgason, Julius Gudmundsson, Jelena P. Kostic, Kristleifur Kristjansson, Thora Jonsdottir, Helgi Sigurdsson, Jon Hrafnkelsson, Jakob Johannsson, Thorarinn Sveinsson, Gardar Myrdal, Hlynur Niels Grimsson, Jon T. Bergthorsson, Laufey T. Amundadottir, Jeffrey R. Gulcher, Unnur Thorsteinsdottir, Augustine Kong, Kari Stefansson. (2006) The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland. PLoS Medicine 3:7, e217
CrossRef540
A.M. Brewster, T.J. Jorgensen, I. Ruczinski, H.Y. Huang, S. Hoffman, L. Thuita, C. Newschaffer, R.M. Lunn, D. Bell, K.J. Helzlsouer. (2006) Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Research and Treatment 95:1, 73-80
CrossRef541
MJ Ghen, R Roshan, RO Roshan, DJ Blyweiss, N Corso, B Khalili, WT Zenga. (2006) Potential clinical applications using stem cells derived from human umbilical cord blood. Reproductive BioMedicine Online 13:4, 562-572
CrossRef542
Kristjana Einarsdóttir, Keith Humphreys, Carine Bonnard, Juni Palmgren, Mark M. Iles, Arvid Sjölander, Yuqing Li, Kee Seng Chia, Edison T. Liu, Per Hall, Jianjun Liu, Sara Wedrén. (2006) Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk. PLoS Medicine 3:6, e168
CrossRef543
David K. Y. Chiu, Yan Wang. (2006) Multipattern Consensus Regions in Multiple Aligned Protein Sequences and Their Segmentation. EURASIP Journal on Bioinformatics and Systems Biology 2006, 1-8
CrossRef544
Christine Friedenreich. 2005. Physical Activity and Prostate Cancer Risk. , 91-117.
CrossRef545
Kari Hemminki, Xinjun Li, Sven-Erik Johansson, Kristina Sundquist, Jan Sundquist. (2005) Familial risks for migraine and other headaches among siblings based on hospitalizations in Sweden. Neurogenetics 6:4, 217-224
CrossRef546
Kari Hemminki, Justo Lorenzo Bermejo. (2005) Relationships between familial risks of cancer and the effects of heritable genes and their SNP variants. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 592:1-2, 6-17
CrossRef547
David Hunter. (2005) Opinion: A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nature Reviews Cancer 5:12, 977-985
CrossRef548
Michael Wirtenberger, Kari Hemminki, Asta Försti, Rüdiger Klaes, Rita K. Schmutzler, Ewa Grzybowska, Justo L. Bermejo, Barbara Wappenschmidt, Peter Bugert, Dorota Butkiewicz, Jolanta Pamula, Wioletta Pekala, Helena Zientek, Claus R. Bartram, Barbara Burwinkel. (2005) c-MYC Asn11Ser is associated with increased risk for familial breast cancer. International Journal of Cancer 117:4, 638-642
CrossRef549
Michael J. Forlenza, Per Hall, Paul Lichtenstein, Birgitta Evengard, Patrick F. Sullivan. (2005) Epidemiology of cancer-related fatigue in the Swedish twin registry. Cancer 104:9, 2022-2031
CrossRef550
E. Esteban, M. Via, E. González-Pérez, J. Santamaría, J.M. Dugoujon, G. Vona, N. Harich, F. Luna, A.A. Saetta, N. Bissar, P. Moral. (2005) An unexpected wide population variation of the G1733A polymorphism of the androgen receptor gene: Data on the Mediterranean region. American Journal of Human Biology 17:6, 690-695
CrossRef551
A Matakidou, T Eisen, R S Houlston. (2005) Systematic review of the relationship between family history and lung cancer risk. British Journal of Cancer 93:7, 825-833
CrossRef552
Go Shioji, Yoichi Ezura, Toshiaki Nakajima, Kenji Ohgaki, Hiromichi Fujiwara, Yoshinobu Kubota, Tomohiko Ichikawa, Katsuki Inoue, Taro Shuin, Tomonori Habuchi, Osamu Ogawa, Taiji Nishimura, Mitsuru Emi. (2005) Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer. Journal of Human Genetics 50:10, 507-515
CrossRef553
Peter Demant. (2005) The Genetic Factors in Cancer Development and their Implications for Cancer Prevention and Detection. Radiation Research 164:4, 462-466
CrossRef554
Kari Hemminki, Bowang Chen. (2005) Are Twins at Risk of Cancer: Results From the Swedish Family-Cancer Database. Twin Research and Human Genetics 8:5, 509-514
CrossRef555
Kari Hemminki, Bowang Chen. (2005) Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. The Prostate 65:2, 188-194
CrossRef556
Christopher Haqq, Rile Li, Daniel Khodabakhsh, Anna Frolov, David Ginzinger, Timothy Thompson, Thomas Wheeler, Peter Carroll, Gustavo Ayala. (2005) Ethnic and racial differences in prostate stromal estrogen receptor α. The Prostate 65:2, 101-109
CrossRef557
Leda I.C.V. Esteves, Afonso C. Javaroni, Inês N. Nishimoto, José Magrin, Jeremy A. Squire, Luiz P. Kowalski, Cláudia A. Rainho, Silvia R. Rogatto. (2005) DNA methylation in the CTCF-binding site I and the expression pattern of theH19 gene: Does positive expression predict poor prognosis in early stage head and neck carcinomas?. Molecular Carcinogenesis 44:2, 102-110
CrossRef558
Maurice P Zeegers, Harry Ostrer. (2005) Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility. Future Oncology 1:5, 683-688
CrossRef559
Hitoshi Nakagama, Masako Nakanishi, Masako Ochiai. (2005) Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP. Cancer Science 96:10, 627-636
CrossRef560
Agnieszka Bartoszek. 2005. Genotoxic Food Components. .
CrossRef561
Paul R Burton, Martin D Tobin, John L Hopper. (2005) Key concepts in genetic epidemiology. The Lancet 366:9489, 941-951
CrossRef562
Ricardo Acevedo, Pamela G. Parnell, Hugo Villanueva, Laura M. Chapman, Tomas Gimenez, Sandra L. Gray, William S. Baldwin. (2005) The contribution of hepatic steroid metabolism to serum estradiol and estriol concentrations in nonylphenol treated MMTVneu mice and its potential effects on breast cancer incidence and latency. Journal of Applied Toxicology 25:5, 339-353
CrossRef563
Peter Malfertheiner, Pentti Sipponen, Michael Naumann, Paul Moayyedi, Francis Megraud, Shu-Dong Xiao, Kentaro Sugano, Olof Nyren, . (2005) Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. The American Journal of Gastroenterology 100:9, 2100-2115
CrossRef564
Richard A. Kerber, Deborah W. Neklason, Wade S. Samowitz, Randall W. Burt. (2005) Frequency of Familial Colon Cancer and Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in a Large Population Database. Familial Cancer 4:3, 239-244
CrossRef565
Javier Hernandez, Edith Canby-Hagino, Ian M. Thompson. (2005) Biomarkers for the detection and prognosis of prostate cancer. Current Prostate Reports 3:3, 112-117
CrossRef566
Sasha Bernatsky, Lawrence Joseph, Patrick Bélisle, Jean-François Boivin, Raghu Rajan, Andrew Moore, Ann Clarke. (2005) Bayesian modelling of imperfect ascertainment methods in cancer studies. Statistics in Medicine 24:15, 2365-2379
CrossRef567
Peter Dauvergne. (2005) Cancer and Global Environmental Politics: Proposing a New Research Agenda. Global Environmental Politics 5:3, 6-13
CrossRef568
Kari Hemminki, Bowang Chen. (2005) Familial risks for colorectal cancer show evidence on recessive inheritance. International Journal of Cancer 115:5, 835-838
CrossRef569
Bruce WS Robinson, Arthur W Musk, Richard A Lake. (2005) Malignant mesothelioma. The Lancet 366:9483, 397-408
CrossRef570
Yuki Young, Jonathan P. Terdiman. (2005) Endoscopic Management of Familial Colonic Neoplasia. Gastrointestinal Endoscopy Clinics of North America 15:3, 549-580
CrossRef571
Christopher M. Masi, Olufunmilayo I. Olopade. (2005) Racial and Ethnic Disparities in Breast Cancer: A Multilevel Perspective. Medical Clinics of North America 89:4, 753-770
CrossRef572
Kenneth Olden, Sandra L. White. (2005) Health-Related Disparities: Influence of Environmental Factors. Medical Clinics of North America 89:4, 721-738
CrossRef573
Kerstin Wagner, Kari Hemminki, Elisabeth Israelsson, Ewa Grzybowska, Magnus Söderberg, Jolanta Pamula, Wioletta Pekala, Helena Zientek, Danuta Mielzynska, Ewa Siwinska, Asta Försti. (2005) Polymorphisms in the IGF-1 and IGFBP3 promoter and the risk of breast cancer. Breast Cancer Research and Treatment 92:2, 133-140
CrossRef574
J. C. Routh, B. C. Leibovich. (2005) Adenocarcinoma of the Prostate: Epidemiological Trends, Screening, Diagnosis, and Surgical Management of Localized Disease. Mayo Clinic Proceedings 80:7, 899-907
CrossRef575
Vincenzo Catalano, Roberto Labianca, Giordano D. Beretta, Gemma Gatta, Filippo de Braud, Eric Van Cutsem. (2005) Gastric cancer. Critical Reviews in Oncology/Hematology 54:3, 209-241
CrossRef576
Javier Hernandez, Edith Canby-Hagino, Ian M. Thompson. (2005) Biomarkers for the detection and prognosis of prostate cancer. Current Urology Reports 6:3, 171-176
CrossRef577
F. Robles-Agudo, F. Sanz-Segovia, J.M. López-Arrieta, M. Beltrán de la Ascensión. (2005) Alimentación y cáncer. Revista Española de Geriatría y Gerontología 40:3, 184-194
CrossRef578
Daniel J. Schaid, Bao Li Chang, . (2005) Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. The Prostate 63:3, 276-290
CrossRef579
Tokuki Sakiyama, Takashi Kohno, Sachiyo Mimaki, Tsutomu Ohta, Noriko Yanagitani, Tomotaka Sobue, Hideo Kunitoh, Ryusei Saito, Kimiko Shimizu, Chie Hirama, Junko Kimura, Go Maeno, Hiroshi Hirose, Takashi Eguchi, Daizo Saito, Misao Ohki, Jun Yokota. (2005) Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. International Journal of Cancer 114:5, 730-737
CrossRef580
Halla Skuladottir, Herman Autrup, Judith Autrup, Anne Tjoenneland, Kim Overvad, David Ryberg, Aage Haugen, Jørgen H. Olsen. (2005) Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. Lung Cancer 48:2, 187-199
CrossRef581
Liselotte Petersen, Per Kragh Andersen, Thorkild I. A. S
CrossRef582
Despina Katsika, Andrej Grjibovski, Curt Einarsson, Frank Lammert, Paul Lichtenstein, Hanns-Ulrich Marschall. (2005) Genetic and environmental influences on symptomatic gallstone disease: A Swedish study of 43,141 twin pairs. Hepatology 41:5, 1138-1143
CrossRef583
Randall Burt, Deborah W. Neklason. (2005) Genetic Testing for Inherited Colon Cancer. Gastroenterology 128:6, 1696-1716
CrossRef584
Richard A. Kerber, Elizabeth O'Brien. (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103:9, 1906-1915
CrossRef585
J. Sun, F. Wiklund, S. L. Zheng, B. Chang, K. Balter, L. Li, J.-E. Johansson, G. Li, H.-O. Adami, W. Liu, A. Tolin, A. R. Turner, D. A. Meyers, W. B. Isaacs, J. Xu, H. Gronberg. (2005) Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk. JNCI Journal of the National Cancer Institute 97:7, 525-532
CrossRef586
William M. Grady, Ken Russell. (2005) Ionizing radiation and rectal cancer: Victims of our own success. Gastroenterology 128:4, 1114-1117
CrossRef587
Bao-Li Chang, Elizabeth M. Gillanders, Sarah D. Isaacs, Kathy E. Wiley, Tamara Adams, Aubrey R. Turner, S. Lilly Zheng, Deborah A. Meyers, John D. Carpten, Patrick C. Walsh, Jeffrey M. Trent, Jianfeng Xu, William B. Isaacs. (2005) Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer. Cancer Letters 219:2, 177-182
CrossRef588
Xinjun Li, Kari Hemminki. (2005) Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 47:3, 301-307
CrossRef589
Stuart G. Baker, Paul Lichtenstein, Jaakko Kaprio, Niels Holm. (2005) Genetic Susceptibility to Prostate, Breast, and Colorectal Cancer among Nordic Twins. Biometrics 61:1, 55-63
CrossRef590
Livia Kelemen, Amanda B. Spurdle, David M. Purdie, Dorota Gertig, Georgia Chenevix-Trench. (2005) RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. Cancer Letters 218:2, 191-197
CrossRef591
Ashwin Kotnis, Rajiv Sarin, Rita Mulherkar. (2005) Genotype, phenotype and cancer: Role of low penetrance genes and environment in tumour susceptibility. Journal of Biosciences 30:1, 93-102
CrossRef592
Miguel Barrueco, Alejandro Alonso, Rogelio González-Sarmiento. (2005) Bases genéticas del hábito tabáquico. Medicina Clínica 124:6, 223-228
CrossRef593
Andreas Luch. (2005) Nature and nurture – lessons from chemical carcinogenesis. Nature Reviews Cancer 5:2, 113-125
CrossRef594
Christopher E. Aston, David A. Ralph, Dominique P. Lalo, Sharmila Manjeshwar, Bobby A. Gramling, Daniele C. DeFreese, Amy D. West, Dannielle E. Branam, Linda F. Thompson, Melissa A. Craft, Debra S. Mitchell, Craig D. Shimasaki, John J. Mulvihill, Eldon R. Jupe. (2005) Oligogenic combinations associated with breast cancer risk in women under 53
CrossRef595
E. Spangler, C.M. Zeigler-Johnson, S.B. Malkowicz, A.J. Wein, T.R. Rebbeck. (2005) Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors. International Journal of Cancer 113:3, 471-474
CrossRef596
Kari Hemminki, Rajesh Rawal, Justo Lorenzo Bermejo. (2005) Prostate cancer screening, changing age-specific incidence trends and implications on familial risk. International Journal of Cancer 113:2, 312-315
CrossRef597
Kee-Seng Chia, Marie Reilly, Chuen-Seng Tan, Jeannette Lee, Yudi Pawitan, Hans-Olov Adami, Per Hall, Benjamin Mow. (2005) Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: A comparative population-based study in Singapore and Sweden. International Journal of Cancer 113:2, 302-306
CrossRef598
Dante D. C
CrossRef599
Tetsuya Mitsudomi. (2005) Mass Screening and Molecular Diagnosis for Lung Cancer. Haigan 45:2, 157-165
CrossRef600
Wayne D. Hall. (2005) Will Nicotine Genetics and a Nicotine Vaccine Prevent Cigarette Smoking and Smoking-Related Diseases?. PLoS Medicine 2:9, e266
CrossRef601
B.A.J. PONDER, A. ANTONIOU, A. DUNNING, D.F. EASTON, P.D.P. PHAROAH. (2005) Polygenic Inherited Predisposition to Breast Cancer. Cold Spring Harbor Symposia on Quantitative Biology 70:1, 35-41
CrossRef602
Ernest T. Hawk, Asad Umar, Ellen Richmond, Jaye L. Viner. (2005) Prevention and therapy of colorectal cancer. Medical Clinics of North America 89:1, 85-110
CrossRef603
John A. Newby, C. Vyvyan Howard. (2005) Environmental influences in cancer aetiology. Journal of Nutritional and Environmental Medicine 15:2-3, 56-114
CrossRef604
John P A Ioannidis, Evangelia E Ntzani, Thomas A Trikalinos. (2004) 'Racial' differences in genetic effects for complex diseases. Nature Genetics 36:12, 1312-1318
CrossRef605
William G Nelson. (2004) Agents in development for prostate cancer prevention. Expert Opinion on Investigational Drugs 13:12, 1541-1554
CrossRef606
Darrell L Ellsworth, Rachel E Ellsworth, Michael N Liebman, Jeffrey A Hooke, Craig D Shriver. (2004) Genomic instability in histologically normal breast tissues: implications for carcinogenesis. The Lancet Oncology 5:12, 753-758
CrossRef607
Xinjun Li, Kari Hemminki. (2004) Inherited predisposition to early onset lung cancer according to histological type. International Journal of Cancer 112:3, 451-457
CrossRef608
Paul D. P. Pharoah, Alison M. Dunning, Bruce A. J. Ponder, Douglas F. Easton. (2004) Association studies for finding cancer-susceptibility genetic variants. Nature Reviews Cancer 4:11, 850-860
CrossRef609
Marika J. Linja, Tapio Visakorpi. (2004) Alterations of androgen receptor in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 92:4, 255-264
CrossRef610
WILLIAM G. NELSON, ANGELO M. DE MARZO, THEODORE L. DeWEESE, WILLIAM B. ISAACS. (2004) THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER. The Journal of Urology 172:5, S6-S12
CrossRef611
Jy-Ming Chiang, Yah-Huei Wu Chou, Shih-Chieh Ma, Jim-Ray Chen. (2004) Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer?rarity of co-occurrence of mutations in APC, K-ras, and p53 genes. Virchows Archiv 445:5, 465-471
CrossRef612
Dalit Barkan, Cristina Montagna, Thomas Ried, Jeffrey E. Green. 2004. Mammary Gland Cancer. .
CrossRef613
Kari Hemminki, Rajesh Rawal, Bowang Chen, Justo Lorenzo Bermejo. (2004) Genetic epidemiology of cancer: From families to heritable genes. International Journal of Cancer 111:6, 944-950
CrossRef614
Albert de la Chapelle. (2004) Genetic predisposition to colorectal cancer. Nature Reviews Cancer 4:10, 769-780
CrossRef615
Steven A. Frank. (2004) Genetic predisposition to cancer — insights from population genetics. Nature Reviews Genetics 5:10, 764-772
CrossRef616
Elaine A. Ostrander, Kyriacos Markianos, Janet L. Stanford. (2004) FINDING PROSTATE CANCER SUSCEPTIBILITY GENES. Annual Review of Genomics and Human Genetics 5:1, 151-175
CrossRef617
G. Haars, P.A.H. van Noord, C.H. van Gils, P.H.M. Peeters, D.E. Grobbee. (2004) Heritable Aspects of Dysplastic Breast Glandular Tissue (DY). Breast Cancer Research and Treatment 87:2, 149-156
CrossRef618
E. M. Gillanders, J. Xu, B.-l. Chang, E. M. Lange, F. Wiklund, J. E. Bailey-Wilson, A. Baffoe-Bonnie, M. Jones, D. Gildea, E. Riedesel, J. Albertus, S. D. Isaacs, K. E. Wiley, C. E. Mohai, M. P. Matikainen, T. L. J. Tammela, S. L. Zheng, W. M. Brown, A. Rokman, J. D. C. D. A. Meyers, P. C. Walsh, J. Schleutker, H. Gronberg, K. A. Cooney, W. B. Isaacs, J. M. Trent. (2004) Combined Genome-Wide Scan for Prostate Cancer Susceptibility Genes. JNCI Journal of the National Cancer Institute 96:16, 1240-1247
CrossRef619
Stephen M. Edwards, Rosalind A. Eeles. (2004) Unravelling the genetics of prostate cancer. American Journal of Medical Genetics 129C:1, 65-73
CrossRef620
Silvana Baglioni, Maurizio Genuardi. (2004) Simple and complex genetics of colorectal cancer susceptibility. American Journal of Medical Genetics 129C:1, 35-43
CrossRef621
Randall W. Burt, Mark F. Leppert, Martha L. Slattery, Wade S. Samowitz, Lisa N. Spirio, Richard A. Kerber, Scott K. Kuwada, Deborah W. Neklason, James A. DiSario, Elaine Lyon, J.Preston Hughes, William Y. Chey, Raymond L. White. (2004) Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127:2, 444-451
CrossRef622
Daphne Hessels, Gerald W Verhaegh, Jack A Schalken, J Alfred Witjes. (2004) Applicability of biomarkers in the early diagnosis of prostate cancer. Expert Review of Molecular Diagnostics 4:4, 513-526
CrossRef623
Mark A. Rochester, Simon F. Brewster. (2004) Genetics for urologists. BJU International 94:2, 232-237
CrossRef624
Fabiana Granja, Joseane Morari, Elaine C Morari, Luiz A.C Correa, Lı́gia V.M Assumpção, Laura S Ward. (2004) Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Letters 210:2, 151-157
CrossRef625
Kari Hemminki, Xinjun Li. (2004) Familial risks of cancer as a guide to gene identification and mode of inheritance. International Journal of Cancer 110:2, 291-294
CrossRef626
Thorunn Rafnar, Steinunn Thorlacius, Eirikur Steingrimsson, Mikkel H. Schierup, Jesper N. Madsen, Violeta Calian, Bjarki J. Eldon, Thorvaldur Jonsson, Jotun Hein, Snorri S. Thorgeirsson. (2004) Opinion: The Icelandic Cancer Project – a population-wide approach to studying cancer. Nature Reviews Cancer 4:6, 488-492
CrossRef627
Annika Lindblom, Xiao-Lei Zhou, Tao Liu, Annelie Liljegren, Johanna Skoglund, Tatjana Djureinovic. (2004) Colorectal cancer as a complex disease: defining at-risk subjects in the general population – a preventive strategy. Expert Review of Anticancer Therapy 4:3, 377-385
CrossRef628
Kati P Porkka, Tapio Visakorpi. (2004) Molecular Mechanisms of Prostate Cancer. European Urology 45:6, 683-691
CrossRef629
Fabiana Granja, Joseane Morari, Elaine C Morari, Luiz A.C Correa, Lı́gia V.M Assumpção, Laura S Ward. (2004) GST profiling may be useful in the screening for thyroid nodule malignancy. Cancer Letters 209:2, 129-137
CrossRef630
(2004) Position of the American Dietetic Association and Dietitians of Canada: Nutrition and Women’s Health. Journal of the American Dietetic Association 104:6, 984-1001
CrossRef631
Kari Hemminki, Xinjun Li. (2004) Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects. Kidney International 65:6, 2298-2302
CrossRef632
H-J Menzel, J Sarmanova, P Soucek, R Berberich, K Grünewald, M Haun, H-G Kraft. (2004) Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations. British Journal of Cancer 90:10, 1989-1994
CrossRef633
Kenneth Olden. (2004) Genomics in environmental health research—opportunities and challenges. Toxicology 198:1-3, 19-24
CrossRef634
Eric Deutsch, Laurence Maggiorella, Pascal Eschwege, Jean Bourhis, Jean Charles Soria, Bassam Abdulkarim. (2004) Environmental, genetic, and molecular features of prostate cancer. The Lancet Oncology 5:5, 303-313
CrossRef635
Christina Fleischmann, Julian Peto, Jeremy Cheadle, Bindiya Shah, Julian Sampson, Richard S. Houlston. (2004) Comprehensive analysis of the contribution of germlineMYH variation to early-onset colorectal cancer. International Journal of Cancer 109:4, 554-558
CrossRef636
Bas A.J. Verhage, Katja K.H. Aben, J. Alfred Witjes, Huub Straatman, Jack A. Schalken, Lambertus A.L.M. Kiemeney. (2004) Site-specific familial aggregation of prostate cancer. International Journal of Cancer 109:4, 611-617
CrossRef637
A. Poulstrup, H.L. Hansen. (2004) Use of GIS and Exposure Modeling as Tools in a Study of Cancer Incidence in a Population Exposed to Airborne Dioxin. Environmental Health Perspectives 112:9, 1032-1036
CrossRef638
Bj
CrossRef639
Takashi Sugimura, Keiji Wakabayashi, Hitoshi Nakagama, Minako Nagao. (2004) Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish. Cancer Science 95:4, 290-299
CrossRef640
Jennifer L. Beebe-Dimmer, David P. Wood, Stephen B. Gruber, Doug M. Chilson, Kimberly A. Zuhlke, Gina B. Claeys, Kathleen A. Cooney. (2004) Risk perception and concern among brothers of men with prostate carcinoma. Cancer 100:7, 1537-1544
CrossRef641
Yvonne Marie Coyle. (2004) The Effect of Environment on Breast Cancer Risk. Breast Cancer Research and Treatment 84:3, 273-288
CrossRef642
Larry I Palmer, Robert CG Martin, David W Hein. (2004) Chemopreventive drug treatment in subjects with genetic predisposition to cancer: prescriber liability and healthcare disparities. Pharmacogenomics 5:3, 319-329
CrossRef643
Jun Wang, Isam-Eldin Eltoum, Coral A Lamartiniere. (2004) Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Molecular and Cellular Endocrinology 219:1-2, 171-180
CrossRef644
Magnus Edlund, Shian-Ying Sung, Leland W.K. Chung. (2004) Modulation of prostate cancer growth in bone microenvironments. Journal of Cellular Biochemistry 91:4, 686-705
CrossRef645
Marcellin Gangbe, Jean-Pierre Thouez, Parviz Ghadirian. (2004) Differences in cancer incidence between men and women in the province of Quebec, Canada, 1984-1993. The Canadian Geographer/Le G?ographe canadien 48:1, 52-61
CrossRef646
William B. Grant. (2004) A Multicountry Ecologic Study of Risk and Risk Reduction Factors for Prostate Cancer Mortality. European Urology 45:3, 271-279
CrossRef647
Rui Medeiros, Andr
CrossRef648
BOB DJAVAN, ALEXANDRE ZLOTTA, CLAUDE SCHULMAN, PIERRE TEILLAC, PETER IVERSEN, LAURENT BOCCON GIBOD, GEORG BARTSCH, MICHAEL MARBERGER. (2004) Chemotherapeutic Prevention Studies of Prostate Cancer. The Journal of Urology 171:2, S10-S14
CrossRef649
Kathryn Dean. (2004) The role of methods in maintaining orthodox beliefs in health research. Social Science & Medicine 58:4, 675-685
CrossRef650
Nina N. Nupponen, Mika J. Wall
CrossRef651
Allan H. Conney. (2004) Tailoring cancer chemoprevention regimens to the individual. Journal of Cellular Biochemistry 91:2, 277-286
CrossRef652
Stella C Lymberis, Preeti K Parhar, Evangelia Katsoulakis, Silvia C Formenti. (2004) Pharmacogenomics and breast cancer. Pharmacogenomics 5:1, 31-55
CrossRef653
Kari Hemminki, Xinjun Li, Kamila Czene. (2004) Familial risk of cancer: Data for clinical counseling and cancer genetics. International Journal of Cancer 108:1, 109-114
CrossRef654
David Jager, Marie L. Borum. 2004. Colorectal Cancer Screening. , 470-473.
CrossRef655
John W. Warren, Theresa L. Jackson, Patricia Langenberg, Deborah J. Meyers, Jianfeng Xu. (2004) Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. Urology 63:1, 17-21
CrossRef656
Laufey T. Amundadottir, Sverrir Thorvaldsson, Daniel F. Gudbjartsson, Patrick Sulem, Kristleifur Kristjansson, Sigurdur Arnason, Jeffrey R. Gulcher, Johannes Bjornsson, Augustine Kong, Unnur Thorsteinsdottir, Kari Stefansson. (2004) Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family. PLoS Medicine 1:3, e65
CrossRef657
Julie M. Cunningham, Shannon K. McDonnell, Angela Marks, Scott Hebbring, Sarah A. Anderson, Brett J. Peterson, Susan Slager, Amy French, Michael L. Blute, Daniel J. Schaid, Stephen N. Thibodeau, . (2003) Genome linkage screen for prostate cancer susceptibility loci: Results from the Mayo Clinic familial prostate cancer study. The Prostate 57:4, 335-346
CrossRef658
(2003) Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. The Prostate 57:4, 270-279
CrossRef659
Douglas F. Easton, Daniel J. Schaid, Alice S. Whittemore, William J. Isaacs. (2003) Where are the prostate cancer genes??A summary of eight genome wide searches. The Prostate 57:4, 261-269
CrossRef660
Johanna Schleutker, Agnes B. Baffoe-Bonnie, Elizabeth Gillanders, Tommi Kainu, Mary-Pat Jones, Diana Freas-Lutz, Carol Markey, Derek Gildea, Erica Riedesel, Julie Albertus, Kenneth D. Gibbs, Mika Matikainen, Pasi A. Koivisto, Teuvo Tammela, Joan E. Bailey-Wilson, Jeffrey M. Trent, Olli-P. Kallioniemi. (2003) Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26. The Prostate 57:4, 280-289
CrossRef661
Marta Janer, Danielle M. Friedrichsen, Janet L. Stanford, Michael D. Badzioch, Suzanne Kolb, Kerry Deutsch, Mette A. Peters, Ellen L. Goode, Russ Welti, Hawkins B. DeFrance, Lori Iwasaki, Sarah Li, Leroy Hood, Elaine A. Ostrander, Gail P. Jarvik. (2003) Genomic scan of 254 hereditary prostate cancer families. The Prostate 57:4, 309-319
CrossRef662
P. Finne, U.-H. Stenman, L. Maattanen, T. Makinen, T.L.J. Tammela, P. Martikainen, M. Ruutu, M. Ala-Opas, J. Aro, P.J. Karhunen, J. Lahtela, P. Rissanen, H. Juusela, M. Hakama, A. Auvinen. (2003) The Finnish trial of prostate cancer screening: where are we now?. BJU International 92:s2, 22-26
CrossRef663
Angel Ferrández, James A DiSario. (2003) Colorectal cancer: screening and surveillance for high-risk individuals. Expert Review of Anticancer Therapy 3:6, 851-862
CrossRef664
Martin G. A. Bäuerle, Rolf Kreienberg, Tanja Volm. (2003) Surgery for elderly patients with ovarian cancer. Current Oncology Reports 5:6, 482-485
CrossRef665
Tapio Visakorpi. (2003) The molecular genetics of prostate cancer. Urology 62:5, 3-10
CrossRef666
Kari Hemminki, Charlotta Granström. (2003) Familial Breast Cancer: Scope for More Susceptibility Genes?. Breast Cancer Research and Treatment 82:1, 17-22
CrossRef667
Lara Lipton, Christina Fleischmann, Oliver M Sieber, Huw J.W Thomas, Shirley V Hodgson, Ian P.M Tomlinson, Richard S Houlston. (2003) Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. Cancer Letters 200:2, 149-152
CrossRef668
David Gaist, Nancy L Pedersen, Markku Koskenvuo, Søren Bak, Simona Giampaoli, Kaare Christensen, Jaakko Kaprio. (2003) Stroke Research in GenomEUtwin. Twin Research and Human Genetics 6:5, 442-447
CrossRef669
Peter Demant. (2003) Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nature Reviews Genetics 4:9, 721-734
CrossRef670
Glenn R. Cunningham, Carol M. Ashton, John F. Annegers, Julianne Souchek, Marcella Klima, Brian Miles. (2003) Familial aggregation of prostate cancer in African-Americans and white Americans. The Prostate 56:4, 256-262
CrossRef671
Susa Enholm, Tuija Hienonen, Anu Suomalainen, Lara Lipton, Ian Tomlinson, Vesa Kärjä, Matti Eskelinen, Jukka-Pekka Mecklin, Auli Karhu, Heikki J. Järvinen, Lauri A. Aaltonen. (2003) Proportion and Phenotype of MYH-Associated Colorectal Neoplasia in a Population-Based Series of Finnish Colorectal Cancer Patients. The American Journal of Pathology 163:3, 827-832
CrossRef672
Katja Mitrunen, Ari Hirvonen. (2003) Molecular epidemiology of sporadic breast cancer. Mutation Research/Reviews in Mutation Research 544:1, 9-41
CrossRef673
FRANCOIS PEYRON, ATHANASE B. ATEBA, MARTINE WALLON, LAURENT KODJIKIAN, CHRISTINE BINQUET, JACQUES FLEURY, JUSTUS G. GARWEG. (2003) Congenital toxoplasmosis in twins: a report of fourteen consecutive cases and a comparison with published data. The Pediatric Infectious Disease Journal 22:8, 695-701
CrossRef674
Annie J Sasco, Rudolf Kaaks, Ruth E Little. (2003) Breast cancer: occurrence, risk factors and hormone metabolism. Expert Review of Anticancer Therapy 3:4, 546-562
CrossRef675
Attilio Giacosa, Jaak Ph Janssens, Reinhold Stockbrügger. (2003) New avenues in cancer prevention. European Journal of Cancer Prevention 12:4, 247-249
CrossRef676
S. W. Marmagas, L. R. King, M. G. Chuk. (2003) Public Health's Response to a Changed World: September 11, Biological Terrorism, and the Development of an Environmental Health Tracking Network. American Journal of Public Health 93:8, 1226-1230
CrossRef677
Nelson, William G., De Marzo, Angelo M., Isaacs, William B., . (2003) Prostate Cancer. New England Journal of Medicine 349:4, 366-381
Full Text678
M. Marchesani, A. Hakkarainen, T.-P. Tuomainen, J. Kaikkonen, E. Pukkala, P. Uimari, E. Seppala, M. Matikainen, O.-P. Kallioniemi, J. Schleutker, T. Lehtimaki, J. T. Salonen. (2003) New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men. JNCI Journal of the National Cancer Institute 95:11, 812-818
CrossRef679
Dimitrios H Roukos, Evangelos Paraskevaidis, Niki J Agnantis, Angelos M Kappas. (2003) Fruits and vegetables: do they protect from gastric cancer?. Gastroenterology 124:7, 2006
CrossRef680
L.E. Johns, R.S. Houlston. (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU International 91:9, 789-794
CrossRef681
Terry Reed, Danielle M Dick. (2003) Heritability and Validity of Healthy Physical Aging (Wellness) in Elderly Male Twins. Twin Research and Human Genetics 6:3, 227-234
CrossRef682
Asta Försti, Chunyan Zhao, Elisabeth Israelsson, Karin Dahlman-Wright, Jan-Åke Gustafsson, Kari Hemminki. (2003) Polymorphisms in the Estrogen Receptor Beta Gene and Risk of Breast Cancer: No Association. Breast Cancer Research and Treatment 79:3, 409-413
CrossRef683
Julia Green Brody, Ruthann A. Rudel. (2003) Environmental Pollutants and Breast Cancer. Environmental Health Perspectives 111:8, 1007-1019
CrossRef684
Torben Bjerregaard Larsen, Henrik Toft Sørensen, Axel Skytthe, Søren Paaske Johnsen, James W. Vaupel, Kaare Christensen. (2003) Major Genetic Susceptibility for Venous Thromboembolism in Men: A Study of Danish Twins. Epidemiology 14:3, 328-332
CrossRef685
Bernd Gerber, Heiner Müller, Toralf Reimer, Annette Krause, Klaus Friese. (2003) Nutrition and Lifestyle Factors on the Risk of Developing Breast Cancer. Breast Cancer Research and Treatment 79:2, 265-276
CrossRef686
Robin Leach, Brad Pollock, Joseph Basler, Dean Troyer, Susan Naylor, Ian M Thompson. (2003) Chemoprevention of prostate cancer. Urologic Clinics of North America 30:2, 227-237
CrossRef687
David E. Comings, Radhika Gade-Andavolu, Lawrence A. Cone, Donn Muhleman, James P. MacMurray. (2003) A multigene test for the risk of sporadic breast carcinoma. Cancer 97:9, 2160-2170
CrossRef688
Xinjun Li, Kari Hemminki. (2003) Familial upper aerodigestive tract cancers: incidence trends, familial clustering and subsequent cancers. Oral Oncology 39:3, 232-239
CrossRef689
Catherine L. Saunders, Colin B. Begg. (2003) Kin-cohort evaluation of relative risks of genetic variants. Genetic Epidemiology 24:3, 220-229
CrossRef690
AH Heald, JE Cade, JK Cruickshank, S Anderson, A White, JM Gibson. (2003) The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutrition 6:02,
CrossRef691
Goutham Narla, Scott L. Friedman, John A. Martignetti. (2003) Krüppel Cripples Prostate Cancer. The American Journal of Pathology 162:4, 1047-1052
CrossRef692
R.Julian Preston. (2003) Molecular epidemiology: potential impacts on the assessment of public health. Mutation Research/Reviews in Mutation Research 543:2, 121-124
CrossRef693
AM Nieder, SS Taneja, MPA Zeegers, H Ostrer. (2003) Genetic counseling for prostate cancer risk. Clinical Genetics 63:3, 169-176
CrossRef694
A. Valeri, L. Briollais, R. Azzouzi, G. Fournier, P. Mangin, P. Berthon, O. Cussenot, F. Demenais. (2003) Segregation Analysis of Prostate Cancer in France: Evidence for Autosomal Dominant Inheritance and Residual Brother-brother Dependence. Annals of Human Genetics 67:2, 125-137
CrossRef695
Xinjun Li, Kari Hemminki. (2003) Familial and second lung cancers: a nation-wide epidemiologic study from Sweden. Lung Cancer 39:3, 255-263
CrossRef696
B. Bjorkholm, P. Falk, L. Engstrand, O. Nyren. (2003) Helicobacter pylori: resurrection of the cancer link. Journal of Internal Medicine 253:2, 102-119
CrossRef697
H. Frederiksen, K. Christensen. (2003) The influence of genetic factors on physical functioning and exercise in second half of life. Scandinavian Journal of Medicine and Science in Sports 13:1, 9-18
CrossRef698
Dev Karan, Ming-Fong Lin, Sonny L. Johansson, Surinder K. Batra. (2003) Current status of the molecular genetics of human prostatic adenocarcinomas. International Journal of Cancer 103:3, 285-293
CrossRef699
NOBUKO MORI, JYOJI YAMATE, SEI-ICHI UMESAKO, DOO-PYO HONG, MASAAKI OKUMOTO, REN NAKAO. (2003) Preferential Induction of Mammary Tumors in p53 Hemizygous BALB/c Mice by Fractionated Irradiation of a Sub-lethal Dose of X-rays. Journal of Radiation Research 44:3, 249-254
CrossRef700
Jon R. Kelley, John M. Duggan. (2003) Gastric cancer epidemiology and risk factors. Journal of Clinical Epidemiology 56:1, 1-9
CrossRef701
Mary S. Wolff, Julie A. Britton, Valerie P. Wilson. (2003) Environmental risk factors for breast cancer among African-American women. Cancer 97:S1, 289-310
CrossRef702
Jun Wang, Isam-Eldin Eltoum, Coral A Lamartiniere. (2002) Dietary genistein suppresses chemically induced prostate cancer in Lobund–Wistar rats. Cancer Letters 186:1, 11-18
CrossRef703
Hendrik Berth, Friedrich Balck, Andreas Dinkel. (2002) Attitudes Toward Genetic Testing in Patients At Risk for HNPCC/FAP and the German Population. Genetic Testing 6:4, 273-280
CrossRef704
Leslie A Lytle, Jayne A Fulkerson. (2002) Assessing the dietary environment: examples from school-based nutrition interventions. Public Health Nutrition 5:6a,
CrossRef705
, Elizabeth M. Ward, Paul A. Schulte, Steve Bayard, Aaron Blair, Paul Brandt-Rauf, Mary Ann Butler, David Dankovic, Ann F. Hubbs, Carol Jones, Myra Karstadt, Gregory L. Kedderis, Ronald Melnick, Carrie A. Redlich, Nathaniel Rothman, Russell E. Savage, Michael Sprinker, Mark Toraason, Ainsley Weston. (2002) Priorities for Development of Research Methods in Occupational Cancer. Environmental Health Perspectives 111:1, 1-12
CrossRef706
Bora E. Baysal, Eugene N. Myers. (2002) Etiopathogenesis and clinical presentation of carotid body tumors. Microscopy Research and Technique 59:3, 256-261
CrossRef707
Romualdo Benigni. (2002) Inequalities in Health: The Value of Sex-Related Indicators. Environmental Health Perspectives 111:4, 421-425
CrossRef708
IVANA BALIC, STANLEY T. GRAHAM, DEAN A. TROYER, BETSY A. HIGGINS, BRAD H. POLLOCK, TERESA L. JOHNSON-PAIS, IAN M. THOMPSON, ROBIN J. LEACH. (2002) Androgen Receptor Length Polymorphism Associated with Prostate Cancer Risk in Hispanic Men. The Journal of Urology 168:5, 2245-2248
CrossRef709
Elihu D. Richter, Lee S. Friedman, Yuval Tamir, Tamar Berman, Or Levy, Jerome B. Westin, Tamar Peretz. (2002) Cancer Risks in Naval Divers with Multiple Exposures to Carcinogens. Environmental Health Perspectives 111:4, 609-617
CrossRef710
IVANA BALIC, STANLEY T. GRAHAM, DEAN A. TROYER, BETSY A. HIGGINS, BRAD H. POLLOCK, TERESA L. JOHNSON-PAIS, IAN M. THOMPSON, ROBIN J. LEACH. (2002) Androgen Receptor Length Polymorphism Associated with Prostate Cancer Risk in Hispanic Men. The Journal of Urology2245-2248
CrossRef711
Nancy L Pedersen, Paul Lichtenstein, Pia Svedberg. (2002) The Swedish Twin Registry in the Third Millennium. Twin Research and Human Genetics 5:5, 427-432
CrossRef712
Claude C Schulman, John B Anderson, Chris H Bangma, Michael J Marberger. (2002) Prevention and Screening. European Urology Supplements 1:7, 3-9
CrossRef713
Maria Antonietta Stazi, Rodolfo Cotichini, Valeria Patriarca, Sonia Brescianini, Corrado Fagnani, Cristina D'Ippolito, Stefania Cannoni, Giovanni Ristori, Marco Salvetti. (2002) The Italian Twin Project: From the Personal Identification Number to a National Twin Registry. Twin Research and Human Genetics 5:5, 382-386
CrossRef714
Patrick J Stover, Cutberto Garza. (2002) Molecular and genetic considerations for long-term nutrition interventions. Asia Pacific Journal of Clinical Nutrition 11:s6, S129-S136
CrossRef715
Joohon Sung, Soo-Hun Cho, Sung-Il Cho, David L Duffy, Jin-Hee Kim, Ho Kim, Kyung Sook Park, Sue Kyung Park. (2002) The Korean Twin Registry ? Methods, Current Stage, and Interim Results. Twin Research and Human Genetics 5:5, 394-400
CrossRef716
Jaakko Kaprio, Markku Koskenvuo. (2002) Genetic and Environmental Factors in Complex Diseases: The Older Finnish Twin Cohort. Twin Research and Human Genetics 5:5, 358-365
CrossRef717
Kari Hemminki, Kamila Czene. (2002) Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 95:6, 1346-1353
CrossRef718
Ola Bratt. (2002) Hereditary Prostate Cancer: Clinical Aspects. The Journal of Urology 168:3, 906-913
CrossRef719
T. Milan, P.K. Verkasalo, J. Kaprio, M. Koskenvuo, E. Pukkala. (2002) Malignant skin cancers in the Finnish Twin Cohort: a population-based study, 1976-97. British Journal of Dermatology 147:3, 509-512
CrossRef720
Karin Annertz, Harald Anderson, Anders Bi
CrossRef721
OLA BRATT. (2002) Hereditary Prostate Cancer: Clinical Aspects. The Journal of Urology906-913
CrossRef722
Kjell Bergfeldt, Bosse Rydh, Fredrik Granath, Henrik Grönberg, Lukman Thalib, Hans-Olov Adami, Per Hall. (2002) Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. The Lancet 360:9337, 891-894
CrossRef723
Liselotte Petersen, Gert G. Nielsen, Per Kragh Andersen, Thorkild I. A. Sorensen. (2002) Case-control study of genetic and environmental influences on premature death of adult adoptees. Genetic Epidemiology 23:2, 123-132
CrossRef724
Kirsi Lillberg, Pia K. Verkasalo, Jaakko Kaprio, Hans Helenius, Markku Koskenvuo. (2002) Personality characteristics and the risk of breast cancer: A prospective cohort study. International Journal of Cancer 100:3, 361-366
CrossRef725
Kari Hemminki, Charlotta Granstr
CrossRef726
Kari Hemminki, Xinjun Li. (2002) Cancer risks in twins: Results from the Swedish family-cancer database. International Journal of Cancer 99:6, 873-878
CrossRef727
K Hemminki, Y Jiang. (2002) Cancer risks among long-standing spouses. British Journal of Cancer 86:11, 1737-1740
CrossRef728
Torbjorn Soderstrom, Mia Wadelius, Swen-Olov Andersson, Jan-Erik Johansson, Sara Johansson, Fredrik Granath, Anders Rane. (2002) Pharmacogenetics 12:4, 307-312
CrossRef729
Kari Hemminki, Charlotta Granstr
CrossRef730
Kari Hemminki, Yongwen Jiang. (2002) Familial myeloid leukemias from the Swedish Family-Cancer Database. Leukemia Research 26:6, 611-613
CrossRef731
Peter R. Holt. (2002) Colorectal Cancer Prevention: Prospects for the First Decade of the 21st Century. Preventive Medicine 34:6, 563-566
CrossRef732
Kamila Czene, Paul Lichtenstein, Kari Hemminki. (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. International Journal of Cancer 99:2, 260-266
CrossRef733
Kamila Czene, Kari Hemminki. (2002) Kidney cancer in the Swedish Family Cancer Database: Familial risks and second primary malignancies. Kidney International 61:5, 1806-1813
CrossRef734
Henrik Frederiksen, Matt McGue, Bernard Jeune, David Gaist, Hanne Nybo, Axel Skytthe, James W. Vaupel, Kaare Christensen. (2002) Do Children of Long-Lived Parents Age More Successfully?. Epidemiology 13:3, 334-339
CrossRef735
Rolf Weitkunat, Manfred Wildner. (2002) Exploratory causal modeling in epidemiology. Journal of Clinical Epidemiology 55:5, 436-444
CrossRef736
Christopher J Hammond, Andrew R Webster, Harold Snieder, Alan C Bird, Clare E Gilbert, Tim D Spector. (2002) Genetic influence on early age-related maculopathy. Ophthalmology 109:4, 730-736
CrossRef737
B. Epe. (2002) Role of Endogenous Oxidative DNA Damage in Carcinogenesis: What Can We Learn from Repair-Deficient Mice?. Biological Chemistry 383:3-4, 467-475
CrossRef738
Mel Greaves. (2002) Cancer causation: the Darwinian downside of past success?. The Lancet Oncology 3:4, 244-251
CrossRef739
Mark A Moyad. (2002) Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture. Urology 59:4, 51-62
CrossRef740
Bengt Isaksson, Fredrik Jonsson, Nancy L. Pedersen, J
CrossRef741
Kari Hemminki, Yongwen Jiang. (2002) Familial and second gastric carcinomas. Cancer 94:4, 1157-1165
CrossRef742
Elizabeth C Miller, Edward Giovannucci, John W Erdman, Robert Bahnson, Steven J Schwartz, Steven K Clinton. (2002) Tomato products, lycopene, and prostate cancer risk. Urologic Clinics of North America 29:1, 83-93
CrossRef743
Sanjay Gupta, Hasan Mukhtar. (2002) Green tea and prostate cancer. Urologic Clinics of North America 29:1, 49-57
CrossRef744
F.M. Johnson. (2002) How many food additives are rodent carcinogens?. Environmental and Molecular Mutagenesis 39:1, 69-80
CrossRef745
Frederica P. Perera. 2002. Molecular Epidemiology and Cancer Risk. , 213-220.
CrossRef746
Alan J. Cameron, Jesper Lagergren, Christer Henriksson, Olof Nyren, G. Richard Locke *, Nancy L. Pedersen. (2002) Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology 122:1, 55-59
CrossRef747
D.E. Goldgar. (2002) Population aspects of cancer genetics. Biochimie 84:1, 19-25
CrossRef748
William B. Grant. (2002) A Multi-country Ecological Study of Dietary Risk and Risk-reduction Factors for Prostate Cancer. Journal of Nutritional and Environmental Medicine 12:3, 187-196
CrossRef749
William B. Grant. (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94:1, 272-281
CrossRef750
Allan Balmain. (2002) Cancer as a Complex Genetic Trait. Cell 108:2, 145-152
CrossRef751
Kari Hemminki, Xinjun Li. (2001) Familial colorectal adenocarcinoma from the Swedish family-cancer database. International Journal of Cancer 94:5, 743-748
CrossRef752
W. P. Bieger. (2001) Oxidativer Stress und Alter. Der Urologe B 41:4, 344-350
CrossRef753
K. Olden, J. Guthrie, S. Newton. (2001) A Bold New Direction for Environmental Health Research. American Journal of Public Health 91:12, 1964-1967
CrossRef754
Thomas M. Semkow, Pravin P. Parekh. (2001) PRINCIPLES OF GROSS ALPHA AND BETA RADIOACTIVITY DETECTION IN WATER. Health Physics 81:5, 567-574
CrossRef755
Bernt Lindelöf, Gunnar Eklund. (2001) Analysis of hereditary component of cancer by use of a familial index by site. The Lancet 358:9294, 1696-1698
CrossRef756
Kerry S. Courneya, Christine M. Friedenreich. (2001) Framework PEACE: An organizational model for examining physical exercise across the cancer experience. Annals of Behavioral Medicine 23:4, 263-272
CrossRef757
J. Hansen. (2001) Light at Night, Shiftwork, and Breast Cancer Risk. JNCI Journal of the National Cancer Institute 93:20, 1513-1515
CrossRef758
N. Tripodis, A. A. M. Hart, R. J. A. Fijneman, P. Demant. (2001) Complexity of Lung Cancer Modifiers: Mapping of Thirty Genes and Twenty-five Interactions in Half of the Mouse Genome. JNCI Journal of the National Cancer Institute 93:19, 1484-1491
CrossRef759
C. G. Daughton. (2001) Emerging pollutants, and communicating the science of environmental chemistry and mass spectrometry: Pharmaceuticals in the environment. Journal of the American Society for Mass Spectrometry 12:10, 1067-1076
CrossRef760
Johnni Hansen. (2001) Breast Cancer Among Women Who Work at Night. Epidemiology 12:5, 588-589
CrossRef761
C.C Schulman, S Ekane, A.R Zlotta. (2001) Nutrition and prostate cancer: evidence or suspicion?. Urology 58:3, 318-334
CrossRef762
Jeanette Falck Winther, Risto Sankila, John D Boice, Hrafn Tulinius, Andrea Bautz, Lotti Barlow, Eystein Glattre, Frøydis Langmark, Torgil R Möller, John J Mulvihill, Gudridur H Olafsdottir, Annukka Ritvanen, Jørgen H Olsen. (2001) Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. The Lancet 358:9283, 711-717
CrossRef763
N. Loman, O. Johannsson, U. Kristoffersson, H. Olsson, A. Borg. (2001) Family History of Breast and Ovarian Cancers and BRCA1 and BRCA2 Mutations in a Population-Based Series of Early-Onset Breast Cancer. JNCI Journal of the National Cancer Institute 93:16, 1215-1223
CrossRef764
A.C Povey, C.N Hall, A.F Badawi, D.P Cooper, M.J Guppy, P.E Jackson, P.J O’Connor, G.P Margison. (2001) Host determinants of DNA alkylation and DNA repair activity in human colorectal tissue: O6-methylguanine levels are associated with GSTT1 genotype and O6-alkylguanine-DNA alkyltransferase activity with CYP2D6 genotype. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 495:1-2, 103-115
CrossRef765
Chris D. Meletis. (2001) Cleansing of the Human Body: A Daily Essential Process. Alternative and Complementary Therapies 7:4, 196-202
CrossRef766
Peter N Schlegel. (2001) What’s new in urology11No competing interests declared.. Journal of the American College of Surgeons 193:2, 179-201
CrossRef767
Asta Försti, Qianren Jin, Lena Sundqvist, Magnus Söderberg, Kari Hemminki. (2001) Use of Monozygotic Twins in Search for Breast Cancer Susceptibility Loci. Twin Research and Human Genetics 4:4, 251-259
CrossRef768
S. Kong. (2001) Cyclin D1 Polymorphism and Increased Risk of Colorectal Cancer at Young Age. Journal of the National Cancer Institute 93:14, 1106-1108
CrossRef769
Daniel Desaulniers, Karen Leingartner, Jose Russo, Garth Perkins, Brock G Chittim, Michael C. Archer, Michael Wade, Jack Yang. (2001) Modulatory Effects of Neonatal Exposure to TCDD, or a Mixture of PCBs, p,p´-DDT, and p-p´-DDE, on Methylnitrosourea-Induced Mammary Tumor Development in the Rat. Environmental Health Perspectives 109:7, 739-747
CrossRef770
Romualdo Benigni, Rosa Giaimo, Domenica Matranga, Alessandro Giuliani. (2001) The Sex Difference in Tumor Incidence Is Related to the Female Condition: Models for Europe and Italy. Environmental Health Perspectives 109:7, 705-709
CrossRef771
Thomas W McDade, Linda S Adair. (2001) Defining the “urban” in urbanization and health: a factor analysis approach. Social Science & Medicine 53:1, 55-70
CrossRef772
Megan O. Schimpf, Steven E. Domino. (2001) Implications of the Human Genome Project for Obstetrics and Gynecology. Obstetric and Gynecologic Survey 56:7, 437-443
CrossRef773
Wenzhong Xiao, Peter J. Oefner. (2001) Denaturing high-performance liquid chromatography: A review. Human Mutation 17:6, 439-474
CrossRef774
INGER THUNE, ANNE-SOFIE FURBERG. (2001) Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Medicine and Science in Sports and Exercise 33:Supplement, S530-S550
CrossRef775
Jisheng Cui, Margaret P. Staples, John L. Hopper, Dallas R. English, Margaret R.E. McCredie, Graham G. Giles. (2001) Segregation Analyses of 1,476 Population-Based Australian Families Affected by Prostate Cancer. The American Journal of Human Genetics 68:5, 1207-1218
CrossRef776
Sudbø, Jon, Kildal, Wanja, Risberg, Björn, Koppang, Hanna S., Danielsen, Håvard E., Reith, Albrecht, . (2001) DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia. New England Journal of Medicine 344:17, 1270-1278
Full Text777
Chuanhui Dong, Kari Hemminki. (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. International Journal of Cancer 92:1, 144-150
CrossRef778
Kirsi Lillberg, Pia K. Verkasalo, Jaakko Kaprio, Lyly Teppo, Hans Helenius, Markku Koskenvuo. (2001) Stress of daily activities and risk of breast cancer: A prospective cohort study in Finland. International Journal of Cancer 91:6, 888-893
CrossRef779
Timothy J Key, Pia K Verkasalo, Emily Banks. (2001) Epidemiology of breast cancer. The Lancet Oncology 2:3, 133-140
CrossRef780
Brita Arver, Åke Borg, Annika Lindblom. (2001) First BRCA1 and BRCA2 Gene Testing Implemented in the Health Care System of Stockholm. Genetic Testing 5:1, 1-8
CrossRef781
C. B. Begg. (2001) The search for cancer risk factors: when can we stop looking?. American Journal of Public Health 91:3, 360-364
CrossRef782
Martin J. Blaser, James M. Musser. (2001) Bacterial polymorphisms and disease in humans. Journal of Clinical Investigation 107:4, 391-392
CrossRef783
K Hemminki, X Li, P Mutanen. (2001) Familial risks in invasive and in situ cervical cancer by histological type. European Journal of Cancer Prevention 10:1, 83-89
CrossRef784
Jussi P Elo, Tapio Visakorpi. (2001) Molecular genetics of prostate cancer. Annals of Medicine 33:2, 130-141
CrossRef785
I.I. Gottesman. 2001. Nature–Nurture Controversy. , 1297-1301.
CrossRef786
Olli-P Kallioniemi. (2001) Biochip technologies in cancer research. Annals of Medicine 33:2, 142-147
CrossRef787
Kari Hemminki, Pertti Mutanen. (2001) Genetic epidemiology of multistage carcinogenesis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 473:1, 11-21
CrossRef788
Amanda B. Spurdle, David M. Purdie, Penelope M. Webb, Xiaoqing Chen, Adele Green, Georgia Chenevix-Trench. (2001) The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer. Molecular Carcinogenesis 30:1, 71-78
CrossRef789
No authorship indicated. (2001) Award for Distinguished Scientific Contributions: Irving I. Gottesman.. American Psychologist 56:11, 864-878
CrossRef790
E OSTRANDER, J STANFORD. (2000) Genetics of Prostate Cancer: Too Many Loci, Too Few Genes. The American Journal of Human Genetics 67:6, 1367-1375
CrossRef791
Pinchas Cohen, David R. Clemmons, Ron G. Rosenfeld. (2000) Does the GH–IGF axis play a role in cancer pathogenesis?. Growth Hormone & IGF Research 10:6, 297-305
CrossRef792
(2000) Cancer, Genes, and the Environment. New England Journal of Medicine 343:20, 1494-1496
Full Text793
(2000) Will Genetics Revolutionize Medicine?. New England Journal of Medicine 343:20, 1496-1498
Full Text794
Manfred Wildner. (2000) Aristotle and the human genome project. The Lancet 356:9238, 1360
CrossRef795
Stephen A Bustin. (2000) Nurture leads the race in the control of cancer. Molecular Medicine Today 6:10, 380
CrossRef796
Hansjakob Müller, RA Eeles, Tom Wildsmith, Tony McGleenan, Susan Friedman. (2000) Genetic testing for cancer predisposition – an ongoing debate. The Lancet Oncology 1:2, 118-119
CrossRef797
Hoover, Robert N., . (2000) Cancer — Nature, Nurture, or Both. New England Journal of Medicine 343:2, 135-136
Full Text
- Letters
